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Abstract 
 
 
The E3 ubiquitin ligase RNF43 (RING finger protein 43) is an important negative 
modulator of the WNT signalling pathway that acts at the plasma membrane by targeting 
Frizzled and its co-receptor LRP for degradation. In the small intestine, this prevents 
uncontrolled expansion of the stem cell compartment and so it is essential to the 
maintenance of normal tissue homeostasis. However, despite its crucial role in fine-tuning 
the WNT pathway and its role as a tumour suppressor, it is unclear whether RNF43 has 
further binding partners and what their functional relevance is to the modulation of WNT 
signalling.  
Here, I describe the development of a new screening strategy which combines 
CRISPR/Cas9 technology with 3D-intestinal organoid culture for the identification of novel 
molecular interactors of RNF43. Overall, this study and the technology developed provide 
a tool to enable the detailed description of the mechanism of action of RNF43, which is 
important not only in order to increase our understanding of WNT pathway regulation but 
also to gain potential new insights into RNF43 paralogs, by analogy.  
The investigation of paralogs is crucial as RNF43 belongs to a newly identified family of 
E3 ubiquitin ligases, named the PA-RING family, whose members are still poorly 
characterised. The majority of PA-RING family members have not been linked to any 
signalling pathway, most of their targets are still unknown and in many cases their in vivo 
function has not been addressed. In this context, my work has specifically focused on the 
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investigation of the potential involvement of additional PA-RING family members in WNT 
pathway modulation and also on target identification for selected members. The results 
summarised in this dissertation show that no other PA-RING family member plays a 
prominent role in WNT pathway modulation aside from Rnf43 and its homologue Znrf3, 
however, different classes of adhesion molecules are likely to be regulated by certain of 
these E3 ligases.  
In conclusion, my work has contributed to unravelling previously unexplored aspects of 
this protein family, with particular regard to RNF43 and its mechanism of action. Thanks to 
this original approach, it was possible to identify potential new players involved either in 
membrane clearance of Frizzled or in RNF43 maturation. In particular, my thesis focuses 
on the characterisation of the role of DAAM in RNF43-mediated Frizzled internalisation.   
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Chapter 1 
 
 
 
 
Chapter 1  
Introduction  
 
 
 
1.1 Maintenance of homeostasis in the adult small 
intestine 
 
1.1.1 Architecture of the adult small intestine 
 
Adult tissue homeostasis is the basis for functional and structural maintenance of the 
organs of our body and is the result of a delicate balance between adult stem cell 
proliferation, quiescence and differentiation. Adult stem cells reside in specialized 
microenvironments, often called niches, where they receive and integrate multiple signals 
from neighbouring cells that contribute to the homeostatic regulation of the tissue.  
De-regulation of these processes results in either loss or hyperplasia of the stem cells, 
which may severely impact the physiology of the organ and even the whole organism 
(Simons & Clevers 2011).  
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The small intestine is considered to be an instrumental model for studying adult stem 
cells in health and disease (Clevers 2013), mainly due to the fact that it is the most rapidly 
self-renewing tissue in adult mammals and has a simple, repetitive architecture. It is 
comprised of the regular alternation of crypt-villus units and its turnover, allowing 
continuous cell replacement, is three to five days in the adult mouse. This feature is 
connected to the dual function of the organ as both a protective barrier against external 
agents and as a selectively permeable mucosa for the absorption of nutrients (Turner 
2009).  
The bottom of the intestinal invaginations, termed the crypts of Lieberkühn, is home to 
the so-called “stem cell zone” where Lgr5+ stem cells reside and divide approximately once 
every 24 hours, giving rise to transit-amplifying progenitor cells. Lineage tracing 
experiments labelling Lgr5+ cells and their progeny showed that “ribbons” of cells extended 
from the crypt base to the villus tip, labelling all of the differentiated epithelial cell types 
of the intestine (Barker et al., 2007): enterocytes, goblet cells, tuft cells, enteroendocrine 
cells and Paneth cells (Figure 1.1). Moreover, it was shown that Lgr5+ stem cells are 
characterised by long-term self-renewal potential and by the capacity to divide 
symmetrically, characteristics which establish neutral competition among the Lgr5+ 
population for the limited space at the bottom of the crypts (Snippert et al. 2010). This 
mechanism represents the basis for cell homeostasis in the small intestine, with a more 
recent analysis of cell dynamics by intravital imaging demonstrating how Lgr5+ stem cells 
residing in the upper border of the stem cell compartment can be passively pushed into 
the transit-amplifying region, following the division of underlying cells (Ritsma et al. 2014). 
These daughter cells can then migrate upwards, differentiate to diverse lineages and 
eventually undergo apoptosis, when they reach the tip of the villus, and be shed into the 
intestinal lumen (Barker, 2014). 
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If the bottom of the crypt is considered the “stem cell area” in the small intestine, villi, 
the digit-like protrusions flanking each crypt, constitute the “differentiated cell domain”. 
Intestinal progenitors can differentiate along two different lineages: absorptive and 
secretory. The former lineage consists of nutrient-absorbing enterocytes, while the latter 
comprises hormone-secreting enteroendocrine cells, mucin-producing goblet cells and 
Paneth cells, which produce lysozyme. The Notch signalling pathway has been shown to 
play a pivotal role in determining lineage specification in the gut and in balancing secretory 
versus absorptive cell type numbers (Stanger, Datar, Murtaugh, & Melton, 2005; 
VanDussen et al., 2012). More specifically, Notch inhibition is crucial for inducing secretory 
cell differentiation, particularly for goblet and Paneth cell formation (VanDussen et al. 
2012b), and the expression of its downstream effector, the helix-loop-helix transcription 
factor Math1, is also required, since the loss of Math1 causes depletion of all secretory cell 
Figure 1.1 The distribution of epithelial cell types in the mammalian small 
intestine. A villus with one of the crypts that contribute to renewal of its 
epithelium. Arrows indicate the upwards flow of cells out of the crypts. Stem 
cells lie near the crypt base, whilst above them there are transit-amplifying (TA) 
cells. In the neck of the crypt and on the villus lie post-mitotic differentiated cells 
(absorptive cells, goblet cells, tuft cells and enteroendocrine cells). Paneth cells 
are intermingled with stem cells at the bottom of the crypt. (Barker, 2014). 
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types without affecting the enterocyte population (Yang, Bermingham, Finegold & Zoghbi, 
2001). 
As previously mentioned, the differentiation process of these cells is concomitant with 
their upward migration, but Paneth cells are an exception to this rule. They are the only 
differentiated cell type that migrates back to the crypt, because, in addition to Notch 
inhibition, for their full maturation they also require a high WNT environment, which can 
be found only at the base of the crypt (van Es, Jay, et al. 2005). Most importantly, in that 
position Paneth cells come into direct contact with Lgr5+ stem cells and provide them with 
trophic support, contributing to a specialized microenvironment that constitutes the stem 
cell niche (Sato et al. 2011).  
 
 
1.1.2 The stem cell niche and signalling pathways  
 
The overall homeostasis of the small intestine is dependent upon the maintenance and 
tight regulation of the stem cell compartment at the bottom of the crypt, which not only 
harbours the Lgr5+ stem cells but also a type of granulated cell named after their 
discoverer, the Paneth cells. 
Paneth cells are the only terminally differentiated cells belonging to the secretory lineage 
that reside at the bottom of intestinal crypts, tightly intermingled with Lgr5+ stem cells as 
delineated very clearly in the Lgr5-GFP knock-in mouse (Barker et al., 2007). These cells 
have a very prominent role in maintaining the health and homeostasis of the intestine and 
their presence at the crypt base is not a coincidence; their major function is to actively 
secrete antimicrobial peptides for host protection and essential trophic factors for stem 
cell maintenance (Zasloff, 2002; Sato et al., 2011).  
Paneth cells were identified as a cellular component of the niche for Lgr5+ stem cells, as 
they produce several ligands and growth factors that are essential for the stem cell 
microenvironment, such as epidermal growth factor (EGF), Notch ligands, TGFα and WNT-
3 (Figure 1.2). These factors reinforce stem cell identity and cooperate in driving stem cell 
proliferation; genetic depletion of Paneth cells following Sox9 ablation results in the 
parallel loss of stem cells in vivo (Sato et al., 2011; Koo & Clevers, 2014). Similarly, complete 
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loss of the stem cell compartment can be observed following the genetic ablation of Notch 
and WNT ligands in Paneth cells in vivo (Notch ligands: Dll1 and Dll4) and in vitro (WNT 
ligand: WNT-3), respectively. Curiously, genetic removal of WNT-3 from the epithelium in 
vivo does not seem to affect stem cell maintenance (Pellegrinet et al. 2012; Farin et al. 
2012).  
 
 
  
 
On the one hand, these observations confirm that Paneth cells play a crucial role as part 
of the niche, however they also suggest a certain level of redundancy with other sources 
of key growth factors in vivo. As might be expected, the subepithelial mesenchyme 
surrounding the crypts is responsible for providing additional niche factors, such as WNT 
ligands other than WNT-3 (Valenta et al. 2016; Kabiri et al. 2014) and the crucial 
molecular family of WNT agonists, the R-spondins (Kang et al. 2016). The ligands BMP-2 
Figure 1.2 The stem cell niche in the adult small intestine. A) Schematic of the adult intestinal 
epithelium showing the spatial gradients of WNT, BMP and EGF signals along the crypt-villus axis. 
B) The stem cell niche at the bottom of the crypts are composed of Lgr5+ CBCs (Crypt base 
columnar cells) intermingled with Paneth cells, which provide them with signals for stem cell 
maintenance. C) EGF, Notch and WNT signalling pathways are essential for intestinal epithelial 
stemness, whereas BMP signalling acts as a negative regulator of stemness. For full WNT 
activation in the intestinal epithelium, R-spondin–Lgr4/5 signalling is required (Sato&Clevers, 
2013). 
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and -4 are also predominantly produced by stromal cells in the villi, where they suppress 
WNT proliferative signals and drive cell differentiation (Haramis et al. 2004); at the base 
of the crypts, the surrounding mesenchyme also has the function of neutralising those 
differentiation signals by secreting BMP inhibitors (Kosinski et al. 2007). 
Taken together, all the observations so far point to the canonical WNT signalling 
pathway as a major driver of crypt proliferation and stem cell maintenance in the adult 
intestinal epithelium. Many of the molecular players involved in this signalling pathway 
have been shown to have a key role in the maintenance of stem/progenitor cells. For 
example, WNT ligands themselves were identified as strong mitogens in the context of the 
intestinal epithelium (Korinek et al. 1998; van de Wetering et al. 2002). Moreover, genetic 
deletion of the WNT receptor Frizzled7 (Flanagan et al. 2015), β-catenin (Ireland et al. 2004) 
or the transcription factor TCF4 (van Es et al. 2012) leads to the loss of proliferating 
intestinal stem/progenitor cells. By contrast, Apc mutation or β-catenin activation causes 
the constitutive activation of WNT signalling and the subsequent formation of intestinal 
adenomas (Sansom et al. 2004;  2007).  
Therefore, the activity of the WNT signalling pathway in regulating intestinal stem cells is 
a double-edged sword, requiring robust control to maintain a delicate homeostatic 
balance, and indeed one of the main focuses of this thesis is the investigation of the 
regulatory mechanisms operating to ensure appropriate levels of WNT activity. 
In conclusion, the orchestration of these different signalling pathways ultimately 
determines the balance of proliferation, quiescence and differentiation in the adult 
intestine, and it was the recreation of this special microenvironment in vitro that was the 
key component that allowed Sato and colleagues to establish a self-sustaining and self-
organising three-dimensional intestinal culture system (Sato et al. 2009).  
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1.2 Modelling the small intestine in vitro 
  
1.2.1 Establishment of intestinal organoid culture 
 
For decades, the technical difficulty of expanding somatic cells derived from adult 
primary tissues in vitro has hampered our understanding of fundamental physiological 
processes; the vast majority of primary cells could not be propagated in culture for long 
periods due to the onset of replicative senescence. The lack of appropriate culture 
conditions for the maintenance of progenitor cell populations prevented the expansion of 
primary tissues in vitro.        
Thanks to the knowledge acquired from in vivo studies regarding the growth factor 
requirements and signalling pathway crosstalk within the intestinal stem cell niche, in 2009 
it was finally possible to establish a murine, long-term, 3D culture system starting from a 
single Lgr5+ stem cell and using Matrigel as an ECM substitute (Sato et al. 2009). These 
multicellular structures were termed “organoids” or “mini-guts” because of their  
resemblance to the tissue of origin and, most importantly, they could be maintened for 
over a year without the cells undergoing senescence or suffering genetic instability (Huch 
& Koo 2015). 
It is noteworthy that analogous cultures were later established from a different source by 
directing the differentiation of human and mouse embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSCs) towards an intestinal tissue identity (Spence et al. 2011). 
As mentioned above, indispensable growth factors for the expansion and maintenance 
of the stem cell pool in the small intestine include WNT, EGF and BMP inhibitors (Sato & 
Clevers 2013); similarly, the WNT agonist R-spondin1, EGF and the BMP inhibitor Noggin 
were identified as essential constituents of organoid culture medium. 
Gene expression analysis conducted on Paneth cells has confirmed that the spectrum of 
growth factor components secreted by these cells in vivo (e.g. EGF, WNT-3) is mirrored in 
the composition of organoid culture medium (Sato et al. 2011). In particular, WNT-3 was 
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observed to be an essential factor in vitro, since WNT-3-depleted Paneth cells cannot 
support organoid growth and maintenance over time (Farin et al. 2012).  
Another fundamental pecularity of this novel culture system is that it consists of 3D, 
self-organising structures which recapitulate the architecture of the adult small intestine 
and contain all of the cell types found there (Ootani et al. 2009; Sato et al. 2009); for 
instance, it is possible to identify the presence of crypt and transit-amplifying regions in 
the organoid bud regions, at the end of which Lgr5+ stem cells and Paneth cells are located, 
and the lumen of the organoid is lined by a villus domain containing all differentiated cell 
types (Figure 1.3). Analogous to the intestine, cells are shed into the lumen of the organoid 
after completion of their life cycle approximately every 5 days, after which the organoids 
will need passaging.  
 
 
 
 
In addition, the organoid cultures recapitulate not only the structural organisation of the 
intestine but also its physiology. To demonstrate that organoids retain a high degree of 
fuctional similarity to their tissue of origin, Yui and collegues transplanted fluorescently-
labelled intestinal organoids into a mouse model of enterocolitis and showed that they 
could engraft and functionally replace the damaged tissue (Yui et al. 2012).  
For all of these reasons, organoid cultures can be considered an unprecedented tool to 
bridge the gap between in vivo models and 2D in vitro culture systems. Given their 
physiological accuracy and robustness, organoids allow the prediction of the in vivo role of 
Figure 1.3 Schematic structure of a small intestinal 
organoid. These “mini-guts” preserve the original in 
vivo architecture of the small intestine by segregating 
into crypt domains, containing Lg5+ stem cells and 
Paneth cells, and villus domains, containing several 
differentiated cell types such as goblet cells, 
enteroendocrine cells and enterocytes. Organoids 
have a central lumen which accumulates the debris 
from differentiated cells when they undergo 
apoptosis. (Picture adapted by Academilib.com from 
Roeselers et al, 2013). 
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a gene, representing a much faster and more affordable approach than traditional mouse 
genetic studies. Despite being slightly more labour-intensive and time-consuming than 
conventional 2D cell culture, organoid culture systems have rapidly been applied globally 
to various problems and fields of study.   
 
 
 
1.2.2 Applications of organoid technology 
 
The arrival of organoid technology has represented a major breakthrough for many 
different fields due to its versatility and physiological relevance; from the study of adult 
stem cells and tissue development to the screening of new compounds for cancer 
treatment, intestinal organoids have turned out to be an excellent model system for a wide 
range of applications. 
An exemplary case is the application of organoid culture to the investigation of cell 
lineage decisions in vitro; Yin and co-workers exploited Lgr5+ stem cell plasticity in vitro to 
shift organoid cell composition to either mainly enterocytes or secretory cells simply by 
modulating WNT and Notch signalling pathways using small molecule inhibitors (Yin et al. 
2014). In addition to the study of stem cell lineage selection, organoids have also been 
fruitfully employed in the investigation of the tissue microenvironment in terms of 
interactions between the intestinal epithelium and the intraepithelial immune cells, such 
as T lymphocytes (Nozaki et al. 2016). 
Given the remarkable physiological relevance of organoids, in recent years there has also 
been a growing interest in applying these 3D culture systems to the study of 
pathophysiology of host-microbe interactions; for instance, many groups have modelled 
bacterial infectious diseases, such as Salmonella infection (Zhang et al. 2014), as well as 
enterovirus replication (Finkbeiner et al. 2012).  
In terms of disease modelling in vitro, most efforts have been directed towards the 
establishment of more accurate and reliable cancer models than traditional cancer cell 
lines. This goal has been pursued from two main directions: firstly, advanced genetic 
engineering tools have allowed the introduction of a combination of mutations to mimic 
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the process of carcinogenesis (Drost et al. 2015; Matano et al. 2015), and secondly, the 
possibility of deriving human organoid cultures directly from patient tumour biopsies has 
opened the way towards a better characterisation of cancer subtypes and potential 
treatments. In this respect, the generation of a colorectal cancer organoid “biobank” gave 
van de Wetering and colleagues the opportunity to characterise different types of 
mutational landscapes, potentially associate those to a particular drug sensitivity via high-
throughput drug screens, and thus address the problem of tumour heterogeneity (van de 
Wetering et al. 2015). The same approach for drug validation and discovery using human 
organoid cultures has been applied to other tissues as well, such as the liver (Sampaziotis 
et al. 2015; Meng 2010), and it holds great promise for providing a new frontier in 
personalised medicine. 
To conclude, it is clear that organoid technology has rapidly revolutionised multiple 
aspects of basic and translational research, and it is no coincidence that some of its major 
accomplishments were possible thanks to a series of tools for genome engineering that will 
be the next major topic of consideration. 
 
 
1.2.3 Genetic manipulation of organoids 
 
The ability to combine intestinal organoids as a model system with the latest 
technological advances in genetic engineering is enabling researchers to modulate the 
expression of genes of interest and explore the function of unknown genes under near 
physiological conditions. Such powerful approaches based on the genetic manipulation of 
organoids can be exploited for various purposes: to generate stable transgenic organoid 
lines, to model cancer or other pathologies in vitro by disrupting or altering a certain 
gene(s) or even to restore the wild-type sequence of a mutated gene. 
The need to investigate gene function in vitro has led to the development of a series of 
protocols based on retroviruses (Koo, Stange, et al. 2012; Koo et al. 2013)  or lentiviruses 
(Miyoshi & Stappenbeck 2013) to perform inducible overexpression or knock down of a 
gene of interest. In this way, transgenes are provided by viral transduction and those cells 
with the modification randomly integrated in their genome are selected by the addition of 
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antibiotics. One alternative to virus-based methods for stable genome integration is the 
piggyBac transposon system, which was utilised by Fujii et al. in 2015 in combination with 
electroporation as a delivery system. 
Besides the generation of stable transgenic lines, efforts have also been directed towards 
developing efficient strategies for gene knock-out in organoids, and the introduction in 
2012 of CRISPR/Cas9 technology for genome editing represented a significant 
breakthrough in the field. CRISPR/Cas9 gene editing is a simple and rapid methodology for 
the disruption of a specific gene, as well as its precise editing (Ran et al. 2013), and it will 
be discussed in greater detail in the next sections. The present section focuses instead on 
notable examples of the pioneering application of this cutting-edge technology to intestinal 
organoid culture by Schwank and colleagues. As a proof of principle, they first knocked out 
Apc, a component of the β-catenin destruction complex and negative regulator of the WNT 
pathway, and showed that mutated organoids overcame their dependency upon both 
WNT and R-spondin for their growth (Schwank et al. 2013). This highlighted a major 
advantage of the organoid system, namely the possibility to easily screen for genetic 
modifications by phenotypic analysis. Following this proof of principle, the authors utilized 
CRISPR/Cas9 technology for site-specific gene modification by providing a DNA template 
to correct the mutant CFTR locus by homologous recombination in intestinal organoids 
derived from cystic fibrosis patients. More recently, a similar approach for knock-in 
purposes was exploited to introduce driver colorectal cancer mutations into human 
intestinal organoids in order to model ex vivo the adenoma-carcinoma sequence (Matano 
et al. 2015). 
Lastly, our group has also contributed to the diversity of tools available for genetic studies 
in organoids with the development of a CRISPR-concatemer vector for simultaneous 
multiple gene knockout (Andersson-Rolf et al. 2016); this system is particularly useful in 
simultaneously targeting a gene together with its paralogues, as well as increasing the 
chances of single gene knockout by using multiple gRNAs targeting the same gene.  
Taken together, these examples of tools for the genetic manipulation of organoids point 
out the great utility of combining novel technologies, especially when conducting loss-of-
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function studies whose speed and feasibility have recently been boosted by the 
introduction of the CRISPR/Cas9 system. 
 
 
 
1.3 CRISPR/Cas9 technology for genome editing  
 
1.3.1 CRISPR/Cas9 for knockout and precise gene editing   
 
Reverse genetics is a widely used approach in the investigation of gene function,  
enabling scientists to assess how genotype influences phenotype. Loss-of-function studies 
in particular can provide conclusive information on the role of a gene and greatly 
contribute to our knowledge of diverse biological processes. For this reason, in the past 
decade, a number of powerful methods for specific gene inactivation or modification began 
to be widely available and have been used in a wide range of applications and model 
systems.  
Prior to the development of CRISPR/Cas9-mediated gene editing, zinc-finger nucleases 
(ZFNs) and transcription activator-like effector nucleases (TALENs) were the most efficient 
and versatile strategies for genome engineering. As a common feature, both of these 
technologies rely on protein/DNA recognition and are centred on site-specific designer 
nucleases consisting of sequence-specific DNA-binding domains fused to a generic DNA 
cleavage domain (Mussolino et al. 2011; Carroll 2011). Similar to the CRISPR/Cas9 system, 
ZFNs and TALENs can induce targeted double-strand breaks (DSBs) in the genome that can 
activate the DNA damage response and be repaired either via error-prone non-
homologous end joining (NHEJ) or via homology-directed repair (HDR), where a suitable 
DNA template is available (Wyman & Kanaar 2006). 
In recent years the introduction of CRISPR/Cas9 technology has revolutionised the 
genome-editing field by emerging as the latest and fastest advance for introducing site-
specific genetic alterations (Mali et al. 2013). In contrast to ZFNs and TALENs, the 
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CRISPR/Cas9 system is based on the formation of a ribonucleotide complex between an 
RNA molecule and the target DNA, which greatly simplifies the target design.  
CRISPR is an acronym that stands for ‘clustered, regularly interspaced, short, palindromic 
repeats’ and Cas9 is the CRISPR-associated endonuclease that is targeted to a specific 
genomic region by a single guide RNA (sgRNA) which is complementary to the target DNA 
sequence. This technology was developed by exploiting key components of the acquired 
immune system that protects prokaryotic cells against foreign DNA. In bacteria, short 
exogenous DNA fragments, termed “spacers”, are integrated into the genome at the 
CRISPR locus to produce CRISPR RNAs (crRNA). These molecules anneal to the 
transactivating crRNAs (tracrRNAs) that are bound to Cas9 and the Cas9-crRNA-tracrRNA 
complex is then responsible for site recognition, DNA binding and cleavage. It has been 
observed that Cas9 requires a “seed” sequence in the crRNA  for DNA recognition as well 
as a conserved protospacer adjacent motif (PAM) upstream of the crRNA binding region 
(Jinek et al. 2012). Our understanding of the system has been exploited to adapt the type 
II CRISPR system from S. pyogenes into a flexible and efficient universal platform for RNA-
programmable genome editing. In the absence of a DNA template for homologous 
recombination, the Cas9 endonuclease generates double-strand breaks that are then 
ligated back together by the DNA repair machinery via NHEJ; since this process is inherently 
error-prone, the insertion or deletion of a nucleotide(s) frequently occurs, resulting in 
frameshift mutations (Ran et al. 2013).  
Alternatively, when a donor vector is co-delivered together with gRNAs and Cas9, it is 
possible for repair to occur via homologous recombination, which therefore allows precise 
gene editing through knock-in (Figure 1.4).  
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One of the most important characteristics of this new approach is its versatility as 
proven by its successful application to a number of different model systems, e.g. to 
perform gene knockout or modification in human and mouse cells (Cho et al. 2013; Xue et 
al. 2016; Wang et al. 2013), zebrafish (Hwang et al. 2013) and Drosophila (Yu et al. 2013). 
Moreover, Gilbert and colleagues demonstrated the modulation of gene expression using 
the CRISPR/Cas9 system by fusing an enzymatically dead Cas9  to transcription effector 
domains with distinct regulatory functions, either activators or inhibitors (Gilbert et al. 
2013). In this way, the authors were able to stably modulate gene expression in both 
human and yeast cells. 
Given its simplicity and speed, the CRISPR/Cas9 approach soon became the tool of choice 
for genome-wide knockout screens, representing a valid alternative to RNA interference 
(Sanjana et al. 2014), and different genome-scale gRNA libraries were generated to target 
genes in mammalian cells (Koike-Yusa et al. 2014; Chen et al. 2015) and Drosophila (Bassett 
et al. 2015).  Lastly, many groups have also developed multiplex CRISPR strategies to 
achieve the knockout of multiple genes at the same time in a variety of model systems: 
Figure 1.4 Schematic representation of CRISPR/Cas9 mechanism of action. Cas9 is targeted to a specific 
genomic region by the sgRNA and cleaves the DNA, generating double-strand breaks. These breaks can be 
repaired in one of two ways: via error-prone NHEJ, in which the DNA repair machinery ligates the DNA ends 
back together, so randomly generating indel mutations, or via HDR, when a repair template is provided for 
homologous recombination. While the NHEJ pathway can lead to gene knockout by the introduction of a 
premature stop codon, HDR allows precise gene editing (Ran et al, 2013). 
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human cell lines (Sakuma et al. 2014; Kabadi et al. 2014), intestinal organoids (Andersson-
Rolf et al. 2016), zebrafish (Yin et al. 2015) and Drosophila (Port et al. 2014). 
In summary, this section has highlighted some of the most crucial aspects of the CRISPR 
revolution and how it has changed our approach to genetic studies; the next paragraph will 
instead focus on how this technology has been employed for disrupting gene expression in 
a conditional manner. 
 
 
 
1.4 WNT signalling pathways 
 
All of the technologies described in detail so far for modelling the small intestine in vitro 
and for gene editing have formed a major part of my PhD studies investigating the 
regulatory mechanisms of the WNT signalling pathway, a fundamental player in the 
maintenance of homeostasis of intestinal stem cells (Clevers et al. 2014). 
WNTs are a class of 19 evolutionarily conserved, secreted lipoglycoproteins in mammals 
that are involved in a variety of biological processes, such as proliferation, differentiation, 
migration and control of embryonic development, as well as adult homeostasis (Niehrs 
2012). WNTs can bind to a multitude of Frizzled receptors and co-receptors and their 
combinatorial binding determines the downstream signalling events that subsequently 
occur (Dijksterhuis et al. 2014). These have been classified into two main branches: a β-
catenin-dependent, or “canonical”, WNT pathway and a β-catenin independent, or “non-
canonical”, pathway (Semenov et al. 2007; Macdonald et al. 2007). Although some WNTs 
preferentially activate the “canonical” pathway over the “non-canonical”, and vice versa, 
the signalling outcome is predominantly dependent upon the cellular context. 
This section will describe the essential traits of both β-catenin dependent “canonical” 
and β-catenin independent “non-canonical” WNT signalling pathways (Figure 1.5). 
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Figure 1.5 Overview of the different WNT signalling pathways. WNT ligands can transduce their 
signal through two types of pathway: the WNT/β-catenin canonical pathway and the non-
canonical pathways. The former is characterised by the binding of WNT to Frizzled (Fz) and its 
co-receptors Lrp5/6. This leads to the recruitment of DVL to the plasma membrane and inhibition 
of the destruction complex, allowing the translocation of β-catenin to the nucleus and its binding 
to the transcription factors TCF/LEF, inducing the expression of target genes (left). The non-
canonical pathways mainly consist of two branches (right); in the Calcium pathway, WNT binding 
to Fz leads to DVL recruitment and thence to an increase in cytosolic Ca2+ that in turn activates a 
series of calcium-dependent kinases (CaMKII). In the PCP pathway, transmembrane proteins like 
Vangl, Celsr and PTK7 assist Wnt docking to Fz that determines the recruitment and activation of 
the intracellular proteins DVL, Prickle and DAAM. This leads to the activation of the small GTPases 
Rho and Rac that in turn stimulate JNK to promote actin cytoskeleton remodelling. Figure 
adapted from Aviles et al. 2013. 
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1.4.1 The “canonical” WNT/β-catenin pathway 
 
The “canonical” WNT/β-catenin pathway is the most well-studied of the two pathways 
and is characterised by WNT interaction with Frizzled and its co-receptor LRP5/6.  
In the absence of WNT stimulation, β-catenin is sequestered in the cytoplasm by the so-
called “destruction complex”, whose function is to target it for degradation. This complex 
is formed from a number of different proteins, such as adenomatosis polyposis coli (APC), 
AXIN, glycogen synthase kinase 3 (GSK3) and casein kinase 1 (CK1). When β-catenin is 
recruited by the complex it is phosphorylated by GSK3 and CK1, leading to its subsequent 
ubiquitination by β-TrCP, which signals it for proteasomal degradation (Yanagawa et al. 
2002; Behrens et al. 1998).  
Conversely, when WNT ligands are present, they bind to the cysteine-rich domain (CRD) of 
Frizzled and to its co-receptor LRP5/6 (MacDonald & He, 2012; Janda et al. 2012). The 
formation of this ligand-receptor complex is followed by conformational changes that lead 
to the recruitment of the scaffolding protein Dishevelled (DVL) to take part in the 
“signalosome”. As a consequence, LRP6 is phosphorylated and this induces a dramatic 
relocalisation of AXIN from the cytoplasm to the plasma membrane, followed by the 
dismantling of the β-catenin destruction complex (Bilic et al. 2007). In this way, β-catenin 
is stabilised and can translocate into the nucleus, where it associates with the transcription 
factors TCF/LEF (T cell factor/lymphoid enhancer-binding factor) to drive the expression of 
WNT target genes, amongst which Cyclin D1, c-myc, Axin2 and Lgr5 are some of the most 
well-known (Tetsu & McCormick 1999; He et al. 1998; Jho et al. 2002; Barker et al. 2007). 
A widely used method to measure WNT/β-Catenin activity levels is the TOP-flash assay, 
which is based on a TCF/LEF luciferase reporter and provides a direct readout for the 
activity of the canonical pathway  (Molenaar et al. 1996). 
Given its high degree of conservation throughout evolution, it comes as no surprise that 
the canonical WNT pathway acts as a key mediator in many cellular processes; above all, 
its centrality in regulating stem cell differentiation and proliferation emerges in the context 
of both embryonic and adult stem cells (Reya & Clevers 2005). Interestingly, whilst some 
groups have shown that WNT signalling prevents the differentiation of mouse ESCs into 
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epiblast stem cells (ten Berge et al. 2011), others have reported that an increase in WNT/β-
catenin activity has been observed before these cells exit from pluripotency and 
commence lineage specification (Turner et al. 2014). As previously discussed, WNT 
signalling is also fundamental for adult stem cell self-renewal and the maintenance of 
homeostasis in the intestine (Barker et al. 2007). In addition, it also plays a crucial role in 
the homeostasis of other adult tissues, such as the hair follicle (Lim et al. 2016) and the 
mammary gland (van Amerongen et al. 2012). In fact, linage tracing approaches using the 
Axin2–CreERT2 mouse line have highlighted the importance of an autocrine WNT/β-
catenin signalling loop in the maintenance of a quiescent stem cell population in the hair 
follicle bulge, and similarly in the mammary epithelium it was shown that Axin2+ progenitor 
cells could contribute to both luminal and basal epithelial lineages.  
Therefore, it is of primary importance that WNT/β-Catenin activity is tightly regulated 
in order to avoid an uncontrolled expansion of the stem cell pool that could lead to 
tumorigenesis; in this regard, the role of the E3 ubiquitin ligase RNF43 acquires a particular 
relevance in terms of tuning the membrane levels of Frizzled and will be discussed in detail 
later on. 
 
 
1.4.2 β-catenin independent WNT signalling pathways 
 
The term “non-canonical”, or β-catenin independent, WNT signalling refers to a diverse 
range of pathways that are triggered by the interaction of WNT ligands with Frizzled and 
alternative co-receptors to the LRPs (van Amerongen et al. 2008). Importantly, these 
pathways employ different downstream signalling modalities which do not rely on the 
transcriptional role of β-catenin. 
One example of a β-catenin-independent signalling cascade is the WNT-Ca2+ pathway. 
It was first observed in the zebrafish embryo, where WNT stimulation caused an increase 
in cytosolic calcium levels (Slusarski et al. 1997). Following WNT docking to Frizzled, 
heterotrimeric G proteins associated with the receptor are activated and, consequently, 
this stimulates phospholipase C (PLC) to activate the cascade responsible for Ca2+ release 
Chapter 1
19 | P a g e  
 
in the cytoplasm. Lastly, this calcium increase activates calmodulin-dependent kinase II 
(CAMKII) that mediates the final transcriptional events (De 2011). Dysregulation in this 
pathway has been associated with cancer, inflammation and neurodegenerative diseases. 
The other well-known β-catenin-independent pathway is the WNT/planar cell polarity 
(PCP) pathway that has been better characterised when compared to WNT/ Ca2+ signalling. 
In this case, WNT signals are transduced through the interaction of the ligand with Frizzled 
and its co-receptors ROR1/2 or PTK7, and this induces the recruitment of intracellular 
proteins like DVL, DAAM and Prickle to activate the small GTPases RAC1 and RHOA. These 
molecules stimulate, respectively, the JUN N-terminal kinase (JNK) and RHO kinase, and as 
a consequence the actin cytoskeleton is remodelled and cell shape and polarity are 
redefined (Oishi et al. 2003). In fact, the PCP pathway plays a major role in those 
morphogenetic processes occurring during vertebrate embryonic development by 
governing cell migration during gastrulation and neural tube closure (Simons & Mlodzik 
2008; Ho et al. 2012). 
This pathway was shown to have an antagonistic relationship to canonical WNT/ β-catenin 
signalling; for instance, it was observed in vitro that the PCP-associated WNT-5A signal 
antagonises the β-catenin-dependent signalling cascade by competing with WNT-3A for 
Frizzled binding and by inhibiting Wnt-3A-dependent LRP6 phosphorylation (Sato et al. 
2010). Nevertheless, it is not appropriate to draw a neat separation between “canonical” 
and “non-canonical” WNT pathways, given that the same ligands and receptors can engage 
various signalling cascades depending on the cellular context and also considering that 
some components are shared between the different pathways, such as Dishevelled (Gao & 
Chen 2010). In this regard, since both WNT/β-catenin and PCP pathways are mediated by 
Frizzled receptors, it is reasonable to assume that both signalling cascades are subject to 
the same mechanisms of regulation at the level of the receptor (Hao et al. 2012).   
In the next paragraph, I will discuss the role of Rnf43 and its homologue ZnrF3 in regulating 
the turnover of Frizzled, which is a critical node in the global modulation of the activity of 
WNT-driven signalling pathways. 
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1.5 RNF43 & ZNRF3, novel key players in WNT pathway   
regulation 
 
1.5.1 Rnf43 & Znrf3 are important tumour suppressors in the small intestine  
 
Aberrant WNT signalling activity has been widely associated with many diseases, 
including cancer. For this reason, it is of the utmost importance that the final signalling 
output of WNT cascades is tightly controlled by feedback mechanisms.  
In 2012, two groups independently identified a novel class of important regulators of WNT-
driven signalling pathways: two E3 ubiquitin ligases, RNF43 (RING finger protein 43) and its 
paralogue ZNRF3 (Zinc/RING finger protein 3), which target the Frizzled family receptors 
for degradation, hence inhibiting WNT signalling responses  (Koo et al. 2012; Hao et al. 
2012).   
Rnf43 and Znrf3 are both WNT target genes encoding transmembrane proteins containing 
a Really Interesting New Gene (RING) domain that, via negative feedback, promote 
endocytosis-mediated degradation of WNT receptors and co-receptors in an 
ubiquitination-dependent manner (Figure 1.6 A-C). The internalised molecules are then 
degraded in the lysosome, thus ensuring optimal surface levels of Frizzled and attenuating 
WNT signalling activity. 
In addition to the intracellular RING domain, which has E3 ligase activity, RNF43 and ZNRF3 
also contain a protease-associated domain or PA, an extracellular domain for protein- 
protein interactions. A recent study reported that this region might be involved in target 
recognition prior to ubiquitination by interacting with the extracellular, cysteine-rich 
domain (CRD) of Frizzled (Tsukiyama et al. 2015). Interestingly, these proteins belong to an 
evolutionarily conserved family of transmembrane E3 ubiquitin ligases, the PA-RING family, 
that are all characterised by the same domain organisation and which will be described in 
detail later on. 
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In situ hybridization experiments showed that both Rnf43 and Znrf3 are uniquely 
expressed at the bottom of intestinal crypts in Lgr5+ stem cells, and gene expression 
profiling revealed that their expression correlates with that of intestinal stem cell genes, 
such as Lgr5, Olfm4 and Ascl2 (Figure 1.7). In fact, in this context, mouse genetic studies 
have demonstrated that these two genes have a fundamental role as tumour suppressors: 
ablation of both Rnf43 and Znrf3 (R&Z) in the intestinal epithelium resulted in the rapid 
formation of adenomas (Figure 1.8b) that ultimately develop into tumours, due to hyper-
activation of WNT signalling (Figure 1.8d). These tumours were found to be strictly 
dependent upon WNT for their growth, as the inhibition of WNT secretion resulted in 
growth arrest (Koo et al. 2015). It is noteworthy that when compared to other known 
negative modulators of WNT signalling, R&Z mutants were the first to show rapid 
tumorigenesis at a rate which phenocopied Apc mutants, so demonstrating their 
physiological importance. In fact, it is important to recall that Apc mutations are 
Figure 1.6 Model of negative feedback regulation of the WNT/β-catenin pathway by RNF43 and ZNRF3.  
A) Resting stage (no WNT stimulation), in which the destruction complex degrades cytoplasmic β-catenin 
and WNT signalling is shut off. B) Upon WNT stimulation, Frizzled and LRP5/6 receptors recruit destruction 
complex components to the plasma membrane, so causing its inactivation; this leads to the accumulation of 
β-catenin and its subsequent translocation to the nucleus, where it induces gene expression of WNT target 
genes, such as Rnf43/Znrf3 and Lgr5 C) RNF43 and ZNRF3 reach the plasma membrane where they 
ubiquitinate Frizzled, and consequently promote its endocytosis and lysosomal degradation. Frizzled 
clearance from the cell surface renders the cell less sensitive to WNT stimulation and, in this way, WNT 
signalling is attenuated. 
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responsible for familiar adenomatous 
polyposis (FAP) as wells as an increased risk of 
sporadic colorectal cancers (Rowan et al. 
2000). 
The mechanistic importance of RNF43 and 
ZRNF3 as E3 ligases is not an isolated case 
when considering the role of this class of 
enzymes in the regulation of stem cell-niche 
interactions; a further example is the E3 
ubiquitin ligase Mib1 (Mind-bomb-1), which is 
known to have an analogous role in Notch 
signalling by promoting the endocytosis of the 
Notch ligands Delta and Jagged in niche cells, 
resulting in the activation of Notch signalling in stem cells (van Es et al. 2005; Koo et al. 
2005; Koo et al. 2007).  
Given their fundamental role in modulating WNT activity in intestinal stem cells, RNF43 
and ZNRF3 are considered essential for tissue homeostasis by preventing uncontrolled 
expansion of the stem cell compartment. However, it is also necessary that, in turn, R&Z 
activity is precisely controlled in order to avoid the loss of the stem cell compartment over 
time. The R-spondins (RSPO), WNT pathway agonist ligands, play a key role in the 
regulation of RNF43/ZNRF3 turnover, together with their concomitant receptors LGR4/5/6. 
R-spondins are soluble niche factors that can bind to the LGR5 receptor and induce the 
formation of a ternary complex with R&Z (Zebisch et al. 2013; Hao et al. 2012). Recently, it 
has been shown that these events are instrumental for the membrane clearance of RNF43 
and ZNFR3, resulting in enhanced WNT responsiveness (de Lau et al. 2014); accordingly, 
the double KO of Lgr4 and Lgr5 results in intestinal crypt loss (de Lau et al. 2011). 
In conclusion, RNF43 and ZNRF3 can be classified as essential negative modulators of 
the WNT signalling pathway that act at the receptor level, preventing uncontrolled 
expansion of the stem cell compartment and providing a major contribution to tissue 
homeostasis. Therefore, it comes as no surprise that mutations affecting components of 
 
Figure 1.7 Lgr5+ stem cell genes: Rnf43 and 
Znrf3. In situ hybridization showing expression of 
Rnf43 (A), Znrf3 (B) and Lgr5 (C) in the mouse 
small intestinal crypt (dotted line indicates the 
intestinal epithelial lining of the crypt). Crypt Base 
Columnar cells (CBC cells) in between Paneth cells 
are indicated with red arrows. Scale bars, 20 mm. 
(Koo et al., 2012). 
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the RNF43/LGR5/RSPO axis can frequently be found in different types of cancer (Hao et al. 
2016). 
  
Figure 1.8 Rnf43 and Znrf3 compound mutant mouse phenotypes in the small intestine. 
Removal of both R&Z in the small intestine leads to strongly increased cell proliferation, as 
demonstrated by Ki67 staining (a, b), WNT/β-catenin activation (c, d) and stem cell (e, f) and 
Paneth cell (g, h) metaplasia, marked respectively by Olfm4 and Cryptidin6 expression (Koo et 
al, 2012).  
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1.5.2 RNF43 and R-spondin are often mutated in cancer  
 
Alterations shifting the balance between the RNF43-mediated negative feedback loop and 
R-spondin-mediated positive modulatory activity towards augmented WNT signalling can 
often be encountered in a variety of human tumours. In particular, those cancer types that 
have been previously characterised as being driven by uncontrolled WNT/ β-catenin 
activity are also likely to harbour abnormalities in RNF43 or RSPO; it is also worth 
mentioning that Rnf43 mutations were found to be mutually exclusive with Apc and β-
catenin mutations (Giannakis et al. 2014), confirming their redundant roles in the outcome 
of WNT pathway activation. 
Inactivating somatic mutations in Rnf43 were observed in over 18% of colorectal 
adenocarcinomas and endometrial carcinomas (Giannakis et al. 2014) and in 21% of 
mucinous ovarian carcinoma samples (Ryland et al. 2013), as well as in gastric (K. Wang et 
al. 2014) and pancreatic cancers (Jiao et al. 2014). In addition, mutations in RNF43 were 
also reported to be present in benign pancreatic tumours, intraductal papillary mucinous 
neoplasm and mucinous cystic neoplasm (Wu et al. 2011) and in 9.3% of 
intrahepatic cholangiocarcinomas (Ong et al. 2012). 
According to the Catalogue Of Somatic Mutations In Cancer (COSMIC), the most common 
mutational events in Rnf43 consist of nonsense and frameshift mutations that lead to a 
truncated protein, which supports the classification of Rnf43 as a tumour suppressor. 
Notably, two main hotspot mutations causing frameshifts were identified, G659fs and 
R117fs, representing, respectively, 41.7% - 48.0% and 8.3% - 12.0% of RNF43 mutations in 
colon and endometrial cancer (Giannakis et al. 2014).  
Another interesting observation is that Rnf43 mutations are more frequent in 
microsatellite-instable tumours compared to microsatellite-stable ones; this is the case for 
gastric cancer, colorectal cancer and endometrial carcinoma (Hao et al. 2016).  
Although it is functionally redundant with RNF43, ZNRF3 is less frequently mutated in 
cancer. Mutations in Znrf3 could only be found in 21% of adrenocortical carcinomas, which 
is the type of cancer showing the highest frequency of Znrf3 mutations (Assie et al. 2014). 
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This difference in relative mutation frequencies might be due to different expression levels 
of the two proteins.  
Additionally, abnormalities in R-spondin proteins are also found in cancer. In particular, 
it has been observed that translocations of Rspo-2 (3%) and Rspo-3 (8%) such that their 
expression is under the control of stronger promoters are recurrent in microsatellite stable 
(MSS) colon cancer (Seshagiri et al. 2012; Shinmura et al. 2014). Usually RSPO-2 and RSPO-
3 are found to be fused to EIF3E and PTPRK, respectively, and their expression levels are 
increased in tumour samples. Interestingly, the same type of fusion products were recently 
observed in traditional serrated colorectal adenomas at an even higher frequency (Sekine 
et al. 2016) and these translocations were found to be mutually exclusive with APC or β-
catenin mutations. Furthermore, Rspo-2/3 translocations have been identified in other 
types of tumours, such as prostate cancer and non-small cell lung cancer (Karkera et al. 
2014).  
In conclusion, these data taken together show that alterations in the R-spondin/RNF43 
module are often implicated in various types of cancer, again supporting the physiological 
relevance of RNF43 as a tumour suppressor. In light of this, it is especially important to 
elucidate the mechanisms through which RNF43 promotes the ubiquitination, 
internalisation and degradation of Frizzled, not only because this could lead to new insights 
into the WNT pathway but also because it might reveal some novel interactors of RNF43 
with an equally important function.  
 
 
1.5.3 Role of Dishevelled in the mechanism of action of RNF43 
 
Despite its crucial role in fine-tuning the WNT pathway and its prominent activity as a 
tumour suppressor, the precise mechanism of action and regulation of RNF43 remain 
poorly understood. Nevertheless, two recent pieces of work have helped to broaden our 
understanding of RNF43-mediated downregulation of Frizzled by revealing a novel and 
unexpected role for Dishevelled as an adaptor for the recruitment of RNF43 to Frizzled 
(Jiang et al. 2015; Tsukiyama et al. 2015).  
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The first observation made by Cong and colleagues was that surface levels of both 
Frizzled and LRP were significantly increased in Dishevelled triple KO cells, even though 
WNT/β-catenin activity was reduced (Jiang et al. 2015). Hence, they investigated the 
ubiquitination and endocytosis of Frizzled in more detail and found that ubiquitination of 
the WNT receptor and its internalisation were greatly impaired in Dvl KO cells.   
To investigate further at a molecular level, the group performed a series of co-
immunoprecipitation experiments that highlighted a region in the intracellular domain of 
RNF43 that is responsible for Dishevelled-2 binding, subsequently termed the Dishevelled-
interaction region or DIR. This region was mapped by Cong and colleagues to be between 
aa 326-454, whereas Tsukiyama’s group instead identified a more C-terminal region as 
being implicated in DVL binding (aa 477-596) and observed that this interaction is only 
required for the suppression of non-canonical WNT signalling. In contrast to the former 
report, they showed by a combination of flow cytometry and luciferase reporter assays 
that the binding of RNF43 to DVL2 is not required for the surface clearance of Fzd4 or for 
the suppression of WNT/β-catenin signalling. 
Interestingly, Cong’s group found the DEP (Dishevelled, EGL-10 and Pleckstrin) domain 
of Dishevelled to be essential for the downregulation of Frizzled, even though the DVL2-
∆DEP protein retains the ability to interact with RNF43. In fact, the biggest limitation of this 
work is that it failed to identify a region of Dishevelled that is necessary and sufficient to 
interact with RNF43. Possible explanations could be the existence of multiple points of 
contact between the two proteins or the possibility that the interaction is not direct and 
might be mediated by a third party. 
These considerations, together with some of the discrepancies between the two 
studies, underlie the need of further investigation into the dynamics of Frizzled-RNF43-DVL 
complex formation, as additional players might be required for FZD internalisation. A 
detailed characterisation of these molecular events could pinpoint novel interactors of 
RNF43 that may also be important regulators of its activity. 
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1.6 The PA-RING family of E3 ubiquitin Ligases 
 
Numerous signalling pathways govern the most basic and essential cellular functions 
and their tight regulation is fundamental to prevent dysregulation and alterations of these 
important processes  (Giancotti 2014). Among various modulatory strategies, a commonly 
used system is the establishment of negative feedback loops using ubiquitination to target 
proteins for degradation. The fine tuning of the immune response by the suppressors of 
cytokine signalling (SOCS) is an exemplary case of an inhibitory feedback mechanism based 
on ubiquitination (Tamiya et al. 2011). SOCS proteins are induced by cytokine stimulation, 
functioning as E3 ubiquitin ligases that then degrade cytokine receptors and consequently 
inhibit the JAK/STAT pathway (Tamiya et al. 2011; 
Babon J, Leila N. Varghese 2014). 
In recent years, interest has been growing in 
ubiquitination as a regulatory modification in 
multiple biological processes (Strikoudis et al. 2014; 
Jia & Sun 2011; Metzger et al. 2012), with particular 
relevance to the control of membrane signalling and 
cell surface remodelling (MacGurn et al. 2012). In 
particular, E3 ubiquitin ligases have turned out to be 
extremely important players in the regulation of 
membrane signalling as they represent the most 
abundant class of enzyme in the ubiquitination 
cascade (Clague et al. 2015) and are responsible for 
substrate specificity (Figure 1.9). 
Several examples of E3 ubiquitin ligases acting on 
signalling receptors have been reported, such as the 
HECT-domain containing ligase Nedd4 that 
promotes the ubiquitination and internalisation of 
the RTK receptors, EGFR (Lin et al. 2010) and FGFR 
(Persaud et al. 2011), or the RING finger E3 Cbl, 
Figure 1.9 Ubiquitination process. The first 
step in the ubiquitination chain reaction is 
the formation of a thioester bond between 
free Ubiquitin (Ub) and the ubiquitin-
activating E1 enzymes. Ubiquitin can then 
be transferred to an ubiquitin-conjugating 
E2 enzyme and finally to the E3 ubiquitin 
ligase that modifies a lysine residue on the 
target protein with an ubiquitin molecule 
and which confers substrate specificity to 
the process. The scheme refers to RING- 
type E3s in particular, but the E3 class is vast 
and comprises other types such as U-box, 
HECT and RBR E3 ligases. In total, over 600 
E3 ligases are present in mammalian cells 
versus 40 E2 and only two E1 enzymes. 
(Clague et al. 2015).  
 
Chapter 1
28 | P a g e  
 
which is responsible for the attenuation of EGF signalling by EGF receptor ubiquitination 
and endocytosis (Umebayashi 2008). The mechanism of action of these proteins greatly 
resembles that of RNF43 and ZNRF3, the RING E3 ligases that promote the endocytosis-
mediated degradation of the WNT receptor via negative feedback (Koo et al. 2012; Hao et 
al. 2012). As previously described, RNF43 and ZNRF3 share a common structural 
architecture consisting of an extracellular protease-associated domain (PA), a 
transmembrane domain and an intracellular RING domain. Bioinformatics analysis based 
on the screening of human sequences in GenBank revealed a 45-63% sequence similarity 
and the same structural organisation with 10 other human E3 ubiquitin ligases (Figure 1.10 
A-C). This led to the identification of a novel conserved gene family, termed the PA-RING 
family (Koo et al. 2012). The members of this family show a high degree of homology 
between different species and, although most of them have not been well characterised 
yet, it is reasonable to hypothesise that they might share a certain degree of functional 
redundancy as well.  
The next sections will focus on this newly identified family of E3 ubiquitin ligases, whose 
members have recently emerged as important regulators of membrane proteins in various 
cellular processes. I will discuss the roles of the most well characterised members and 
speculate on the putative role of the others by linking them to their orthologous genes in 
other species. 
 
 
1.6.1 The Goliath-related protein family  
 
As previously outlined, the PA-RING family has been reported to be highly conserved 
throughout evolution from yeast to human and evolutionary history as reconstructed in 
the Ensembl Compara database (Vilella et al. 2009) showed ancient proteins with the same 
domain architecture in plants and fungi (Bocock et al. 2009). 
In early Metazoan evolution two clusters derived from these proteins (Lau et al. 2014): 
from the first cluster, PLR-1 is one of the earliest remaining representatives in C. elegans 
(Moffat et al. 2014; Bhat et al. 2015), whereas from the second cluster, the Goliath gene 
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family of E3 ubiquitin ligases evolved in Drosophila (Bouchard & Côté 1993). These genes 
have orthologues in many other vertebrates (Guais et al. 2006), such as GREUL1 or RNF128 
in X. laevis (Borchers et al. 2002), c-rzf or RNF13 in the chicken embryo (Tranque et al. 1996) 
and G1RP or Rnf130 in mouse (Baker & Reddy 2000). 
The Drosophila family is composed of only two members, Goliath and Godzilla, that 
exhibit strong homology to the human PA-RING members Rnf130 and Rnf167, respectively 
(Yamazaki et al. 2013). Goliath was the first PA-RING member to be identified and was 
originally described as a developmentally important gene encoding a zinc-finger-motif 
protein involved in the regulation of gene expression during mesoderm formation 
(Bouchard & Côté 1993). Later, another E3 ligase was identified, Godzilla, displaying the 
same structural organisation as Goliath. Both proteins contain a PA domain that is located 
extracellularly and considered to be implicated in protein recognition (Mahon & Bateman 
2000), in addition to a RING domain that is intracellular and contains six conserved cysteine 
and two histidine residues which coordinate Zn2+ ions and are essential for the ubiquitin 
ligase activity (Yamazaki et al. 2013). These ligases have been reported to act as key 
regulators of recycling endosome trafficking; they are expressed in endosomes, where they 
direct the ubiquitination of the v-SNARE protein VAMP3 and consequently inhibit 
transferrin receptor recycling (Yamazaki et al. 2013). Interestingly, this function is 
analogous to that of its human orthologue, Rnf167, which is similarly responsible for 
VAMP3 ubiquitination and degradation.  
This does not represent the only case of evolutionary preservation of gene function 
among the PA-RING members in different species. For instance, the C. elegans orthologue 
of RNF43 and ZNRF3, PLR-1, also negatively regulates WNT receptor turnover and 
therefore inhibits the WNT signalling pathway (Moffat et al. 2014).  This function has been 
associated with the regulation of the cellular response to WNTs during neuronal 
development in C. elegans, which is crucial for the establishment of the polarity of the 
nervous system (Bhat et al. 2015). In addition, PLR-1 lowers surface levels of the Frizzled 
co-receptors CAM-1/ROR and Lin28/RYK and targets them to endosomes, comparable to 
the function of its mammalian orthologues that are known to induce the internalisation of 
Frizzled together with its co-receptor, LRP. 
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In conclusion, these examples suggest that Goliath-related PA and RING domain-
containing proteins have not only conserved their structural architecture but also their 
functional roles throughout evolution.  
 
 
1.6.2 The mammalian PA-RING family 
 
In mammals, the PA-RING family of E3 ubiquitin ligases consists of 12 transmembrane 
proteins divided into four distinct branches (Koo et al. 2012, Figure 1.10 A). As might be 
expected, most of its members are still poorly characterised and many aspects about them 
remain unexplored. However, there are a few exceptions, such as RNF128, RNF13 and its 
homologue RNF167 that, together with RNF43 and ZNRF3, represent the most extensively 
characterised PA-RING members.  
Rnf128, also known as GRAIL (gene related to anergy in lymphocytes) was firstly 
identified as a gene encoding an endosomal E3 ubiquitin ligase upregulated in anergized 
CD4+ T cells (Anandasabapathy et al. 2003) and implicated in immune self-tolerance 
through the inhibition of cytokine production (Mueller 2004). The importance of RNF128 
in the induction of T cell anergy was also demonstrated in vivo by showing that its 
constitutive expression leads to the development of an anergic phenotype in naïve CD4+ T 
cells (Seroogy et al. 2004). An enzymatically inactive form of RNF128 was consistent in its 
ability to abrogate this induction process. These data suggest that the ubiquitination 
activity of RNF128 is required for the induction of tolerance in naïve T cells. In support of 
this, it was shown that RNF128 acts as a gatekeeper of unresponsiveness in T cells by 
promoting TCR-CD3 ubiquitination and degradation (Nurieva et al. 2010); RNF128-/- T cells 
are hyper-responsive to TCR stimulation and RNF128-deficient mice display an enhanced 
susceptibility to autoimmune diseases. 
The juxtaposition of the PA and RING finger domains across the lipid bilayer was shown to 
be crucial for the molecular mechanism of action of RNF128. This spatial organisation is 
considered to be instrumental for the binding of transmembrane substrates of RNF128, 
which include the TCR complex and its costimulatory molecules, CD40 (Lineberry et al. 
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2008) and CD83 (Su et al. 2009). It is proposed that the PA domain serves as an extracellular 
recruitment platform to capture the target, which is then subsequently ubiquitinated by 
the intracellular RING domain. 
In terms of other members of the family, Rnf13 and Rnf167 are homologous genes that  
encode endosomal membrane proteins involved in intracellular vesicular trafficking 
(Lussier et al. 2012; Zhang et al. 2013). In particular, Rnf13 regulates SNARE complex 
assembly by ubiquitinating the SNARE-associated protein, Snapin (Zhang et al. 2013), while 
Rnf167 acts as a negative regulator of cellular endosome trafficking by targeting the SNARE 
protein VAMP3, analogous to its orthologue in Drosophila (Yamazaki et al. 2013). Both 
ligases are targeted to endosomal membranes by their PA domain and point mutations 
that affect their cellular localisation can be detected in a number of human tumours (van 
Dijk et al. 2014); nevertheless, the most frequent mutations in RNF13 and RNF167 result in 
loss of function of their ligase activity. Recently, it has been observed that Rnf13 mutant 
mice are prone to develop a high number of metastatic foci in the lungs (Cheng et al. 2015), 
hence, it can be hypothesised that this protein and its homologue may function as tumour 
suppressors similar to their paralogues Rnf43 and Znrf3. 
Besides the members described so far, the PA-RING family comprises several other 
proteins; however, the information available on them is still rather limited. Some members 
have been linked to certain pathologies, such as pulmonary diseases and urinary bladder 
cancer in the case of Rnf150 (Press 2015; Zaravinos et al. 2011) or Barrett’s Oesophagus in 
the case of Rnf130 (Wang et al. 2014). Two other ligases, Rnf148 and Rnf133, have been 
associated with the process of sperm maturation (Anon 2014; Liu et al. 2013; Nian et al. 
2008), whereas the Rnf43 homologue Rnf215 has not been characterised yet. A general 
summary of the mammalian PA-RING proteins can be found in Table 1.1. 
In light of this, it becomes clear that many questions are still open and many aspects of 
members of this family are worth investigating. For example, the majority of PA-RING 
proteins have not been linked to the regulation of any particular signalling pathway yet, 
most of their targets remain unknown, and in many cases their in vivo function has never 
been addressed. It has to be acknowledged, though, that potential genetic redundancy 
could represent a limiting factor in the study of members belonging to the same gene 
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family, as exemplified by the case of Rnf43 and Znrf3: adenoma formation could be 
observed only when ablating both genes in parallel in the murine intestine (Koo et al. 2012).   
It is therefore not unreasonable to speculate that PA-RING family members may differ in 
their target specificity and physiological role, but it is likely that their mechanism of action 
in regulating the abundance of membrane proteins has been preserved throughout 
evolution.  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.10 The PA-RING family of E3 ubiquitin ligases. A) Phylogenetic tree of the newly identified members 
of the PA-RING family in humans (Koo et al. 2012). B) Schematic representation of protein domain 
organisation of PA-RING family members, where PA is the protease-associated domain. C) Sequence 
alignment of all PA-RING members, where the RING domain is highlighted in yellow (ClustalW2). 
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C 
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Table 1.1 Summary of reported traits of PA-RING family members. 
 
 
 
Tissue 
Expression* 
Cellular 
Localisation
** 
Targets Putative Role 
In vivo 
model 
RNF215 n/a n/a n/a n/a n/a 
RNF150 n/a n/a n/a 
Common differentially 
expressed gene in 
urinary bladder 
cancer. 
n/a 
RNF130 
Broadly 
expressed. 
Upregulated 
in complete 
H-mole 
tissues and in 
Barrett’s 
Oesophagus 
samples. 
n/a n/a 
Originally identified in 
Drosophila as a 
transcription factor 
involved in the 
formation of the 
mesoderm in the 
embryo. Transcription 
factor involved in 
apoptosis in the 
mouse. 
n/a 
RNF149 
Broadly 
expressed. 
n/a BRAF 
Attenuation of the 
increase in cell growth 
induced by wild-type 
BRAF. Associated with 
FDG uptake in PET and 
survival in patients 
with resected non-
small cell lung cancer. 
n/a 
RNF148 
Testis and low 
expression in 
pancreas. 
n/a n/a 
Testicular interstitial 
gene. Its expression is 
regulated by histone 
deacetylases. 
n/a 
RNF133 
Expressed 
during 
spermatogen-
esis. 
ER 
localisation 
n/a 
May play a role in 
sperm maturation. 
n/a 
RNF128 
High in the SI, 
liver, kidney, 
muscle and 
bone marrow. 
Endo-
membrane 
system 
TCR-CD3, 
CD40, 
CD83, 
CD151, 
TBK1 
 
Negative regulator of 
the T-cell receptor, 
role in 
haematopoiesis. 
Mutations associated 
with chronic kidney 
disease. 
KO mice 
develop 
auto- 
immune 
disease 
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RNF13 
Broadly 
expressed, 
overexpressed 
in pancreatic 
cancer. 
Late 
endosomes Snapin 
Assembly of the 
SNARE complex, 
mediation of ER 
stress-induced 
apoptosis through the 
IRE1α-TRAF2-JNK 
signalling pathway. 
KO mice 
show 
accelerated 
muscle 
regenerati-
on and 
enhanced 
metastasis. 
RNF167 
Broadly 
expressed. 
Endo- 
membrane 
system 
AMPAR, 
VAMP3, 
Arl8B  
 
Selective regulator of 
AMPAR-mediated 
neurotransmission.  
Abrogates recycling 
endosome trafficking, 
regulates lysosome 
positioning. 
n/a 
RNF204 n/a 
ER 
localisation 
Calnexin 
Regulator of Calnexin 
turnover and ER 
homeostasis. 
n/a 
 
* Information from the EMBL-EBI Expression Atlas. 
** According to COMPARTMENTS, Subcellular localization database.  
 
 
 
 
1.7 Aims of my PhD  
 
In recent years, RNF43 emerged as an important negative regulator of the WNT 
signalling pathway. It is a transmembrane E3 ubiquitin ligase localised at the plasma 
membrane, where it promotes ubiquitination and subsequent degradation of the WNT 
receptor Frizzled and its co-receptor LRP. RNF43 activity acquires a prominent role in the 
murine small intestine where it prevents uncontrolled expansion of the stem cell 
compartment and significantly contributes to tissue homeostasis. However, despite this 
crucial role in the fine regulation of the WNT pathway, the precise regulatory mechanisms 
of RNF43 remain poorly understood.  
For this reason, during my PhD I aim to elucidate details of the precise mechanism of action 
of RNF43, beginning with the identification of genes with a functional connection to RNF43 
itself by using a new screening strategy that combines CRISPR/Cas9 technology and 
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intestinal organoid culture. The use of this screening strategy with RNF43 provides a 
paradigm for other PA-RING proteins; for instance, different members could exhibit similar 
functions as regulators of transmembrane proteins such as, e.g., signalling receptors.  
The identification of this novel gene family has opened up various questions and 
possible lines of investigation, some of which my thesis proposes to address by studying 
the potential involvement of other PA-RING members in the regulation of the WNT 
pathway, as well as other signalling pathways, and the identification of PA-RING members’ 
targets. 
Tackling these points, in combination with the identification of genes functionally related 
to RNF43, will help us potentially gain new insights into the WNT signalling pathway and 
broaden our understanding of the specificity and mechanism of action of each of these 
novel E3 ligases. 
 
To summarise, my thesis has the following specific aims:  
  
1) The identification of novel genes that are involved in the mechanism of action of 
RNF43, and the subsequent characterisation of their role both in vitro and in vivo, in 
order to understand in detail the molecular mechanisms through which RNF43 
promotes Frizzled endocytosis and degradation; 
 
2)   The characterisation of additional PA-RING family members, in order to:  
- assess whether there are any other members of this family that are involved in the 
WNT signalling pathway in addition to RNF43 and ZNRF3  
- identify novel targets for selected PA-RING family members. 
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Chapter 2  
Materials and Methods  
 
 
2.1 Materials 
 
2.1.1 Devices, consumables and chemicals  
Devices, consumables and chemicals are listed in Tables S1 and S2 of Appendix A. 
 
2.1.2 Kits and enzymes 
All Kits and enzymes used are listed in Tables S3 and S4 of Appendix A. 
 
2.1.3 Plasmids 
All DNA constructs used are listed in Table S5 of Appendix A. 
 
2.1.4 Cloning and genotyping primers 
Primers for cloning and PCR genotyping are listed in Tables S6 – S10 of Appendix A. 
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2.1.5 RT-qPCR primers 
Primers for RT-qPCR are listed in Tables S11 of Appendix A. 
 
2.1.6 Primary/Secondary Antibodies 
Primary and secondary antibodies with relative dilution factors are listed in Tables S12 of 
Appendix A. 
 
 
 
2.2 Methods  
 
2.2.1 Vector generation 
 
PiggyBac constructs for dox-inducible RNF43 overexpression  
In order to generate pBhCMV-hRNF43-mCherry, pPB-CAG-rtTA2ACas9_Neo and pPB-CAG-
rtTA_Hyg, cDNAs of human RNF43, S. pyogenes WT Cas9 and Hygromycin resistance were 
PCR-amplified using Phusion® High-Fidelity Polymerase (NEB) and cloned into PiggyBac-
based vectors containing inducible tet-responsive transgenes using the In-Fusion® HD 
Cloning Kit (Clontech) according to manufacturer’s instructions. RNF43 and rtTA expression 
constructs were always transfected in combination with the Super PiggyBac Transposase 
expression vector in a 2:2:1 ratio. All the PiggyBac plasmids were a kind gift from Prof. 
Austin Smith’s laboratory.   
 
 Vectors for inducible overexpression of PA-RING family members 
To obtain vectors for inducible overexpression of the other PA-RING family members, their 
cDNAs were cloned into pcDNA™4TO (Thermo Fisher) by In-Fusion cloning; the peculiarity 
of this vector is the presence of Tetracycline operator sequences that are recognised by 
the Tet repressor in T-REx™-293 cells. 
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Similarly, these cDNAs were cloned downstream of the floxed dsRed cassette in the 
retroviral vector pMSCV-loxp-dsRed-loxp-3xHA-Puro-WPRE (Addgene). 
 
Generation of CRISPR concatemer vectors for multiple gene KO 
Single guide RNAs for CRISPR knockout were designed using the Zhang lab webtool 
(http://crispr.mit.edu/) and their sequences modified by the addition of specific overhangs 
for cloning into MSCV-puro concatemer vectors (Andersson-Rolf et al. 2016). 
As a first step, oligos were pooled together in one reaction for their annealing and 
phosphorylation by T4 PNK and T4 DNA ligases (NEB) with the following thermocycler 
settings: 37°C for 30 minutes, 95 °C for 5 minutes, ramp down to 25 °C at 0. 3 °C/minute 
and 4 °C. Generation of 2 gRNA-containg MSCV vector was achieved by Golden Gate 
cloning as described in Ran et al., 2013. For incorporation of 3 and 4 gRNAs, annealed oligo 
mix was diluted 1:100 and Golden Gate cloning was performed with the following settings: 
37°C for 5 minutes and 21°C for 5 minutes for 50 cycles, then 37°C for 5 minutes and 4°C. 
All cloning reactions were treated with Plasmid-safe exonuclease (Cambio) for 30 minutes 
at 37°C and other 30 minutes at 70°C.  
Concatemer vectors were used in a 1:1 ratio with a WT Cas9 expression plasmid (Addgene). 
 
Generation of Daam1 expression vectors 
Human DAAM1 cDNA was purchased from TransOMIC, PCR-amplified using Phusion® High-
Fidelity Polymerase and cloned into pcDNA4TO backbone with different tags via In-fusion 
cloning.  
 
Generation of gRNA expression vectors 
A vector from the Church lab containing a gRNA to target GFP (Addgene) was used as a 
template in an inverse PCR reaction using Phusion® High-Fidelity Polymerase. The aim 
was to exchange the pre-existhing gRNA with a new one. The PCR mix was then digested 
with DpnI (NEB) for 2 hours 37°C. Ligation was performed with T4 DNA Ligase (NEB) for 1-
2 hours at room temperature.  
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All reaction mixtures were directly used for transformation into either 10G (Cambridge 
Bioscience) or Stellar (Takara) competent bacteria, DNA was purified using a Miniprep kit 
(Qiagen) and plasmids were checked by restriction digest and Sanger sequencing. Once the 
success of the cloning was confirmed, DNA was purified with a Plasmid Midiprep kit 
(Qiagen). See Tables S6-8, S13 and S4 of Appendix A for information about cloning primers, 
PCR programs and enzymes respectively. 
 
 
2.2.2 Cell culture  
 
Cell lines 
 
Mouse embryonic stem cells (E14Tg2a) were cultured feeder-free on 0.1% gelatin-coated 
dishes in in Serum-LIF medium supplemented with 2i (CHIRON + PD03) without antibiotics 
or alternatively, in basal N2B27 medium supplemented with 2i. 
Platinum-E cells (Cell Biolabs) were grown in DMEM + 10% FBS and Penicillin-Streptomycin 
in the presence of Puromycin (1 µg/ml) and Blasticidin (10 µg/ml). 
T-REx™-293 cells (Life Technologies) and HEK293 cells (SCI TC facility) were cultured in 
DMEM + 10% FBS and Penicillin-Streptomycin, supplemented with 10 µg/ml Blasticidin 
only in case of T-REx™-293 cells.  
HS27 human skin fibroblasts (SCI TC facility) were grown in GMEM (Sigma) supplemented 
with 1x non-essential amino acids (Life Technologies), 1 mM sodium pyruvate, 2 nM L-
Glutamine (Life Technologies), 50 µM β-mercaptoethanol (Sigma) and 10% FBS.  
Cells were mitotically inactivated for 3 hours at 37°C with 10 µg/ml Mitomycin C (Sigma). 
All cells were kept in a tissue culture incubator at 37°C and 5% CO2 and split in a variable 
ratio depending on confluency every 2-4 days. All cultures were mycoplasma free.  
See Table S14 of Appendix A for medium composition. 
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Cell transfection by lipofection 
Transfections were performed using the Lipofectamine2000 Transfection Reagent 
(Invitrogen) following the manufacturer’s instructions, when cells reached 60-70% of 
confluency. Medium was replaced the day after. 
 
Cell transfection by electroporation 
Mouse ESC were resuspended in phosphate buffered saline without calcium and 
magnesium (Sigma) and mixed with a total of 50 μg of DNA per 106 cells. The mixture was 
transferred to a 4 mm cuvette (Biorad) and electroporation was performed using the Gene 
Pulser XCell electroporation system (Biorad) with the following settings: 240 V, 500 uF, 
unlimited resistance.  
Following drug selection, single colonies were picked into 96-well plates and cells were 
subsequently lysed with freshly-made lysis buffer for 2 hours at 56°C (see Table S16 of 
Appendix A for lysis buffer composition). Clones were genotyped by long-range PCR using 
LongAmp polymerase (NEB) following manufacturer’s protocol.  
 
Isolation of single clones by cell sorting 
To obtain clonal populations of HEK293, cells were washed twice in PBS and filtered 
through a 70 μm cell strainer and sorted into 96-well plates as single cells on a Beckman 
Coulter high-speed MoFlo cell sorter. Clones were lysed and genotyped as described 
above. 
 
ESC rederivation  
Embryos at E2.5 stage were flushed out of the oviduct using a syringe with a blunt needle 
with M2 medium (Sigma) containing Penicillin-Streptomycin. Embryos were transferred by 
mouth pipetting to a 35 mm culture dish containing pre-equilibrated BlastAssist medium 
(Origio) supplemented with 2i and incubated at 37°C for 3 days. 
After blastocysts had hatched (E5.5), embryos were moved to 4-well dishes, previously 
coated with a layer of inactivated human fibroblasts, and culture medium was changed to 
2i-Lif with Penicillin-Streptomycin. Embryos were kept in the incubator at 37°C for 10 to 14 
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days until trophectoderm cells attached to feeders, allowing inner cell mass (ICM) 
outgrowth. When the ICM outgrew into a primary colony, this was mechanically split into 
fragments using a pulled glass pipette. The subsequent dissociation of ICM-derived 
colonies into single cells was performed by Accutase treatment for 5 minutes at 37°C and 
cells were transferred to 6-well plates for expansion. Cultures were then adapted to 
feeder-free conditions within two passages and cells were genotyped as previously 
described. 
  
ESC retroviral transduction 
Platinum-E cells were transfected with 9 μg of the retroviral expression vector pMSCV-puro 
(Clontech) containing single gRNAs against Daam1 and Daam2. After two days, viruses 
were harvested by passing the media through a 0.45 μm filter and viral supernatant was 
mixed with 4 μg/ml Polybrene and added to newly-derived ESC plated on Laminin (Sigma) 
for overnight incubation. After 24 hours the viral mixture was discarded, cells were washed 
in PBS and their media changed to 2i-Lif. Culture media was supplemented 2 days later 
with Puromycin (1 μg/ml) for selection of transduced cells. 
 
 
2.2.3 Organoid culture and genetic manipulation 
 
Intestinal crypt isolation 
Mice were dissected to collect the small intestine from the cecum to the stomach. Crypts 
derived from duodenum, jejunum and ileum were used to establish organoid culture. 
Firstly, the intestine was flushed by a 10 ml syringe with pre-chilled PBSO (without Calcium 
and Magnesium), cut longitudinally and spread open by using forceps.  
Villi were removed by gently scraping the intestine with a coverslip, 5 mm pieces were 
obtained and transferred to a 50 ml tube with pre-chilled PBS0. The remaining villi were 
washed away by vigorous shaking. Then the tissue was incubated 15 minutes on a rocking 
platform with 25ml of Gentle Cell Dissociation Reagent (Stem Cell Technologies) and 
enrichment for crypts in solution was confirmed by checking a drop under the microscope. 
The solution was spun at 1200 rpm for 3 minutes and pellet resuspended in 1 ml of PBS0.  
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After spinning at 500 xg for 5 minutes, Matrigel was added to the pellet considering 20 µl 
of matrix per well and approximately 50-100 crypts were seeded in each well of a pre-
warmed 48-well plate. The plate was incubated at 37°C for 10 minutes to let the Matrigel 
solidify and 250 µl of WENR+Nic medium added on top. 
 
Organoid culture and maintenance 
Murine intestinal organoids were derived from small intestinal crypts of WT, VillinCreERT2 
and RZ-DKO VillinCreERT2 mice and embedded in Matrigel. Culture media was refreshed 
every 2-3 days and organoids were split with a 1:3 ratio every 6-7 days. For passaging, 
Matrigel domes were disrupted and organoids were mechanically fragmented into single-
crypt domains which were spun at 600 xg for 5 minutes. The pellet was resuspended in 
fresh Matrigel and seeded in pre-warmed 48-well tissue culture plates (for culture medium 
composition see Table S15 of Appendix A). 
 
Organoid transfection by lipofection 
Organoids were cultured at high density in WENR+Nic media in preparation to this 
procedure so that they displayed a cystic morphology and contained a higher number of 
stem cells. Organoids were mechanically disrupted and spun at 900 xg for 5 minutes; the 
pellet was resuspended in TrypLE Express and incubated at 37°C for 5 minutes. The 
dissociation process was terminated by adding 500 μl of EN media supplemented with Y-
27632 (Rho-Kinase inhibitor) and CHIRON without antibiotics and fragments were spun at 
900 xg for 5 minutes (for EN medium composition see Table S15 of Appendix A). In parallel, 
two separate mixes containing 50 µl Opti-MEM Reduced Serum Medium (Gibco) plus 4 µl 
of Lipofectamine 2000 or 1.6 µg of DNA were prepared and incubated for 5 minutes at 
room temperature; they were then pooled together and incubated for 30 minutes. This 
Lipofectamine-DNA mixture was combined with 100 µl of cell suspension in a 48-well tissue 
culture plate and then spinouculated at 32°C, 600 xg for 1 hour. This was followed by 
another 6 hour incubation at 37°C, after which the mix was spun at 500 xg for 5 minutes. 
The pellet was resuspended in 20μl of Matrigel and seeded in one well of a pre-warmed 
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48-well tissue culture plate. WENR+Nic media supplemented with Y-27632 was overlaid. 
Selection of transfected organoids with 100 μg/ml Hygromycin B started 2-3 days later.   
 
Organoid transfection by electroporation 
Two days prior to electroporation, culture media was changed from WENR+Nic to EN 
without antibiotics, supplemented with Y-27632 and CHIRON. Organoids were treated with 
1.25% v/v DMSO 24 hours before electroporation and were subsequently dissociated into 
small clusters of 10-20 cells by TrypLE Express treatment for 3-5 minutes at 37°C. After 
spinning for 5 minutes at 500 xg, cells were counted and a minimum of 105 cells was used 
per condition. Organoid pellet was resuspended in 1 ml of BTXpress buffer (Harvard 
Apparatus) and mixed with a total amount of 10-20 µg of DNA. The cell-DNA mixture was 
then transferred to the cuvette and electroporation performed according to the following 
settings using the NEPA21 Super Electroporator (NEPA Gene): 
 
 
 
 
 
 
 
 
 
 
This was followed a 30 minute incubation with 400µl BTXpress buffer + Y-27632 to allow 
cells to recover, after which they were spun at 400 xg for 3 minutes. Then the pellet was 
resuspended in Matrigel and EN medium supplemented with Y-27632, CHIRON and DMSO 
was overlaid. After 24 hours medium was changed to EN + Y-27632 + CHIRON and 4-5 days 
later normal organoid medium was applied. 
 
 
 Poring pulse Transfer pulse 
Voltage 175 V 20 V 
Pulse length 5 msec 50 msec 
Pulse interval 50 msec 50 msec 
Number of pulses 2 5 
Decay rate 10% 40% 
Polarity + +/- 
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Isolation of single organoids by manual picking 
After drug selection, single organoids were manually isolated in safety cabinet under a light 
microscope. Matrigel was gently disrupted without damaging the organoids that were 
pooled together in a Petri dish containing DMEM/F-12 supplemented with HEPES (10mM), 
L-glutamine (20mM) and Penicillin-Streptomycin (1x). Single organoids were aspirated in 
the tip of a p20 pipette and placed into a 1.5 ml tube containing 10 µl of WENR+Nic + Y-
27632 medium. Organoids were then seeded directly in a 48 well plate by adding 10 µl of 
Matrigel and pipetting up and down to fragment single organoids into pieces. WENR+Nic + 
Y-27632 medium was overlaid when Matrigel had solidified and refreshed every 2 days. 
 
Organoid retroviral transduction 
Virus production. Platinum-E cells were transfected with 24 μg of the retroviral vector 
pMSCV-loxp-dsRed-loxp-3xHA-Puro-WPRE (Addgene) containing the cDNA of PA-RING 
family members. After two days, viruses were harvested by passing the media through a 
0.45μm filter and spinning it at 8000 xg at 4°C for 12 hours. The next day, the supernatant 
was discarded and the pellet was resuspended in transduction medium: WENR+Nic 
supplemented with Y-27632 and polybrene (8μg/ml).  
Organoid fragmentation. Organoids were mechanically disrupted and spun at 900 xg for 
5 minutes. Pellet was then resuspended in TrypLE Express and incubated at 37°C for 5 
minutes. The dissociation process was terminated by adding 500 μl of WENR+Nic medium 
and fragments were spun at 900 xg for 5 minutes and the pellet was resuspended in 
transduction medium.  
Viral transduction. The organoid fragments were combined with the retroviral suspension 
in a 48-well tissue culture plate and then spinouculated at 32°C, 600 xg for 1 hour. This was 
followed by another 6 hour incubation at 37°C, after which the mix was spun at 900 xg for 
5 minutes. The pellet was resuspended in 50μl of Matrigel and seeded in one well of a pre-
warmed 48-well tissue culture plate. Transduction media without polybrene was overlaid. 
Two/three days after transduction, selection of infected organoids with 1 μg/ml Puromycin 
began. After they reached full size, culture media was changed to ENR + Puromycin so that 
they could regain their budding structures within two weeks. Expression of the gene of 
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interest was induced with 1μM 4-hydroxytamoxifen (4-OHT) for 12 hours and then culture 
conditions were changed to EN (RSPO withdrawal). 
 
 
2.2.4 Other techniques and assays 
 
Quantitative RT-PCR 
Total RNA was extracted from HEK293 and mESC using RNeasy Mini kit (Qiagen) and from 
intestinal organoids using RNeasy Micro kit (Qiagen). On-column DNase digestion was 
performed to avoid contamination from genomic DNA and 1 µg of RNA was retro-
transcribed using M-MLV Reverse Transcriptase (Promega). Quantitative RT-PCR reactions 
were run in triplicates or quadruplicates using iQSYBR Green Supermix (Biorad) according 
to the manufacturer’s instructions. Average gene expression was normalized the reference 
gene GAPDH. 
 
Immunofluorescence 
Cells were washed twice with PBSO and fixed in 4% PFA for 20 minutes at room 
temperature. Then they were permeabilised in 0.2% Triton X-100 (Sigma) for 15 minutes 
and blocked in 5% donkey serum (Sigma) and 0.1% Triton X-100 or in 10% BSA (Sigma) for 
1 hour at room temperature. Primary antibody was incubated overnight at 4°C and the 
excess was washed away on the following day, prior to incubation with secondary antibody 
for 1 hour at room temperature. DAPI (Sigma) was added while performing the final washes 
in PBS and cells were mounted in RapiClear (Sunjin lab). 
 
Image acquisition 
Images of intestinal organoids and HEK293 cells were acquired with the Evos fl inverted 
digital fluorescence microscope, equipped with the following lenses and filters: 10x (AMG, 
10x Plan AMEP-4632) dry objective, 20x (AMG, 20x Plan FL AMEP-4624) dry objective; 
filters for DAPI, GFP, RFP and Texas Red. Confocal microscopy was instead conducted on 
mESC using the software LAS AF and Leica SP5 TCS confocal microscope.  
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Flow cytometry 
Cells were pelleted 2 days after transfection, resuspended in 200 µl of ice-cold FACS buffer 
(0.1% BSA PBS) and incubated with primary antibody on ice for 45 minutes. Cells were then 
washes twice with 200 µl of ice-cold FACS buffer and incubated on ice with secondary 
antibody for 30 minutes. After two washes, pelleted cells were resuspended in 500 µl of 
ice-cold FACS buffer, filtered and analysed using the BD LSRFortessaTM cell analyser. 
Subsequently, data were analysed with the FlowJo software. 
 
Western blotting 
Cells were lysed on ice for 30 minutes in a buffer containing complete protease-inhibitor 
cocktail tablets (Roche) and centrifuged at maximum speed for 30 minutes at 4°C. Protein 
concentration was measured using Pierce™ BCA Protein Assay Kit (Thermo Fisher) and 
equal amounts were loaded on polyacrylamide gel and run at 140 V for 1.5 hours. Proteins 
were subsequently transferred to an Immobilon-FL PVDF 0.45 μm membrane (Millipore) 
using the Trans-Blot® Turbo™ Transfer apparatus (Biorad) and the membrane was blocked 
for 1 hour with a 5% milk blocking buffer at room temperature.  This was followed by an 
overnight incubation in primary antibody solution at 4°C. The membrane was then washed, 
secondary antibody was applied for 1 hour at room temperature and detection was 
performed using ECL prime Western blotting Detection system (GE Healthcare). See Tables 
S17-18 of Appendix A for Western blot buffer composition. 
 
Immunoprecipitation 
Two days after transfection, cells were treated with 10 mM MG132 (PeptaNova) for 4-6 
hours to inhibit proteasome activity. On the next day, cells were harvested and lysed on 
ice as previously described. Then 15 µl of Protein G Resin (Invitrogen) were incubated with 
1 µl of 4 µg/µl mouse monoclonal antibody for 1 hour at 4°C.  After washing, the 
bead/antibody conjugate was incubated with the cell lysates at 4°C overnight. The resin 
was then washed 5 times with lysis buffer before elution in 15 µl of 5X Laemli buffer. 
Samples were kept 95°C for 5 minutes and analysed by Western Blot.  
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Ubiquitination assay 
HEK293T cells were transfected 2 days prior to analysis with HA-Ubiquitin and V5-Frizzled5 
constructs. Frizzled5 was then pulled down using V5-bound Protein-G-sepharose beads 
(Invitrogen) and its ubiquitination levels assessed by Western Blot against HA.  
 
Endocytosis assay 
Subcellular localization of SNAP-tagged Frizzled5 (SNAP-FZD5) was analysed in DAAM KO 
HEK293 cells compared to WT cells, with or without RNF43 co-expression. Surface SNAP-
FZD5 was labelled with SNAP-Alexa549 (NEB) for 15 minutes at room temperature in the 
dark, cells were washed and the labelled receptor was chased for 30 and 120 minutes.  
 
Surface Proteome Analysis 
Dox-inducible E3-overexpressing T-REx™-293 cells were treated overnight with 1 µg/ml 
doxycycline (Sigma) to induce overexpression of the E3 ubiquitin ligase of interest. Samples 
were prepared in triplicate and surface proteins from were enriched by using Pierce Cell 
Surface Protein Isolation Kit (Thermo Fisher) according to manufacturer’s instructions; 
surface proteins were first labelled with Sulfo-NHS-SS-Biotin, cells were then lysed and 
Biotin-labelled surface proteins were affinity-purified by a using NeutrAvidin agarose resin.  
The resin was extensively washed with PBS to remove traces of detergents, before 
biotinylated proteins were eluted by incubating the resin for 1 hour at room temperature 
with 5 mM dithiothreitol (DTT) and 0.5% RapiGest SF surfactant (Waters) in 50 mM 
ammonium bicarbonate. A second and third elution were obtained by incubating the resin 
with 8 M urea/ 2M thiourea and 5 mM DTT in ammonium bicarbonate.  
Each elution was handed over to the Proteomics Core facility of Masaryk University (Czech 
Republic) for alkylation with iodoacetamide, digestion with Lys-C (Promega) and overnight 
trypsin treatment. Each sample variant was analysed separately three times by nano-ultra 
performance liquid chromatography (LC)–tandem mass spectrometry (MS/MS) on an 
RSLCnano/Orbitrap-Elite system (Thermo Fisher) with a 90 minute LC gradient. MS was 
recorded by Orbitrap analyzer with a resolution of 60000 at 400 m/z; MS/MS, after Higher-
energy collisional dissociation, was recorded by Orbitrap analyzer with a resolution of 
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15000 at 400 m/z. MS/MS data processing was performed using Proteome Discoverer™ 
software (version 1.4) and applying the following search algorithms: Mascot (version 2.4.1) 
and SEQUEST. UniProtKB-Human (version from 16.9.2015) was searched as a protein 
database and contaminant proteins were filtered out by referring to cRAP contaminant 
database (http://www.thegpm.org/crap). A minimum of one unique peptide and peptide 
identifications with q value <0.01 were considered for protein identification. Dox-treated 
samples were compared to non-treated samples and a ratio was calculated by dividing the 
normalized area for each protein in the Dox+ samples by the Dox− samples.  
 
 
2.2.5 Mouse procedures 
 
Mouse handling 
Rosa26-floxed STOP-Cas9 mouse was imported from Jackson Laboratories.  In this mouse 
line, Cre recombinase-dependent expression of Cas9 endonuclease is directed by a CAG 
promoter and, in combination with single guide RNAs and Cre, it can lead to gene 
disruption, as described in Platt et al., 2014.  
This line was crossed with a VillinCre-ERT2 that expressed the Cre recombinase fused to 
the estrogen receptor under the Villin promoter. ESC were then rederived from Rosa26-
floxed STOP-Cas9::VillinCre-ERT2 mice, infected with gRNAs against Daam1 and Daam2 
and used to generate chimeras. In the chimeras, Cas9 expression was induced in mouse 
intestine by one intraperitoneal administration of 3 mg/20g mouse weight of Tamoxifen in 
corn oil (Sigma). Tamoxifen administration led to translocation of Cre-ERT2 into the nucleus 
and subsequent excision of the stop codon that prevents Cas9 expression.  
All mouse breeding and experimental procedures were subjected to ethical approval and 
performed under the terms of the Animals (Scientific Procedures) Act, 1986. All mice were 
kept in pathogen-free conditions and all the work was performed according to the United 
Kingdom Home Office regulations. 
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Chimeric mouse generation 
Chimeras were generated by blastocyst microinjection of newly-derived ESC by the Stem 
Cell Institute Transgenic Facility. 
 
Intestine collection and preparation 
Intestinal samples were obtained 7 and 14 days after tamoxifen injection. Mice were 
euthanized by cervical dislocation, dissected and the intestine removed for fixation in 
Formalin overnight at room temperature on a rocking platform. After fixation, samples 
were rinsed twice in PBS and kept in 70% Ethanol.  
 
 
2.2.6 Immunohistochemistry 
Samples were paraffin-embedded, sectioned and stained by the Stem Cell Institute 
Histology Core Facility. 
Antigen retrieval was performed by boiling the slides for 15 minutes at 95°C in 0.01 M Citric 
Buffer (pH 6.0), and then slides were washed several times in PBS. Peroxidase Block was 
added on top for 5 minutes at room temperature, slides were again washed and incubated 
for 1 hour at room temperature with the blocking/permeabilisation solution (0.1% Tween/ 
2% NDS). Primary antibody solution was applied overnight at 4°C, slides were then washed 
and incubated for 30 minutes with the polymer-HRP labelled secondary antibody (DAKO 
Envision Kit). This was followed by DAB colour development and finally sections were 
counterstained with Mayer’s Haematoxylin, dehydrated and mounted. 
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Chapter 3  
 
Development of an inducible system 
for the identification of RNF43-related 
genes 
  
 
3.1 Aims of the chapter 
 
RNF43 is an E3 ubiquitin ligase crucial for fine regulation of the WNT signalling pathway 
at the plasma membrane through ubiquitination of Frizzled. Because the precise molecular 
events of this process, including the regulation of RNF43, still need to be clarified, my aim 
is to identify novel genes that have a functional connection to RNF43; I believe that this 
represents the fundamental starting point in order to understand in detail how RNF43 is 
capable of controlling membrane clearance of the WNT receptor. 
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For this purpose, an alternative gene-screening approach was created which would in 
parallel provide functional information on the candidate genes; such a strategy required a 
system of inducible RNF43 overexpression, referred to here as iRNF43 for simplicity, in 
combination with CRISPR/Cas9 knockout of genes encoding putative interactors of the 
RNF43 intracellular domain. 
In particular, the specific aim of this chapter is the establishment of a solid and reliable 
screening platform for the identification of functional partners of RNF43 which meets the 
following requirements: 
1) The induction of RNF43 overexpression results in a clear phenotypic effect supposedly 
due to WNT pathway downregulation (e.g. changes in cell morphology, cell death); as 
this represents the readout of the system, it must not leave any room for 
misinterpretation. 
2) Knockout of genes that are required for RNF43 function should counter the effect of 
its overexpression and be able to revert the phenotypic change associated with 
overexpression. 
The next section will describe two different iRNF43 systems that have been generated and 
tested to establish the most appropriate screening platform.   
 
 
3.2 Results 
 
3.2.1 iRNF43 mESC-based screening platform 
 
In order to capitalise on a previously described WNT-dependent system, mouse 
embryonic stem cells (mESC) were cultured in N2B27 medium supplemented with 10% 
WNT-conditioned medium and LIF (Leukaemia Inhibitory Factor), as it was previously 
reported that mESC can be maintained in an undifferentiated state under these conditions 
in a feeder-free culture by virtue of a synergistic action of WNT and LIF (Ogawa et al. 2006). 
Therefore, mESC cultured in this condition were initially considered as an ideal screening 
platform, since they represent a particularly convenient system for genetic screens, 
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including large scale screens, and also because the WNT/β-catenin pathway has been 
shown to play a major role in the maintenance of mESC pluripotency (ten Berge et al. 2011; 
Nusse et al. 2008). For instance, addition of WNT3a to mESC was reported to strongly 
promote their self-renewal and chemical inhibition of the WNT negative regulator GSK3 
was seen to facilitate ESC pluripotency (Sato et al. 2004).  
Based on these reports, I hypothesised that WNT pathway inhibition caused by RNF43 
overexpression would make ESC lose their pluripotency. 
In light of the above considerations, the first system established for the CRISPR/Cas9 
knockout screen was a stable line of mESCs with constitutive expression of rtTA-Cas9 and 
doxycycline-inducible expression of RNF43 together with a mCherry red fluorescent 
protein as a reporter. To generate this cell line the Tet-On method for inducible gene 
expression and the PiggyBac Transposon system were employed, as summarised in the 
schematic of Figure 3.1. The exploitation of this Transposon-based strategy for stable 
integration of transgenes into the genome offered several advantages over the more 
traditional lentivirus-based approaches, such as its time effectiveness, no limits in cargo 
capacity as wells as no need of producing viral particles beforehand.  
In my system, RNF43-mCherry overexpression was triggered by the addition of doxycycline 
and within 4 days of doxycycline addition, it was possible to observe a dramatic cell 
morphology change in the WNT+LIF + dox condition (Figure 3.2): RNF43 overexpressing-ES 
colonies lost their round and domed shape to become flat and much less compact.  
As a substantial body of literature shows that the role of the WNT/β-catenin pathway in 
both ESC pluripotency and differentiation is rather controversial (Kelly et al. 2011; Wray et 
al. 2011; ten Berge et al. 2011), I sought to probe more deeply what this morphological 
change meant. For instance, I speculated that the morphological changes observed in 
RNF43-overexpresisng cells could have been due to ESC differentiation caused by WNT 
pathway shutdown, as LIF alone was shown to be unable to sustain ESC pluripotency 
(Ogawa et al. 2004). 
To thus determine if RNF43 overexpression led to ESC differentiation, eGFP was targeted 
into the Rex1 locus to generate eGFP knock-in iRNF43 ESC. Rex1 is a commonly used marker 
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for naïve undifferentiated ES cells (Toyooka et al. 2008) that is rapidly downregulated at 
the onset of differentiation (Guo et al. 2011). 
If overexpression of RNF43 caused the morphological changes observed due to 
downregulation of WNT signalling and concomitant differentiation of the mESC colonies, 
as depicted in Figure 3.3, then I would expect doxycycline to induce a progressive reduction 
in Rex1-eGFP expression as the mESCs differentiate, concomitant with an increase in 
RNF43-mCherry expression. In this context, knockout of genes that are essential for the 
mechanism of action of RNF43 should prevent the loss of Rex1 expression in RNF43-
overexpressing cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
However, when the system was investigated by both flow cytometry and confocal 
imaging this hypothesis was rejected as the majority of iRNF43-expressing ESC still retained 
Rex1-eGFP expression after 5 days under WNT+LIF + dox conditions in spite of  morphology 
Figure 3.1 PiggyBac constructs for iRNF43-mCherry mESC generation. Schematic 
representation of the PiggyBac vectors used to generate a stable mESC line that 
constitutively expresses Cas9 and inducibly expresses RNF43-mCherry upon 
doxycycline treatment by exploiting the Tet-On system. In one vector, the Cas9 
sequence is linked to the reverse tetracycline trans-activator (rtTA) by a 2A peptide 
sequence (left), while the other vector carries the human cDNA sequence of RNF43 
fused to the IRES-mCherry reporter downstream of the Tet-responsive element (TRE; 
right). When doxycycline is provided, it binds to the rtTA activator that can then 
translocate into the nucleus, bind to the TRE region and activate RN43-mCherry 
transcription. Use of the PiggyBac SuperTransposase allows random, stable integration 
of the constructs into the genomic DNA (gDNA).  
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changes (Figure 3.4). Furthermore, both treated and non-treated samples in WNT+LIF 
showed higher levels of background differentiation compared to the control (Serum+LIF + 
2i: CHIRON + PD03, inhibitors of glycogen synthase kinase 3 and mitogen-activated protein 
kinase).  
I speculated then that the observed morphological change might have been an effect of 
RNF43 overexpression on the non-canonical WNT PCP (Planar Cell Polarity) pathway; for 
instance, RNF43 was reported to also inhibit this β-catenin independent signalling branch 
that regulates cytoskeleton organisation (Hao et al. 2012).   
These data, taken together, indicated that the iRNF43 ESC line was not a suitable 
platform for the CRISPR knockout screening because of the lack of a clear readout. Hence, 
it was needed to establish a different system, one in which the role of the WNT pathway 
was unequivocally crucial and well characterised.  
 
 
  
Figure 3.2 Doxycycline treatment test to iRNF43 mES clones. Three 
different iRNF43-mCherry ESC clones were subjected to doxycycline 
treatment. After 4 days, RNF43-mCherry expression is clearly detectable in 
all the cells under WNT+LIF + dox conditions. In particular, clone #5 shows a 
dramatic morphological change upon RNF43 overexpression, whereas 
colonies retain an undifferentiated morphology in both control 
Serum+LIF+2i (SL2i) and WNT+LIF conditions. Scale bar =400 µm. 
 
WNT+LIF WNT+LIF+ dox 
dox 
Serum+LIF+2
i 
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Figure 3.3 Working hypothesis for CRISPR/Cas9 screening in Rex1-GFP iRNF43 mESC. A) When 
Rex1-GFP iRNF43 ESC are cultured in WNT + LIF, the WNT ligand binds to its receptor Frizzled (Fzd), 
the signalling cascade is activated and cells present an undifferentiated morphology concomitant 
with Rex1-GFP expression. B) Upon doxycycline treatment, RNF43 is overexpressed and Fzd 
cleared from the cell surface, causing WNT signalling shut down. Since cells undergo profound 
morphology changes, we hypothesise they could be differentiating, which would result in loss of 
Rex1 expression. C) If doxycycline treatment leads to differentiation, performing knockout of 
genes that are functionally essential for RNF43 action could prevent the loss of undifferentiated 
morphology and Rex1 expression. 
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3.2.2 iRNF43 organoid-based screening platform 
 
Based on the results obtained with iRNF43 ESC, I decided to focus on mouse intestinal 
organoids for my screening platform. Although less straightforward for screening purposes 
than ES cells, intestinal organoids are heavily dependent on WNT/β-catenin signalling for 
their maintenance and survival, and clear phenotypes in this system are associated with 
alterations in WNT pathway activity. 
Therefore, a stable organoid line with doxycycline-inducible overexpression of RNF43-
mCherry was generated in a manner similar to that of the iRNF43 ESC lines by exploiting 
the PiggyBac Transposon systems (Figure 3.5), and subjected to doxycycline treatment. 
After 36 hours, all induced organoids showed a strong and homogeneous expression of 
mCherry and no leaky mCherry expression could be detected in non-treated samples 
(Figure 3.6).  
  
 
 
 
  
Figure 3.5 PiggyBac constructs for iRNF43-mCherry intestinal organoid generation. 
Schematic representation of the PiggyBac vectors used to generate a stable mouse 
intestinal organoid line that constitutively expresses the reverse tetracycline trans-
activator (rtTA) and inducibly expresses RNF43-mCherry upon doxycycline treatment 
by exploiting the Tet-On system. The human cDNA sequence of RNF43 fused with the 
IRES-mCherry reporter is located downstream of the Tet-responsive element (TRE); 
when doxycycline is provided, it binds to the rtTA activator that can then translocate 
into the nucleus, bind to the TRE region and activate RNF43-mCherry transcription. 
Use of the PiggyBac SuperTransposase allows random, stable integration of the 
constructs into the genomic DNA (gDNA).  
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In line with the importance of WNT signalling in the maintenance of intestinal stem cells, it 
was anticipated that overexpression of the WNT pathway negative regulator RNF43 would 
reduce the viability of intestinal organoids. To test whether RNF43 overexpression affected 
the viability of my system as predicted, organoids were cultured in doxycycline-containing 
medium for 3 to 5 days, passaged and maintained under these conditions until the culture 
was lost over time (Figure 3.7).  
Since organoid death/ survival seemed to be a clear phenotypic readout for my genetic 
screening, I hypothesised that organoids depleted of RNF43 functional interactor genes 
would remain viable in doxycycline-containing medium, as outlined in the updated model 
in Figure 3.8. More specifically, depleting an essential component for the action of RNF43 
should abolish Frizzled internalisation and so restore WNT activity levels back to normal. 
This will therefore allow organoids to survive even in the context of RNF43 overexpression. 
In summary, intestinal organoids with doxycycline-inducible overexpression of RNF43 
proved to be a much more appropriate system for my screening platform development, as 
RNF43 overexpression could effectively cause organoid death, a clear phenotypic effect 
resulting from WNT pathway inhibition.   
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Figure 3.6 Doxycycline treatment test to iRNF43 mouse intestinal organoids. iRNF43-
organoid clonal population showing strong and homogenous overexpression of RNF43-
mCherry 36 hours after doxycycline treatment. No RNF43 leaky expression can be observed 
in the non-induced organoids. Scale bar= 1000 µm. 
Figure 3.7 iRNF43 intestinal organoids die after prolonged RNF43 expression. After 3-5 days of 
doxycycline treatment, followed by passaging under the same culture conditions, iRNF43 
organoids start showing a drastic reduction in their viability. As expected, RNF43 overexpression 
leads to intestinal organoid death. Scale bar= 1000 µm. 
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Figure 3.8 Working hypothesis for CRISPR/Cas9 screening in iRNF43 mouse intestinal organoids. 
A) In non-induced iRNF43 organoids, WNT binds to its receptor Frizzled (Fzd) to activate the 
pathway and this sustains organoid growth and viability. B) Upon doxycycline treatment, RNF43 is 
overexpressed and FZD cleared from the cell surface, causing WNT signalling inhibition. As a result, 
organoids die over time. C) Under conditions of RNF43-overexpression, knockout of genes that are 
functionally essential for the mechanism of action of RNF43 could prevent organoid death, even 
though RNF43 is overexpressed. 
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3.2.3 iRNF43 organoid line validation 
 
The previous section has described the establishment and preliminary testing of the 
iRNF43 organoid line and pointed out those characteristics that theoretically make it a 
suitable knockout-screening platform for the identification of genes encoding RNF43 
functional interactors. Nevertheless, further validation of the system was required before 
carrying out the actual screening experiments that will be the focus of the next chapter.  
As already stated, the underlying idea behind my screening strategy is that knockout of 
genes with a functional connection to RNF43 can interfere with Frizzled internalisation and 
prevent organoid death, which is the phenotype associated with RNF43 overexpression 
(Figure 3.8). However, the ablation of other genes can also lead to organoid survival when 
RNF43 is overexpressed; for instance, the loss of any downstream negative effectors of the 
WNT pathway can also prevent organoid death. This is due to downstream activation of 
the WNT pathway that can bypass the inhibitory effect of RNF43 at the plasma membrane 
and the ablation of such downstream genes can be exploited to check that my system 
works according to predictions. 
Thus, iRNF43 organoids were transfected with a Cas9-expressing plasmid and gRNA-
expressing vectors against Axin1 and Axin2 as well as Rnf43 and Znrf3 (RZ), then induced 
with doxycycline and passaged under these culture conditions (Figure 3.9). Furthermore, 
transfected organoids were also subjected to withdrawal of the essential medium 
components WNT and RSPO, as a control to verify that CRISPR-mediated gene knockout 
had occurred; a schematic summary on the expected outcomes in terms of organoid 
survival under the different culture conditions can be found in Figure 3.10. 
As AXIN is a key component of the β-catenin destruction complex, its knockout is known 
to strongly boost WNT activity, as β-catenin cannot be degraded. In terms of organoid 
culture conditions, this translates into complete WNT ligand-independent β-catenin 
activity. Therefore, not only could Axin-knockout organoids be cultured in doxycycline-
containing medium, but they could also survive without any of the essential organoid 
medium components, RSPO and WNT, represented by growth under WEN (WNT-EGF-
Noggin) + Nic (Nicotinamide) and ENR (EGF-Noggin-RSPO) + IWP2 conditions, where IWP2 
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is a chemical inhibitor of the Porcupine palmitoyltransferase which is essential for WNT 
protein secretion. In this regard, it is important to recall that wildtype intestinal organoids 
can autonomously produce WNT ligands as they contain Paneth cells that are responsible 
for WNT3 production (Farin et al. 2012). For this reason, they do not require WNT-
conditioned medium to survive but, when treated with IWP2 that blocks WNT secretion 
from Paneth cells, they die unless they have some loss-of-function mutations in 
downstream negative effectors of the WNT pathway.  
Furthermore, my organoid platform and its compatibility with CRISPR gene editing tools 
were further validated by performing RZ knockout. As expected, loss of RZ was not 
sufficient to counteract the deleterious effect of RNF43 overexpression and RZ KO 
organoids died when treated with doxycycline, whilst being independent of RSPO addition 
when uninduced (growth under the WEN + Nic condition). As shown by Koo et al. in 2012, 
intestinal organoids lacking Rnf43 and Znrf3 are known to survive in medium lacking 
addition of RSPO, whereas control organoids die in the absence of RSPO.  
In conclusion, functional testing of the iRNF43 organoid line using CRISPR/Cas9 
confirmed the reliability and robustness of my screening strategy and underlines the 
decision to perform the knockout screen for genes encoding RNF43-interacting proteins in 
this system.   
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Figure 3.10 Schematic diagrams outlining WNT pathway activity and organoid survival under different 
medium conditions.  
The top panel summarises the WNT/β-catenin pathway in intestinal organoids cultured under three 
different medium conditions. In the standard WENR+ Nic condition (left), signalling is activated by the 
concomitant presence of WNT and RSPO ligands, the latter leading to RNF43 internalisation. During RSPO 
withdrawal (WEN+ Nic, middle), RNF43 is no longer removed from the cell surface and its inhibitory 
activity does not allow sufficient levels of WNT signalling for organoid survival. Finally, during WNT 
withdrawal (ENR + IWP2, right), the total absence of signalling-initiating ligands results in complete 
pathway shut down.  
The bottom panel summarises the outcomes in terms of organoid survival under different culture 
conditions depending on organoid genotype: WT organoids can only survive when the culture medium is 
supplemented with both RSPO and WNT, while Axin mutant organoids can survive regardless of the 
presence or absence of those components. RZ KO organoids do not need RSPO to promote RNF43 
internalisation but are still sensitive to WNT depletion.  
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3.4 Summary and conclusions 
 
In order to build a novel knockout-screening platform to test candidate genes for their 
functional connection to RNF43, two different inducible RNF43-overexpression systems 
were generated and tested.  
The first system to be established was an iRNF43 mouse embryonic stem cell line, for 
mainly two reasons: firstly, mESC are particularly suitable for screening purposes and 
secondly, their pluripotency maintenance has been previously shown to be dependent on 
WNT pathway activity (ten Berge et al. 2011; Nusse et al. 2008).  
Given these premises, I speculated that RNF43 overexpression and consequent WNT 
signalling downregulation would lead to ESC differentiation; however, prolonged 
doxycycline treatment did not result in the downregulation of the pluripotency marker 
Rex1, even though cells acquired a more differentiated morphology. Such phenotypical 
effect could simply be the result of actin cytoskeleton rearrangements following RNF43 
overexpression; for instance, this E3 ligase was also reported to affect the WNT PCP 
pathway (Hao et al. 2012), which is responsible for cell shape regulation (Oishi et al. 2003).   
The fact that the WNT pathway has also been associated with ES cell lineage 
diversification (Aubert et al. 2002) could be a possible explanation for the observed 
phenotype, together with the consideration that the precise role of WNT/β-catenin 
signalling in the maintenance of pluripotency, as well as the induction of differentiation, 
has always been regarded as controversial.  
For example, it was observed that the expression of a form of β-catenin which could not 
promote transcription did not impede the formation of undifferentiated colonies and that 
ablation of β-catenin itself could result in normal mES colonies within a few passages (Kelly 
et al. 2011; Wray et al. 2011). In addition to this, an increase in WNT transcriptional activity 
was reported to mark the early phases of the exit from pluripotency in ESC (Trott & 
Martinez Arias 2013).  
In light of these conflicting reports, it would appear that the WNT/β-catenin pathway can 
regulate both ES cell pluripotency and differentiation in a context-dependent manner and 
this makes it difficult to anticipate the effect of its downregulation on the ESC state. For 
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this reason, I was not able to establish a clear link between RNF43 overexpression and ESC 
differentiation and I decided to switch from ES cells to intestinal organoids for the 
development of my screening system.  
In comparison to mESCs, the role of WNT/β-catenin signalling in intestinal stem cells is 
more defined and this makes intestinal organoids a much simpler model system for 
identifying RNF43-related genes. WNT ligands are known to be essential stem cell niche 
factors in the murine intestine, responsible for promoting intestinal stem cell proliferation 
and maintenance of their self-renewal (Sato&Clevers, 2013); consistent with their role in 
the intestine, the same ligands are indispensable for the growth and maintenance of 
intestinal organoids, a system that therefore fully relies on the WNT/ β-catenin pathway 
for its survival (Sato et al. 2011). 
Given the clear role of WNT signalling in maintaining organoid viability, an organoid line 
with inducible RNF43 overexpression was successfully generated and tested for viability 
effects upon doxycycline treatment. Further testing by the application of CRISPR/Cas9 
validated iRNF43 organoids as a reliable and robust knockout screening platform. 
Specifically, knockout of the WNT negative regulator Axin could support organoid survival 
under a number of different culture conditions, regardless of RNF43 overexpression, and 
the absence of RSPO and/or WNT. Lastly, I also confirmed that depletion of RZ was not able 
to rescue the RNF43 overexpression phenotype, although non-induced organoids could 
survive in the absence of RSPO; an additional indicator that CRISPR technology can be 
successfully applied to my screening system.  
Taken together, these data validate my initial hypothesis on the working principles of a 
CRISPR/Cas9 knockout screen performed in RNF43-overexpressing organoids, as depicted 
in Figure 3.8. 
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Chapter 4  
 
CRISPR/Cas9-mediated knockout 
screening of RNF43-interacting 
proteins  
 
 
4.1 Aims of the chapter 
 
The focus of my work is the study of the mechanism(s) of action of RNF43, aimed at 
unravelling new players in Frizzled membrane clearance and RNF43 regulation. The 
previous chapter has described in detail the screening platform I designed as well as the 
organoid line established to identify potential novel genes with a functional connection to 
RNF43.  
Here, I show how I selected the candidate genes encoding putative RNF43-interacting 
proteins to perform their knockout in iRNF43 organoids and how this system provided us 
with preliminary functional insights into the role of these genes in the context of RNF43.  
Chapter 4 
 
71 | P a g e  
 
Therefore, the main aspects this chapter intends to address can be summarised as follows: 
1) Creation of a set of candidate genes for knockout screening following identification of 
mass spectrometry hits obtained from RNF43 Immunoprecipitation-Mass Spectrometry 
(RNF43 IP-MS) and subsequent generation of CRISPR constructs to target candidate genes 
and their paralogs;  
2) Description of the CRISPR knockout screen of the candidate genes in iRNF43 intestinal 
organoids to shortlist those candidates whose depletion promoted organoid survival in 
the context of RNF43 overexpression; 
3) Elucidation of where exactly in the context of WNT pathway regulation the identified 
candidates act, either in membrane-proximal events of Frizzled internalisation or in 
more downstream events of the signalling cascade. 
 
 
 
4.2 Results 
 
4.2.1 Selection of genes for CRISPR/Cas9 KO screening 
 
After establishing the organoid-based screening platform, the next step was to select 
the genes to screen by knockout in the iRNF43 line. Following a goal-oriented approach, I 
focused on the investigation of genes encoding proteins that emerged as potential RNF43 
interactors in RNF43 IP-MS (Immunoprecipitation-Mass Spectrometry).  
These preliminary data had been previously generated by Dr. Koo by performing RNF43 
pull-down followed by Mass Spectrometry (MS) analysis and the relative MS hit list was 
selected as a starting point in order to narrow down the number of candidate genes to be 
tested in organoids. 
The available MS dataset referred to a total of 5 independent experiments of RNF43 pull-
down followed by mass spectrometry analysis; for technical reasons, pull-down 
experiments had to be performed with three different RNF43 constructs: the full length 
(two technical replicates), the PA/TM RNF43 and ∆CRNF43 (two technical replicates).  
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The reason for this is that an unexpected cleavage of the full length protein was found to 
occur during sample processing prior to mass spectrometry analysis, resulting in truncation 
of the protein to only the intracellular domain of RNF43 (“full length RNF43”,  as indicated 
in Figure 4.1). To overcome this and avoid possible artifacts due to protein mislocalisation, 
a complementary deletion form containing the extracellular and transmembrane domains 
was generated (PA/TM RNF43) and employed to repeat the analysis. Interestingly, it was 
noticable that removal of the C-terminus (aa 524-784) from the full length protein greatly 
increased its stability (∆CRNF43) and therefore the experiment was repeated once more 
including this form. The different forms of RNF43 that were employed in IP-MS 
experiments are outlined in Figure 4.1, with each of them providing information on 
interactions occuring in different domains of RNF43.  
For this study, particular 
attention was paid to those MS hits 
showing the greatest number of 
peptides in the experiments 
conducted on the “full length” and 
∆CRNF43 forms; these hits were 
usually absent or had a low number 
of peptides in the PA/TM deletion 
form, suggesting that selected 
proteins were likely to interact with 
the cytoplasmic tail of RNF43. In this 
way, I thought possible to effectively 
identify molecules helping RNF43 to 
trigger Frizzled internalisation on the 
cytoplasmic side.   
Other criteria taken into account to 
narrow down the list of genes for 
screening included their expression 
in the mouse intestine and their 
Figure 4.1 Different RNF43 constructs used in mass 
spectrometry experiments. Three different types of RNF43 
constructs were employed for RNF43 pull-down followed 
by mass spectrometry: the “full length” (“FL” RNF43), a 
fragment containing PA and TM domains only (PA/TM) and 
a form with all the functional domains but lacking the C 
terminus for stability purposes (∆C RNF43). The PA/TM 
form was employed to compensate for a cleavage event 
during processing which left only the intracellular domain 
of FL RNF43 intact and the ∆C RNF43 form employed 
following recognition that removal of the C terminal 
portion resulted in increased stability.     
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known or putative function. For example, genes already known to  be implicated in 
processes like ubiquitination, membrane trafficking, the WNT pathway and endocytosis 
were of particular interest. In light of the above considerations, it is therefore worth 
mentioning that not only were the top-ranked hits chosen for the genetic screening, but 
also those that seemed promising based on their function, irrespective of a low MS score.  
Lastly, one additional parameter considered in the selection process was the number of 
paralogs each gene had; for instance, genes with more than 2 paralogs expressed in the 
intestine were excluded, given the difficulty of obtaining simultaneous knockout of that 
many genes.  
Thus, by combining all the MS data and considering the above-mentioned criteria, a list of 
27 genes was drawn up. The complete list can be found in Table 4.1, together with 
information about paralogs, MS score and gene function. 
In conclusion, this section has detailed the rationale for selecting the genes to be 
screened in iRNF43 organoids.    
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Table 4.1 Summary information about MS hits selected for CRISPR screen  
 
# GENES PARALOGS* 
MS 
SCORE** 
Function 
1 UBR2 UBR3 high E3 ubiquitin-protein ligase 
2 SLC12A2 
SLC12A8; 
SLC12A9 
high 
Mediates sodium and chloride ion 
reabsorption 
3 WDR26 - high 
Interacts with DDB1-CUL4A/B E3 
ligase complexes 
4 ARMC8 - high 
Armadillo repeat-containing 
protein 8 
5 EMERIN - medium 
Influences nuclear accumulation 
of beta-catenin  
6 ADAM17 - medium 
Proteolytic release of several cell 
surface proteins 
7 AP2M1 - medium 
Vesicle transport in different 
membrane traffic pathways 
8 VANGL1 VANGL2 medium 
Interacts with Dvl. Regulates 
wound healing in the intestine 
9 PLD1 PLD2 medium 
Implicated in numerous cellular 
pathways, including membrane 
trafficking 
10 ZMYND19 - medium Deubiquitinating enzyme 
11 TMED10 - medium 
Involved in vesicular protein 
trafficking, mainly early secretory 
pathway 
12 BAG6 - medium 
Misfolded protein binding and 
ubiquitin protein ligase binding 
13 ZYG-11B ZER1 medium 
Component of the E3 ubiquitin 
ligase complex ZYG11B-CUL2-
Elongin BC. 
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14 IGSF8 PTGFRN medium 
Prostaglandin regulatory-like 
protein 
15 SPTLC1 - medium Serine palmitoyltransferase 
16 BRI3BP TMEM109 low Involved in tumorigenesis  
17 SYNTENIN -1 SYNTENIN-2 low 
May play a role in vesicular 
trafficking 
18 DAAM1 DAAM2 low Interacts with Dishevelled and Rho 
19 DVL2 DVL1, DVL3 low 
Transducer of WNT signals to 
downstream effectors  
20 SORT1 SORL1; SORCS1 low 
Required for protein transport 
from the Golgi apparatus to the 
lysosomes 
21 UBL4A - low Component of the Bag6 complex 
22 SEC16A SEC16B low 
Secretory cargo traffic from the 
endoplasmic reticulum to the 
Golgi  
23 RAB8A RAB15; RAB10 low 
Regulators of intracellular 
membrane trafficking 
24 LMAN2 - low 
Involved in the transport and 
sorting of glycoproteins  
25 AP2A2 AP2A1 low 
Vesicle transport in different 
membrane trafficking pathways 
26 TMEM59 - low 
Regulator of autophagy and 
protein processing  
27 SH3BP4 MACC1 low Transferrin receptor endocytosis 
 
 
* According to TreeFam database of animal gene trees. Only genes expressed in the 
murine intestine 
** Low score: <3 peptides; high score: > 9 peptides 
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4.2.2 Single guide RNA vector generation for multiple gene knockout  
 
The final readout of my CRISPR knockout screening is a phenotypic effect caused by 
gene deletion in RNF43-overexpressing organoids; however, if a gene has multiple paralogs 
with similar functions, a phenomenon known as “genetic compensation” may occur when 
a single gene is knocked out and its role is replaced by a similar gene (Diss et al. 2014). 
Since this can mask any potential phenotypic effect, in my screening I aimed to perform 
knockout of the selected MS hits as well as their paralogous genes in order to overcome 
the limitations of single-gene knockout approaches. 
To achieve multiple gene knockout using CRISPR/Cas9 technology, our group has 
recently developed a one-step method to clone up to four different gRNAs into a single 
vector (Andersson-Rolf et al. 2016). As the backbone is composed of several consecutive 
gRNA expression cassettes, the construct has been termed a CRISPR-concatemer. Each 
cassette is approximately 400 bp and contains two inverted BbsI restriction sites, a U6 
promoter driving gRNA expression and a gRNA scaffold. During a cloning process involving 
Golden Gate assembly each BbsI site is replaced by a pre-annealed gRNA oligo with 
matching overhangs and permanently lost (Figure 4.2). Thus, our strategy exploits the 
unique nature of Type IIS restriction enzymes, like BbsI, in cleaving target DNA outside of 
their recognition sequences; in this way, each cassette can have a different sequence with 
customised overhangs flanking BbsI core sites and this can mediate the incorporation of 
different gRNA fragments at specific positions within the vector.  
The great advantage of this method is the ease of cloning multiple annealed gRNAs into 
the same vector in a straightforward one-step reaction, which is highly efficient because it 
is based on consecutive cycles of digestion and ligation until all BbsI sites are lost, as 
outlined in Figure 4.3. In addition, this tool is also extremely flexible since several versions 
of the vector exist differing in the number of gRNA cassettes (for cloning two, three or four 
gRNAs).  
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Another advantage to our CRISPR-concatemer approach is its versatility, as it can be 
used to perform simultaneous knockout of several genes as well as to increase CRISPR 
knockout efficiency by targeting the same gene with multiple gRNAs.  
For the planned screening, I generated constructs containing three or four different gRNAs, 
depending on the number of paralogs for each candidate: for genes with only one paralog, 
I designed two gRNAs to target each gene and cloned these into the 4 gRNA-concatemer 
vector (e.g PLD1/2), whereas for genes with no paralogs three gRNAs were designed to 
target the same gene and thus increase the efficiency of knockout (e.g. Bag6).   
In this way, gRNAs against all the selected MS hits and their paralogs were generated, 
specific overhangs were added to each end (Supplementary Table S7) and the resulting 
oligonucleotides were cloned into the required CRISPR-concatemer vectors. 
Figure 4.3 Schematic outlining the cloning strategy to integrate multiple gRNAs into the 
CRISPR-concatemer vector. The scheme illustrates the Golden Gate, or shuffling, reaction by 
which multiple annealed oligos are incorporated into a single concatemer vector by repeated 
cycles of BbsI digestion (37°C) and ligation (21°C). Each gRNA expression cassette has custom-
designed overhangs that originally constitute BbsI recognition sites. When BbsI digests the 
vector, its restriction sites are replaced by annealed gRNA oligos that are integrated thanks to 
their vector-matching overhangs. In this way, the BbsI sites are lost and the gRNAs cannot be 
removed during the following rounds of digestion (Andersson-Rolf et al, 2016).  
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To perform the CRISPR knockout screening, the gRNA concatemer vectors were 
introduced together with a Cas9 expression plasmid into iRNF43 organoids by 
electroporation (Merenda et al., 2017). Thanks to careful optimisation of the 
electroporation protocol for this organoid line using the NEPA21 Super Electroporator, it 
was possible to achieve very high levels of transfection efficiency (up to 70% with generic 
GFP-expression plasmids) so that I could confidently assume that the majority of the cells 
received both the gRNA expression vector and the Cas9 plasmid (Figure 4.4 B). 
In summary, gRNA vectors were generated for the selected genes as part of a CRISPR-
concatemer strategy for multiple gene knockout in RNF43-overexpressing organoids.  
  
A 
BF GFP 
CRISPR concatemer  
WT Cas9 
gRNA 1 gRNA 2 gRNA 3 U6 U6 U6 
B 
 
Figure 4.4 Intestinal organoid transfection by electroporation. A) CRISPR-concatemer vectors containing 
gRNAs targeting the selected MS hits and their paralogs are co-transfected with an equal amount of a 
WT Cas9 expression plasmid into intestinal organoids by using the NEPA21 Super Electroporator. B) 
Images of intestinal organoids electroporated with an eGFP-expressing plasmid showing a high 
transfection efficiency thanks to protocol optimisation.  
 
Chapter 4 
 
80 | P a g e  
 
4.2.3 Candidates of interest revealed by the CRISPR screen   
  
Following recovery from electroporation, iRNF43 organoids were subjected to 
prolonged doxycycline treatment and their survival was monitored after several rounds of 
splitting in order to functionally screen the selected MS hits (Figure 4.5 B). The same 
number of cells was seeded into each well and all wells were spilt in parallel at the same 
ratio for each round of splitting.  
Once again, knockout of the destruction complex component Axin was employed as a 
positive control, a proxy for the correct functioning of my screening system, as described 
in the previous chapter. In brief, Axin1/2 KO organoids can survive indefinitely despite 
prolonged RNF43 overexpression due to downstream activation of the pathway, in 
contrast to WT iRNF43 organoids which die around passage #2 when cultured in dox-
supplemented medium.   
While knock out of most of the candidates resulted in organoid death after 2-3 passages, 
the depletion of Daam1/2 could render organoids insensitive to RNF43 overexpression 
(Figure 4.5 C). Daam mutant organoids were comparable to Axin1/2 KO organoids in terms 
of their size, levels of RNF43 overexpression (indicated by the mCherry reporter) and 
growth rate; for example, they could be passaged at the same time and in the same ratio 
as Axin1/2 KO organoids for over 6-7 passages.  
Interestingly, knockout of Dvl also produced organoids capable of surviving prolonged 
doxycycline treatment, confirming previously reported observations according to which  
DVL is assisting RNF43 in promoting Frizzled internalisation (Jiang et al. 2015). 
Furthermore, as DAAM (DVL Associated Activator of Morphogenesis) is known to interact 
with DVL, albeit in the context of the WNT planar cell polarity (PCP) pathway, it was striking 
to see it emerging during the screening and I thus decided to further examine its role in the 
mechanism of action of RNF43.  
Nevertheless, DAAM is not the only potential interactor in RNF43-mediated 
downregulation of Frizzled my CRISPR screen in iRNF43 organoids revealed. A few other 
candidates from the MS hit list emerged as interesting molecules to study in the context of 
RNF43 activity and, even more broadly, WNT pathway regulation. For example, knockout 
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of Ubl4a, Sec16a and Slc12a2, together with their paralogs, resulted in organoids viable for 
over 6-7 passages in doxycycline-supplemented medium, similar to Axin KO organoids 
(Figure 4.6).  
In contrast to Daam, none of these genes has ever been associated with the WNT pathway 
before. Ubl4a is a known interactor of Bag6 that promotes tail-anchored protein biogenesis 
(Kuwabara et al. 2015), Slc12a2 encodes a solute carrier that mediates sodium and chloride 
reabsorption and SEC16A acts as a scaffold to recruit COPII components and facilitate 
protein export from the endoplasmic reticulum to the secretory pathway (Sprangers & 
Rabouille 2015).  
Considering that these biological roles refer to broad cellular processes, it might not be 
easy to pinpoint a direct contribution of the candidates to WNT pathway regulation, as 
they could directly or indirectly affect multiple signalling components in parallel. On the 
other hand, it is intriguing to consider the specific function these genes may have in the 
mechanism of action of RNF43 and/or WNT pathway regulation.  
Nonetheless, I decided to focus on DAAM for further characterisation as it already had a 
specific role in WNT regulation described in the literature. 
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Figure 4.5 Daam1/2 knockout renders intestinal organoids insensitive to RNF43 overexpression. A) 
Schematic representation of Daam1 and Daam2 genes with the relative targeted exons. Two gRNAs were 
used to target each gene. B) The scheme illustrates the experimental timeline followed when performing 
CRISPR knockout and doxycycline induction. Approximately 2 weeks after electroporation, RNF43 
overexpression was induced by addition of doxycycline and surviving organoids were cultured under 
these conditions for over 6 passages. C) Representative images of iRNF43 organoids in WENR +Nic + dox 
medium. After passage # 3, all WT iRNF43 organoids were dead but Daam1/2 KO organoids were still 
alive, similar to Axin1/2 KO organoids. Dvl knockout could also sustain organoid survival during RNF43 
overexpression, whereas knocking out R&Z could not. Scale bar= 1000 μm. D) Bar chart displaying iRNF43 
organoid survival in terms of number of passages according to genotype in WENR medium with or 
without doxycycline (red and blue bars, respectively). Data from two independent biological replicates. 
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Figure 4.6 Additional positive hits identified during CRISPR screening. A) Images of iRNF43 organoids in 
WENR +Nic + dox medium. After passage # 3, all iRNF43 WT organoids were dead, whereas knockout of 
the following genes enabled organoids to survive in dox-supplemented medium for over 6 passages, thus 
phenocopying Axin1/2 KO organoids: Ubl4a, Sec16a/b and Slc12a2/8/9. Scale bar= 1000 μm. B) Bar chart 
displaying iRNF43 organoid survival in terms of number of passages according to genotype in WENR 
medium with or without doxycycline (red and blue bars, respectively). The chart includes all MS hits 
screened (see also Table 4.1). 
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4.2.4 DAAM is identified as a potential component of RNF43-mediated Frizzled 
internalisation 
 
Since the previously described CRISPR screen does not provide any information on 
where in the pathway DAAM might act, growth factor withdrawal experiments in WT 
background organoids were necessary to understand whether the candidate was taking 
part in RNF43-related events at the plasma membrane or was instead implicated in more 
downstream events (described in Figure 4.7).  
Therefore, Daam KO organoids were subjected to withdrawal of both RSPO and WNT (EN 
and EN+IPW2 conditions, respectively) and their behaviour compared in parallel to the 
same set of controls, including WT, Axin KO and RZ KO organoids. 
As expected, WT organoids died after 1-2 passages in both culture conditions, while Axin 
mutants remained viable in both media conditions for several passages. What was 
interesting to observe was that knockout of Daam could perfectly mimic the RZ KO 
organoid phenotype, with Daam KO organoids insensitive to the absence of RSPO but 
sensitive to the complete absence of WNT (Figure 4.8). This allowed us to conclude that 
DAAM was likely to be involved in membrane-proximal events, potentially promoting 
Frizzled ubiquitination and internalisation together with RNF43.   
These data are preliminary and obviously need to be integrated with additional in vitro 
evidence in order to prove a direct link between DAAM and RNF43. The biochemical assays 
employed to assess Frizzled endocytosis and ubiquitination in a Daam-mutant background 
will be outlined in the next chapter. 
I next asked whether knockout of both paralogs, Daam1 and Daam2, was required to 
mediate such an effect in intestinal organoids, or whether loss of only one of them was 
responsible for it. To address this, the same withdrawal experiments were carried out but 
compared the behaviour of only single mutant organoids to controls, as summarised in 
Figure 4.9 B, C. Notably, knockout of Daam1 was sufficient for organoids to display 
insensitivity to RPSO withdrawal; this was actually not surprising considering that murine 
intestinal organoids predominantly express Daam1 (Figure 4.9 D). Importantly, these 
experiments were repeated from the beginning with independent sets of gRNAs, allowing 
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us to exclude the possibility that the observed phenotypes were a consequence of possible 
off-target effects (Figure 4.9 A).  
In conclusion, the knockout of Daam in intestinal organoids rendered them insensitive 
to RNF43 overexpression or to the absence of RSPO. These data indicate that DAAM is likely 
to participate in RNF43-mediated downregulation of Frizzled, possibly through direct 
interaction and the formation of a ternary complex with Dishevelled.  
 
 
 
  
Figure 4.7 Schematic diagram of the different levels of regulation of the WNT 
pathway. The scheme illustrates how RSPO and WNT withdrawal experiments 
can pinpoint if a candidate gene functions at the receptor level (pink rectangle) 
or in more downstream events of the WNT pathway (blue rectangle). For the 
former, since CRISPR knockout of genes involved in the mechanism of action 
of RNF43 can interfere with its inhibitory activity, intestinal organoids should 
become insensitive to the absence of RSPO. However, WNT ligands will still be 
essential in order to trigger pathway activation. For the latter, organoids 
depleted of downstream effectors of the WNT pathway would be completely 
unaffected by absence of either growth factor (e.g. Axin KO).  
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Figure 4.8 Daam1/2 knockout intestinal organoids are insensitive to RSPO withdrawal but are still 
dependent on WNT. A) The scheme illustrates the experimental timeline followed when performing 
CRISPR knockout and growth factor withdrawal experiments in intestinal organoids with a WT 
background. Approximately 2 weeks after electroporation, organoids were cultured both in the absence 
of RPSO (blue arrow) and WNT (red arrow) to determine viability. B) Images of intestinal organoids under 
three different culture conditions: WENR +Nic, EN (-RSPO) and EN +IWP2 (-WNT;-RSPO). After two 
passages, WT organoids could not survive under any of the withdrawal conditions, while Axin1/2 KO 
organoids could be cultured in both. Daam1/2 KO organoids instead displayed similar behaviour to RZ 
KO organoids, by being able to survive in the absence of RSPO but being sensitive to the absence of WNT. 
Scale bar= 2000 μm. C) Bar chart displaying organoid survival in terms of number of passages according 
to genotype in EN and EN +IWP2 culture conditions (blue and red bars, respectively). Data from two 
independent biological replicates. 
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Figure 4.9 Daam1 knockout is sufficient for intestinal organoid survival in the absence of RSPO. 
Continues on next page. 
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Although Daam remained my major focus, RSPO and WNT withdrawal experiments 
were conducted for the other candidates too, in order to gain more insight into their roles.  
While Sec16 KO phenocopied RZ and Daam KO, with organoids surviving only under EN 
conditions, the knockout of Slc12a surprisingly resulted in viable organoids under both 
withdrawal conditions, thus phenocopying Axin mutants (Figure 4.10). By contrast, Ubl4 
KO organoids rapidly died under both EN and EN+IWP2 conditions, similar to the WT 
control, suggesting that Ubl4 is not a strong candidate for further work. 
In summary, complementing my doxycycline screening with growth factor withdrawal 
experiments in organoids turned out to be an effective strategy to determine at what level 
in the WNT cascade my candidates were likely to be involved. 
 
 
 
Figure 4.9 Daam1 knockout is sufficient for intestinal organoid survival in the absence of RSPO.  
A) Schematic representation of Daam1 and Daam2 genes with the relative targeted exons. Different sets 
of gRNAs were employed, compared to previous experiments. B) Images of intestinal organoids in EN 
(RSPO withdrawal) and EN +IWP2 (WNT and RSPO withdrawal) media, with magnified areas (dotted 
outline) to the right. After two passages, no WT organoids could survive under any of the withdrawal 
conditions, while Axin1/2 KO organoids could be cultured in both. Daam1 single knockout could mimic 
the effects of Daam1/2 double KO, with organoids surviving under EN but dying under EN +IWP2 
conditions. By contrast, knocking out Daam2 only did not support organoid growth in EN. Scale bar= 1000 
μm. C) Bar chart displaying organoid survival in terms of number of passages according to genotype under 
EN and EN +IWP2 culture conditions (blue and red bars, respectively). D) Relative abundance of Daam2 
transcripts in mouse intestinal organoids compared to Daam1. 
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Figure 4.10 Further candidates tested using growth factor withdrawal. A) Images of intestinal organoids 
under growth factor withdrawal conditions: EN (-RSPO) and EN +IWP2 (-WNT;-RSPO). After two passages, 
WT organoids could not survive under any of the withdrawal conditions, while Axin1/2 KO organoids 
could be cultured in both. Surprisingly, KO of Slc12a could phenocopy Axin knockout, with organoids 
surviving in both growth factor-deprived media, and KO of Sec16 could phenocopy RZ KO, with organoids 
able to survive without RSPO but not without WNT. By contrast, Ubl4 KO organoids behaved like the WT 
control and died within a few passages. Scale bar= 1000 μm. B) Bar chart displaying organoid survival in 
terms of number of passages according to genotype under EN and EN +IWP2 culture conditions (blue and 
red bars, respectively). 
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4.3 Summary and conclusions 
 
An important first step in understanding the details of the mechanism of action of 
RNF43 is the identification of genes with a functional connection to RNF43 and the WNT 
pathway in general.   
Here I have shown how I successfully built a reliable and robust intestinal organoid-based 
screening platform with the intent of identifying RNF43-related genes. The system turned 
out to be particularly useful in order to screen selected mass spectrometry hits potentially 
interacting with the intracellular portion of RNF43. In particular, the choice of selectively 
focusing on potential RNF43 cytoplasmic interactors finds its motivation in the intent of 
identifying molecules taking part in the membrane-proximal events of RNF43-mediated 
Frizzled downregulation.   
As a result, the following genes emerged as promising candidates from the CRISPR 
knockout screening in iRNF43 organoids: Daam, Sec16, Slc12a and Ubl4 (Figure 4.11). I 
observed that knocking out each of these genes allowed organoids to survive regardless of 
RNF43 overexpression, suggesting that these gene products might have a role either in 
promoting RNF43-mediated surface clearance of Frizzled or in inhibiting WNT activity by 
other means. 
Hence, I conclude that my strategy validates at least some of the RNF43-MS hits, since it 
can immediately provide corroborative functional data on the screened candidates; this is 
a considerable advantage if compared to traditional validation approaches, such as co-
immunoprecipitation or the yeast two-hybrid screen. For instance, these assays provide 
information on the physical interaction between two proteins but are often carried out 
under non-physiological conditions, whereas organoid-based assays are performed in a 
contextual mammalian culture system. 
My system could be employed to screen even more candidates from the RNF43 IP-MS list 
in order to test more hits and, theoretically, it might also be possible to develop an 
analogous approach for other negative regulators of the WNT pathway in order to identify 
their functionally related molecules.  
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However, this screening strategy is not flawless and has some intrinsic limitations; for 
example, if a gene is essential for cell survival its knockout will result in organoid death 
soon after electroporation; in this case it would not be possible to subject organoids to 
doxycycline induction and screening could not be performed. Combining the current 
strategy with a Cas9-inducible system would be a potential method to overcome this 
limitation.  
Furthermore, another aspect worth taking into account when conducting a knockout 
screening is the eventuality that a gene is involved in multiple cellular processes and/or has 
multiple functions; under these circumstances, the observed screening outcome might be 
the result of indirect modulation of RNF43 or WNT/β-catenin pathway activity via unknown 
mechanisms. Thus, not all of the hits emerging from the CRISPR screening in iRNF43 
organoids are necessarily involved in membrane-proximal events. For this reason, growth 
factor withdrawal experiments are required and organoid data need to be supported by 
additional in vitro data too, which will be the focus of the next chapter.  
Lastly, although the screening can be extended to other MS hits, it will still only be possible 
to screen a limited number of candidates, given the labour-intensive nature of organoid 
culture that renders it unsuitable for high-throughput experiments.  
Despite the above-mentioned drawbacks, overall my screening approach was highly 
effective in identifying interesting candidate genes that are worthy of further investigation. 
These candidates might be involved either in Frizzled clearance or in RNF43 regulation 
and/or maturation and trafficking to the plasma membrane, an obvious candidate for this 
being the COPII coat assembly protein SEC16. Importantly, this study could bring some 
interesting new insights into WNT/β-catenin pathway regulation, since it is the first time 
these genes are being associated with it.  
Daam immediately caught my attention as a putative player in Frizzled downregulation, 
as it is already known to interact with Dishevelled, and it is intriguing to view it as a 
potential missing link to the unanswered questions raised by previous work on the role of 
Dishevelled in RNF43 activity (Jiang et al. 2015; Tsukiyama et al. 2015). In fact, the precise 
mechanism by which these two proteins cooperate is still unclear and it has been even 
suggested that their interaction might not be direct. 
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Following its clear ability to phenocopy R&Z, and given its previously described specific 
association with the WNT pathway, Daam was the candidate that I decided to focus on and 
I have thus tried to address its role in RNF43-mediated Frizzled clearance from the cell 
surface using both in vitro and in vivo approaches, as described in the next chapter. 
 
 
 
  
Figure 4.11 Schematic summary of candidate genes identified in the CRISPR knockout 
screen in iRNF43 intestinal organoids. When iRNF43 organoids are treated with 
doxycycline, Frizzled is depleted from the cell surface causing WNT pathway shut down and 
organoid death (A); however, ablating the following genes selected from RNF43 IP-MS hit 
lists allowed iRNF43 organoids to overcome the harmful effects of RNF43 overexpression 
and survive in doxycycline-supplemented medium: Daam, Sec16, Ubl4 and Slc12a (B). 
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Chapter 5  
 
The role of DAAM in RNF43-mediated 
clearance of Frizzled from the plasma 
membrane  
 
 
 
5.1 Aims of the chapter 
  
The CRISPR/Cas9 screen in iRNF43 organoids combined with growth factor withdrawal 
experiments proved to be a fruitful approach resulting in the identification of novel 
candidates with functional links to RNF43 activity or WNT/β-catenin pathway regulation. 
In particular, DAAM1 could be pinpointed as a potential new regulator of RNF43-mediated 
Frizzled internalisation. 
As a matter of course, DAAM has always been described in the context of the non-canonical 
WNT PCP pathway as a protein which interacts with Dishevelled to activate the small 
GTPases, RAC1 and RHOA, and promote cytoskeleton remodelling via JNK activation (Oishi 
et al. 2003). Nevertheless, what I aim for in this chapter is to characterise this protein in a 
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different context, which is the regulation of Frizzled surface levels within the canonical 
WNT/β-catenin signalling pathway.  
In order to understand how DAAM might participate in Frizzled downregulation, I 
employed in vitro, cell-based assays to analyse receptor behaviour in the presence or 
absence of DAAM upon RNF43 overexpression, in terms of the following: 
1) mature Frizzled levels;  
2) dynamics of Frizzled endocytosis; 
3) levels of Frizzled ubiquitination. 
Furthermore, I also examined the physical interaction between epitope-tagged versions of 
RNF43 and DAAM. 
Lastly, a separate goal of this study was the generation of a conditional DAAM1/2 double 
knockout mouse line to investigate the role of these genes in vivo in the murine intestine 
and to assess whether their depletion could still recapitulate the RNF43&ZNRF3 knockout 
phenotype.  
 
 
5.2 Results  
 
5.2.1 Characterisation of DAAM function in vitro 
 
 Organoid-based approaches highlighted DAAM as a potential interaction partner of 
RNF43, and the fact that this protein was already classified as interacting with Dishevelled 
(DVL) made it of particular interest in the context of regulation of Frizzled surface levels. 
Given its classification as a DVL interactor, I speculated that both DVL and DAAM together 
could be required for the efficient clearance of Frizzled from the cell surface and that 
perhaps DAAM was the missing piece within previously described DVL-mediated 
downregulation of Frizzled. Previous studies on this topic have failed to adequately 
describe the mechanism by which DVL promotes Frizzled clearance, although such studies 
did report cooperation of DVL with RNF43 (Jiang et al. 2015; Tsukiyama et al. 2015). Despite 
this advance, it is still unknown which region of DVL is responsible for RNF43 binding, 
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whether their binding is direct, and why RNF43 deletion mutants that have lost the ability 
to interact with DVL can still downregulate WNT/β-catenin pathway activity.   
To investigate this topic further and to try to understand the role of DAAM within the 
context of DVL-mediated Frizzled clearance, DAAM1 and DAAM1/2 knockout cell lines 
were generated in order to perform cell-based assays in collaboration with Dr. Jihoon Kim.  
For this purpose, human embryonic kidney (HEK) 293T cells were chosen as they possess 
the complete and intact WNT pathway machinery and, for this reason, are often employed 
in the investigation of both canonical and non-canonical WNT signalling. 
Thus, CRISPR/Cas9 technology was applied to HEK293T cells to obtain several clones with 
small frameshift mutations which were confirmed by TIDE analysis (Tracking of Indels by 
Decomposition, an online tool for quantitative assessment of CRISPR gene editing). While 
conducting TIDE analysis, it was possible to notice that some of the mutant clones 
displayed a small fraction of cells with a wildtype genotype; this could be due to 
contamination from WT cells during clone handling prior to genotyping or to reversion of 
frameshift mutations to in-frame modifications (Figure 5.1 A). 
Thus, an alternative approach that allowed the generation of additional CRISPR knockout 
clones was pursued in order to achieve insertion/deletions of larger portions of DNA (  ̴220 
bp); in this way PCR-based genotyping could be utilised to identify mutant clones and the 
risk of reversion was eliminated (Figure 5.1 B). While depletion of DAAM1 protein could be 
confirmed by Western Blot for all the clones, loss of DAAM2 could not be verified due to 
the lack of a specific commercial antibody; in order to circumvent the problem, AbFrontier 
was requested to produce a rabbit polyclonal antibody against DAAM2. 
Nevertheless, all the knockout clones described were employed in the analysis of the 
internalisation and ubiquitination behaviour of Frizzled5, a member of the WNT receptor 
family that was formerly reported as being prominently expressed in small intestinal 
epithelium (van Es et al., 2005). 
First, Frizzled5 endocytosis upon RNF43 overexpression was compared to WT cells in all 
the DAAM mutant cell lines with small frameshift mutations; pulse chase experiments with 
a SNAP-tagged version of Frizzled5 were conducted at different time points and, 
interestingly, they revealed that Frizzled internalisation was impaired in Daam1/2 KO cells 
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(Figure 5.2). For instance, while RNF43 overexpression could induce rapid receptor 
internalisation in WT cells, very little internalisation was observed following RNF43 
overexpression in the two different DAAM double KO clones with small frameshift 
mutations. Although Frizzled endocytosis did still occur in mutant cells, it was greatly 
reduced and cells could retain surface receptor labelling even after 2 hours compared to 
wildtype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.1 Daam KO HEK293T clones. A) DAAM1 and DAAM1/2 knockout HEK293T cells generated using 
CRISPR/Cas9 technology. The genotype of each clone is displayed in the table (from TIDE analysis) and 
the schematic below illustrates which exons are targeted by the different gRNAs. B) Additional DAAM KO 
clones with a representative western blot showing DAAM1 levels in the clones (right). These clones were 
generated by using a different CRISPR strategy targeting two gRNAs 200bp from each other against each 
gene. Such a large deletion allows PCR-based genotyping. The schematic illustrates which exons are 
targeted by the different gRNAs. 
DAAM1 DAAM2 
A 
B 
DAAM1 DAAM2 
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Because HEK293 cells are subject to large inter-clone variations in phenotype, pulse chase 
experiments were repeated with the additional DAAM KO clones created by deletion of 
larger genomic regions (Figure 5.3). When further clones were analysed, it was clear that 
there were large differences in terms of the dynamics of Frizzled internalisation between 
the mutant lines; in fact, only one DAAM1 KO clone retained Frizzled surface labelling after 
a 2-hour chase, whereas the receptor was seen to be internalised over time in all other 
clones at a rate similar to that of WT cells.  
Although all images shown here are representative of the relative cell populations, 
quantification will provide more solid basis to infer on each clone’s behaviour.   
Nevertheless, given the great variability of the dynamics of Frizzled internalisation between 
clones, I could not conclude that the endocytosis of Frizzled was altered in the absence of 
DAAM, although some clones did show a loss of internalisation upon loss of DAAM.  
In order to examine the internalisation of Frizzled over a longer time period, mature levels 
of V5-tagged Frizzled5 were checked by western blot 2 days after transfection in both WT 
and mutant cells, before and after RNF43 overexpression.  
This longer-term investigation demonstrated that the overexpression of RNF43 reduced 
Frizzled5 levels in both WT and DAAM KO cells in a comparable fashion; this effect was 
clone-independent and could be rescued by Bafilomycin treatment, which inhibits 
lysosomal protein degradation (Figure 5.4). 
Surface levels of V5-Frizzled5 were also investigated by FACS indirect staining with PE-
Texas Red®-conjugated antibody in DAAM1/2 knockout cells 2 days post-transfection. 
Once again, it was possible to observe complete Frizzled internalisation in both WT and 
mutant cells upon RNF43 overexpression (Figure 5.5). Interestingly, it was also noticeable 
that without RNF43 overexpression DAAM KO cells seemed to display higher levels of 
Frizzled5 at the cell surface when compared to WT, not only as a proportion of the 
population but also in terms of Texas Red intensity. 
However, despite an initial delay in some clones, Frizzled5 was cleared from the cell surface 
with comparable efficiency in WT and DAAM KO cells. 
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Figure 5.2 Dynamics of Frizzled internalisation in DAAM KO cells. Pulse chase 
experiments of SNAP-Frizzled5 comparing WT cells (panel A) and two DAAM1/2 
KO clones (panel B and C). Whereas RNF43 overexpression causes a rapid 
internalisation of Frizzled5 in WT cells (A), both DAAM1/2 KO clones retain 
significant surface labelling, even after 2 hours (B, C). The presence of intracellular 
puncta suggests that these cells are not completely deficient in the ability to 
internalise Frizzled, but internalisation is decreased compared to wildtype cells.     
  
C 
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Figure 5.3 DAAM mutant clones display variable dynamics of Frizzled internalisation. Pulse chase 
experiments of SNAP-Frizzled5 with additional DAAM KO clones. While Frizzled labelling appears to be 
slightly higher in DAAM mutant clones when compared to WT cells at time 0 upon RNF43 overexpression, 
surface levels of the receptor decrease over time at a comparable rate in all samples, except for DAAM1 
KO clone E1 which retains Frizzled labelling even after 2 hours, as observed with the original DAAM KO 
H11 and B11 clones. 
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Figure 5.4 RNF43 overexpression reduces Frizzled5 levels in both WT and Daam KO cells. Western blot 
comparing mature FZD5 levels in WT and DAAM KO HEK293T 2 days post-transfection. Regardless of 
FZD5:RNF43 transfection ratio, RNF43 overexpression reduces Frizzled5 to comparable levels in both WT 
and DAAM1 KO cells (E1 clone, A). Bafilomycin treatment can restore FZD5 to basal levels under all 
conditions by inhibiting lysosomal protein degradation. B) A similar decrease in Frizzled5 levels is seen in 
both WT and DAAM1/2 double KO cells (A7 and G1 clones). 
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Given that Frizzled endocytosis did not seem to be significantly affected by the absence 
of DAAM, ubiquitination of Frizzled was investigated next.  
Immunoprecipitation of V5-Frizzled5 followed by western blot against HA-ubiquitin 
showed that RNF43 overexpression was able to induce ubiquitination of Frizzled in both 
WT and DAAM1 KO cells. Bafilomycin treatment increased the level of ubiquitination in 
both WT and DAAM1 KO cells. Moreover, levels of receptor ubiquitination again appeared 
to be very similar between knockout and control, suggesting that Frizzled5 ubiquitination 
was unlikely to be impaired in the absence of DAAM (Figure 5.6). 
However, before concluding that Frizzled surface levels are not regulated by DAAM in 
HEK293T cells, the same experiments should ideally be repeated by looking at the global 
endogenous population of Frizzled receptors. 
Figure 5.5 Frizzled5 surface expression is downregulated following RNF43 
overexpression in both WT and DAAM KO cells. FACS analysis of V5-Frizzled5 
surface levels revealed that RNF43 overexpression could induce receptor 
internalisation in both WT and DAAM KO cells (H11 clone) to a comparable 
level. Surface levels of V5-FZD5 were analysed by staining with a PE-Texas 
Red®-conjugated secondary antibody in GFP+-gated cells 2 days after 
transfection. 
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Finally, to check whether DAAM1 and 
RNF43 could physically interact with 
each other, co-immunoprecipitation 
experiments were performed on 
epitope-tagged proteins. I could not 
detect evidence of direct physical 
interaction, as only a faint band could be 
seen on the western blot after a long 
exposure.  
However, when DVL2 was co-
transfected with RNF43 and DAAM1, it 
was possible to detect an interaction 
between DAAM1 and RNF43 (Figure 
5.7). The observation that DVL2 seems 
required to trigger DAAM1 binding to 
RNF43 is quite interesting and supports 
my initial hypothesis of a ternary 
complex regulating the RNF43-mediated 
downregulation of Frizzled.  
This result raised various questions: what are the respective roles of DAAM and DVL? Do 
they cooperate to enhance RNF43 function? Does DAAM act as a cofactor for DVL, or are 
both equally important? 
Given the inconclusive nature of the results presented in this section, it is clear that 
further investigation to elucidate the role of DAAM is needed and experiments to better 
characterise its in vitro function are ongoing.   
Figure 5.6 Frizzled5 ubiquitination levels are 
unchanged in DAAM KO cells. Ubiquitination assay 
showing that, in both WT and DAAM1 KO cells, RNF43 
overexpression leads to augmented Frizzled5 
ubiquitination. No significant difference can be 
observed in FZD ubiquitination levels between WT 
and mutant cells (red rectangles). Bafilomycin 
treatment emphasises accumulation of the 
ubiquitinated receptor.  
V5- Fzd5 
RNF43-HA 
HA-Ubiquitin 
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5.2.2 Study of the in vivo role of Daam in the small intestine 
 
The majority of the in vivo studies investigating Daam1 and Daam2 have been 
conducted on Drosophila and Xenopus and have highlighted the importance of these genes 
in the regulation of actin cytoskeleton organisation and in tissue morphogenesis 
(Prokop  Andreas et al. 2011).  
Mouse genetic studies have also confirmed a prominent role for Daam1 in development, 
as Daam1-deficient mice exhibited embryonic and neonatal lethality due to several cardiac 
abnormalities (Li et al. 2011). More recently it has been shown using a conditional double 
knockout approach that both Daam1 and Daam2 are required for cardiomyocyte 
maturation (Ajima et al. 2015) but until now, no reports have attempted conditional 
depletion of both genes in the intestine. 
Consultation of the Catalogue Of Somatic Mutations In Cancer (COSMIC) reveals a 
prevalence of point mutations in both DAAM1 and DAAM2 (especially missense) in human 
Figure 5.7 An interaction between RNF43 and DAAM1 is detectable in the presence of DVL2. Co-
immunoprecipitation experiments demonstrate that Myc-DAAM1 can interact with DVL2-HA, but not 
with RNF43-FLAG or FZD5-V5. However, when DVL2 is co-transfected with RNF43-FLAG and Myc-DAAM1, 
it possible to observe a DAAM1 band in the FLAG pull-down (red rectangles). Of note, pre-treating cells 
with RSPO-conditioned medium does not have any effect (left).  
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tumours of the gut epithelium, at frequencies ranging from 2.21% to 3.82% in the intestine. 
By comparison, mutations in the well-known tumour suppressor RNF43 are found in 5.77% 
of small intestinal tumours. 
In light of the above, I decided to generate an intestine-specific Daam1 and Daam2 
double knockout mouse model and to analyse whether Daam depletion could recapitulate 
the Rnf43&Znrf3 KO phenotype.  
In order to accelerate the time-consuming process of mouse line generation, a line with 
ubiquitous inducible expression of Cas9 (Rosa26-floxed STOP-Cas9 or Rosa-iCas9 for 
simplicity) was imported and crossed with a tamoxifen-inducible, intestine-specific Cre-
expressing line, VillinCre-ERT2.  
Thence, the first step was to rederive ESC from double heterozygous mice and to apply our 
CRISPR-concatemer strategy to them in order to obtain a gRNA-carrying Rosa-
iCas9::VillinCre-ERT2 ESC line. Our concatemer constructs are based on the MSCV retroviral 
vector backbone and thus can be exploited to infect ESC and stably modify their genome 
by gRNA integration (Figure 5.8).  
Cells in which the gRNA expression cassette against Daam1 and Daam2 had been 
integrated were used for blastocyst injection and successfully contributed to chimera 
generation with 12.5% efficiency (90-95% chimerism). Injection of WT Rosa-
iCas9::VillinCre-ERT2 ESC was carried out in parallel to create matching controls.  
As a pilot study, preliminary experiments were conducted on adult chimeras which were 
injected with 3 mg of tamoxifen and analysed after either one or two weeks from induction. 
These time points were chosen based on the fact that Rnf43&Znrf3 KO mice already show 
intestinal adenoma formation after one week from tamoxifen treatment (Koo et al, 2012).  
However, at these stages it was not possible to identify any morphological alteration or 
difference in the epithelium thickness of my gRNA-carrying chimeras compared to the 
wildtype control from hematoxylin and eosin staining (Figure 5.9). Thus, the sections were 
stained for Ki67 to evaluate whether gRNA-carrying mice were characterised by an 
increased proliferative activity, but this was not the case as both WT and gRNA-carrying 
mice showed comparable Ki67 staining at the bottom of the crypts. It would therefore 
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appear that depletion of Daam1 and Daam2 does not lead to a clear phenotype in these 
mice.  
Immunohistochemistry for DAAM1 and DAAM2 levels is necessary to demonstrate that 
gene knockout has occurred as required, and that both proteins are absent in the intestine 
of gRNA-carrying chimeras. Only once this is confirmed it can be definitively concluded that 
no phenotype is evident 2 weeks from Daam1/2 depletion in the mouse intestine. 
Moving forwards with this part of the study, rederived ESC were shown to be germ-line 
competent and so further experiments are now ongoing with the progeny of the chimeras. 
For instance, it could be possible that a longer time is needed for Daam depletion to 
generate a phenotype when compared to RZ KO mice and it is also possible that this 
CRISPR-based system takes longer to achieve conditional knockouts compared to 
conventional strategies based on floxed genes. This is plausible as, following tamoxifen 
injection, Cre recombinase must translocate to the nucleus in intestinal cells and excise the 
stop codon in front of Cas9 to trigger its expression before the genes of interest can then 
be targeted.    
In conclusion, I have presented an alternative system that could potentially be very 
useful for the generation of conditional knockout mouse lines in a timely manner.  
This strategy has been employed to allow the double knockout of Daam1 and Daam2 in 
mouse intestine; although no manifest phenotype could be observed in preliminary 
experiments, further studies are still required to validate the efficacy of the strategy.  
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Figure 5.8 Daam1/2 conditional double knockout mouse generation. A) Schematic drawing illustrating 
the steps in conditional knockout mouse line generation. Double heterozygous Rosa-iCas9::VillinCreERT2 
mice are crossed with WT 129 background mice to rederive ESC ready for viral infection of gRNAs against 
Daam1 and Daam2. Infected ESC are then used to generate adult chimeras that can be injected with 
Tamoxifen to induce Daam1/2 knockout in the mouse intestine. B) Representative pictures for the 
different steps in the ESC rederivation protocol: 1) culturing of E2.5 embryos; 2) attachment of the ICM 
(inner cell mass) to the feeder layer; 3) rederived ESC colonies growing on feeders. C) Genotyping PCR to 
confirm that clone #3 has inherited both alleles (Rosa-iCas9 and VillinCreERT2). D) Positive control for 
successful viral infection in rederived ESC (pMSCV-GFP). 
 
Chapter 5 
 
109 | P a g e  
 
  
Figure 5.9 Cas9 induction does not result in any obvious phenotype in the 
small intestine of chimeric mice carrying gRNAs against Daam. A) H&E 
(hematoxylin and eosin) staining of mouse intestinal epithelium of 
RosaiCas9::VilCreERT2 chimeras obtained from injection of both WT and 
gRNA-infected ESC, 1 or 2 weeks after Tamoxifen administration. Cas9 
induction does not seem to cause any morphological alteration in the 
epithelium of gRNA-carrying chimeras. B) Ki67 staining of mouse intestinal 
epithelium 2 weeks after Tamoxifen treatment does not show any 
increased proliferation in gRNA-carrying chimeras compared to wildtype 
chimeras.  
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B 
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5.3 Summary and conclusions 
 
The CRISPR screen in intestinal organoids and subsequent growth factor withdrawal 
experiments highlighted DAAM as an interesting candidate for further study in order to 
characterise the mechanism of action of RNF43. 
Thus, I started investigating the role of DAAM in RNF43-mediated downregulation of 
Frizzled through a series of in vitro assays aimed at examining Frizzled endocytosis and 
ubiquitination in DAAM knockout HEK293T cells compared to WT cells. 
Pulse chase experiments suggested that upon RNF43 overexpression, Frizzled 
internalisation did not occur at the WT rate in DAAM KO clones as receptor surface labelling 
could be retained for up to 2 hours. However, with further analysis clone-to-clone 
variations in Frizzled endocytosis could be observed, and at least some of the mutant 
clones behaved similarly to the control. Further, complete removal of Frizzled from the cell 
surface could be achieved in the presence or absence of DAAM 2 days after transfection, 
as confirmed by both western blot and FACS experiments. In addition, no significant 
differences in Frizzled ubiquitination levels between DAAM KO and WT cells could be 
detected upon RNF43 overexpression. 
Overall, it was surprising that the results of the cell-based assays did not support the 
phenotype and the hypothesised role of Daam observed in organoids; it is therefore 
planned to repeat all experiments by analysing endogenous receptors with a pan-Frizzled 
antibody in order to globally monitor all the Frizzleds expressed at the cell surface and not 
just Frizzled5. It cannot be excluded that different members of the Frizzled family may be 
subject to different mechanisms of regulation by RNF43.  
One additional aspect worth pointing out is that my in vitro system in HEK293 cells is rather 
far from physiological conditions as it is based on overexpressed proteins. For instance, 
having large amounts of both Frizzled and RNF43 at non-physiological levels could increase 
their ability to interact by simple kinetics, potentially masking any effect of DAAM in 
promoting association at physiological levels.  
On the other hand, it is also plausible that Daam has a context-dependent role, and that 
an immortalised cell line like HEK293 does not represent an appropriate system for the 
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study of its mechanism of action. If this is the case, checking Frizzled endocytosis and 
ubiquitination in mutant organoid lines will be essential.  
Lastly, since HEK293 cells are of human origin and organoids are murine, potential specie-
specific effects should be taken into account. 
Based on recent reports demonstrating how the inhibitory activity of RNF43 relies on 
the  presence of Dishevelled (Jiang et al. 2015; Tsukiyama et al. 2015), I postulated that 
DAAM could physically bridge RNF43 and DVL. Although this hypothesis was strengthened 
by my co-immunoprecipitation experiments showing that DVL2 overexpression seemed to 
induce DAAM1 binding to RNF43, additional experiments are necessary in order to 
generate evidence for the formation of a ternary complex. Biophysical methods for the 
study of endogenous protein complexes such as Proximity Ligation Assay (PLA) or Protein 
complementation assays (PCAs) will be key in the understanding of the interaction 
dynamics among RNF43, DVL2 and DAAM1. 
For instance, the respective roles of each player are still unclear and further investigation 
is necessary; for example, DAAM and DVL could synergise in binding to RNF43, each with 
similar contributions to binding, or DVL could be the more important partner.  
If it is true that DAAM has a secondary or partly redundant role compared to DVL, it could 
be worthwhile to perform the same in vitro experiments in a DVL mutant background to 
assess whether Frizzled internalisation and ubiquitination are affected under these 
circumstances.  
In parallel to the in vitro studies, I also pursued the investigation of the role of Daam in 
vivo by adopting an alternative CRISPR-based strategy for generating a conditional 
Daam1/2 knockout mouse line. 
Preliminary experiments on adult chimeras injected with tamoxifen to induce Cas9 
expression, and consequently gene knockout, have failed to highlight differences in 
morphology and proliferation activity in the intestine of gRNA-carrying mice compared to 
controls. However, proving that the system has worked and that both genes have been 
depleted in the intestinal epithelium is an absolute prerequisite for definitive conclusions.  
In this regard, it is noteworthy to mention that the alternative strategy I employed relies 
on the concerted action between an inducible Cas9 and constitutively expressed gRNAs 
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and it might not be as efficient as expected in terms of knockout induction. We ignore, for 
example, the number of copies of retroviral DNA (the concatemer vector against Daam1/2) 
that got inserted into ESC genome following their infection and thus it is not possible to 
predict whether the gRNA dosage in each cell is sufficient for Cas9 activity. 
In addition, this is the first time that our concatemer strategy has been applied in vivo and 
we are still in the process of assessing its efficiency and robustness. For this reason, all 
mouse experiments will be repeated with existing conditional Daam KO lines as a backup 
plan in case my system turns out to be unsuitable.  
Taken together, the observations made so far have pointed out on one hand potentially 
conflicting data between two different in vitro systems, while on the other hand they have 
hinted promisingly at the formation of a ternary complex between RNF43, DVL and DAAM. 
A deeper analysis of these membrane-proximal events, combined with in vivo studies, is 
now ongoing and will hopefully clarify the mechanism of RNF43-mediated Frizzled 
downregulation as well as the role that DAAM fulfils. 
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Chapter 6  
 
Investigation of other PA-RING family 
members 
 
 
6.1 Aims of the chapter 
 
In recent years, several reports describing the role of E3 ubiquitin ligases in the 
regulation of membrane signalling have seen ubiquitination move to centre stage as a 
critical regulatory modification, especially in terms of membrane receptor remodelling 
(MacGurn et al. 2012). For instance, E3 ligases like Nedd4 and Cbl were shown, 
respectively, to regulate the FGF and EGF signalling pathways (Persaud et al. 2011; 
Umebayashi 2008), in the same way that RNF43 and ZNRF3 modulate the WNT pathway, 
namely by the ubiquitination of the signalling receptor leading to its subsequent 
internalisation.    
Bioinformatics studies have identified an additional 10 transmembrane E3 ubiquitin 
ligases in human that are closely related to RNF43 and ZNRF3 through sequence homology 
and domain organisation; these proteins have therefore been designated as members of 
the the same gene family, the PA-RING family, which remains mostly uncharacterised. 
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In light of this, it is possible that additional PA-RING ligases could have a similar function to 
RNF43 by targeting signalling receptors, or more generally, transmembrane proteins, for 
degradation. In addition, I thought that elucidating the mechanism of action of RNF43 
could provide new insights into other PA-RING family members and generalities of their 
molecular behaviour. 
Amongst all of the many unexplored aspects and possible questions, I specifically 
focused on the following:  
 
1) Addressing the potential involvement of other PA-RING members in the regulation of 
the WNT pathway, and 
2) Identifying molecular targets for some representative members of the family. 
 
This chapter describes how PA-RING ligases were overexpressed in mouse intestinal 
organoids in parallel with RNF43 to address the first question, and how Surface Proteome 
Analysis was employed in order to address the second question and identify new targets 
for the selected E3 ligases.   
Overall, the ultimate goal of this study is to unravel the biological function of some of the 
uncharacterised PA-RING family members and potentially link them to the regulation of 
transmembrane proteins.    
 
 
6.2 Results 
 
6.2.1 Overexpression screen of PA-RING members in intestinal organoids 
 
Given their remarkable structural similarity to RNF43 and ZNRF3, it is reasonable to 
assume that there could be additional PA-RING family members involved in the regulation 
of the WNT pathway. 
In order to test this hypothesis, mouse intestinal organoids were employed once again as 
a physiologically relevant model system to perform gain-of-function experiments of 
uncharacterised PA-RING E3 ligases.  As already outlined previously, the WNT pathway 
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plays a pivotal role in the maintenance of intestinal organoids, and for this reason, they 
represent a particularly useful system to study genes that could potentially be involved in 
the regulation of WNT signalling. 
Therefore, PA-RING family members were cloned into a retroviral vector suitable for Cre-
induced overexpression and before being transduced into WT organoids carrying the Villin-
CreERT2 transgene; of note, PA-RING genes were placed downstream of a floxed dsRed 
cassette, removal of which allowed their overexpression (Figure 6.1 A). Protein expression 
of the candidate genes was confirmed by western blot using HEK293 cells transfected with 
the same retroviral vectors in which the dsRed cassette had been removed prior to 
transfection by amplification in Cre-expressing E. coli (Figure 6.1 B).  
Stably transduced organoids were selected with Puromycin before being induced with 4-
hydroxytamoxifen (4-OHT) to trigger overexpression of my genes of interest. The pMSCV 
loxP-dsRed-loxP-eGFP vector was used in parallel as a control to test the correct 
functioning of the cassette in organoids; for instance, when 4-OHT is administered to Villin-
CreERT2 organoids, the dsRed cassette is removed and organoids lose dsRed fluorescence 
to acquire GFP expression (Figure 6.2 B, panels V-VIII).  
Growth and survival of PA-RING-expressing organoids were then tested under two 
different culture conditions: standard ENR medium and in EN medium lacking RSPO.  
AS RSPO is a strong WNT pathway agonist, it is an essential component of the growth 
medium that allows survival of intestinal organoids; consequently, if a gene involved in 
WNT pathway activation is overexpressed it should render organoids viable in the absence 
of RSPO, and similarly, overexpression of a gene involved in WNT signalling inhibition 
should lead to organoid death, as is observed with overexpression of RNF43. 
As summarised in Table 6.1, none of the candidates caused organoid death when 
overexpressed, such as in the case of RNF43-overexpressing cultures, suggesting that no 
other PA-RING members play a similar role to RNF43 in downregulation of the WNT 
pathway. On the other hand, none of the candidates promoted organoid survival under 
RSPO withdrawal when overexpressed, indicating that none of them is involved in WNT 
pathway activation either. 
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Nevertheless, since I could not exclude any possible masking effects of paralog 
compensation, the same overexpression screen was conducted in Villin-CreERT2 organoids 
that lacked expression of both RNF43 and ZNRF3 (RZ KO). As a reminder, this organoid line 
displays the phenotype of survival in the absence of RSPO because WNT receptor levels are 
not downregulated. 
As a result, while the overexpression of RNF43 led to rapid organoid death in both ENR and 
EN medium due to WNT pathway downregulation, the overexpression of other PA-RING 
family members did not affect organoid growth or survival (Figure 6.3). This indicated that 
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Figure 6.1 Retroviral construct for E3 overexpression in intestinal organoids.  
A) Retroviral expression vector carrying the cDNA of my genes of interest (GOI) 
for their conditional overexpression in VillinCreERT2 organoids. The expression 
cassette is flanked by LTR (long terminal repeat) regions for genome integration 
and contains a floxed dsRed cassette upstream of the GOI. The Puro resistance 
cassette allows selection of stably transduced organoids and the WPRE sequence 
enhances expression of the construct. B) Confirmation by western blot of protein 
overexpression of PA-RING members in HEK293T cells. 
Chapter 6 
 
118 | P a g e  
 
none of the PA-RING ligases behaved similarly to RNF43 by being able to revert the RZ KO 
phenotype when overexpressed.  
Taken together, these data indicate that no E3 ligases in the PA-RING family, other than 
RNF43 and ZNRF3, are likely to be involved in modulation of the WNT pathway. Further, 
none of the candidates when overexpressed led to either organoid death under standard 
culture conditions or increased survival under growth factor withdrawal, suggesting that 
there are no members of the family acting either to inhibit or to promote WNT pathway 
activity, respectively.  
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Figure 6.2 Viral transduction of intestinal organoids for E3 overexpression 
screening. A) Timeline of the overexpression screen of PA-RING members in 
intestinal organoids. Continued on next page. B) Organoids successfully transduced 
with pMSCV-eGFP display green fluorescence in WENR+Nic medium 3 days after 
infection (I) and in ENR medium 2 weeks after infection (II). Organoids successfully 
transduced with pMSCV-dsRed display red fluorescence in WENR+Nic medium 3 
days after infection (III) and after 2 weeks in ENR medium (IV). Scale bar = 400µm. 
Panels V-VIII show an organoid transduced with loxP-dsRed-loxP-eGFP that has 
lost red fluorescence and has started expressing GFP 4 days after 4-OHT treatment. 
Scale bar = 400µm. 
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Table 6.1 Gain-of-function experiment using overexpression of PA-RING members in 
VillinCreERT2 intestinal organoids. 
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Figure 6.3 Gain-of-function experiment using overexpression of PA-RING members in RZ KO 
VillinCreERT2 intestinal organoids. Overexpression of PA-RING E3 ligases in RZ KO organoids after 4-OHT 
treatment, carried out in both ENR and EN media. While overexpression of RNF43 resulted in complete 
organoid death after passage 2 in both ENR and EN media, overexpression of other PA-RING family 
members did not affect organoid survival and cultures could be propagated over the course of 4 passages, 
suggesting that no other members of the family are likely to have a similar role to RNF43 and ZNRF3. Scale 
bar = 400 µm.  
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6.2.2 Identification of novel targets of PA-RING proteins by Surface Proteome 
Analysis  
 
Overexpression experiments with additional PA-RING family members in intestinal 
organoids suggested that there are no additional members likely to interact with Frizzled 
receptors and to work in WNT pathway regulation. Hence, I next asked whether these 
members were involved in the regulation of some other signalling pathway or more 
generally in targeting transmembrane proteins for degradation. By address this question 
and investigating the molecular targets of some representative members of the family, it 
was hoped to gain more insight into PA-RING proteins and their biological function.  
Accordingly, one member of each unexplored branch of the PA-RING family 
phylogenetic tree was selected for further characterisation through a proteomic approach. 
Based on their expression levels in various tissues, RNF13, RNF128 and RNF150 were 
selected because of their broad expression pattern (Figure 6.4). Stable HEK293 cell lines 
were generated for their inducible overexpression by exploiting the T-REx™ system based 
on dox-dependent Tet Repressor release from the Tet operator, as described in Figure 6.5 
A. Single clones were screened by western blot for their capacity to express my HA-tagged 
genes of interest upon doxycycline treatment and their homogeneous expression was 
confirmed by immunocytochemistry (Figure 6.5 B, C). For completeness, my initial plan was 
to generate also RNF215-overexpressing cell lines but a series of technical difficulties 
hampered the study of the E3 ligase, which is the most closely related to RNF43 and ZNRF3. 
Thus, two clones for each candidate gene were chosen to undergo Surface Proteome 
Analysis or SPA, a novel mass spectrometry-based technique developed by Dr. Koo to 
identify the targets of RNF43 (Koo et al, 2012). Briefly, the technique relies upon 
comparative mass spectrometry between membrane fractions of E3 ligase-overexpressing 
cells (dox-treated samples) and control cells (non-treated samples); this method should 
highlight those proteins whose levels are significantly reduced in dox-treated samples and 
who are therefore candidate targets for the E3 ligase of interest (Figure 6.6). 
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After treating cells with doxycycline overnight, surface proteins were labelled with biotin 
and subsequently pulled down by NeutrAvidin affinity to obtain membrane fractions that 
were then used in mass spectrometry. 
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Figure 6.4 PA-RING protein comparison. A) RNF13, RNF128 and RNF150 were the selected PA-RING 
members for inducible cell line generation and proteomic analysis. Continues on next page. 
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Figure 6.4 PA-RING protein comparison. B) Expression profile of PA-RING family members in various 
tissues based on microarray data. The selected members have a broad expression profile. Black, no/low 
levels of expression; green, middle level of expression; yellow, high level of expression. C) Summary table 
of the selected members compared to RNF43. D) Partial sequence alignment between Rnf43 and the 
selected members displaying domain conservation (ClustalW2). It is possible to notice a higher similarity 
between Rnf128 and Rnf150. 
Figure 6.5 Generation and validation of doxycycline-inducible E3 ligase-overexpressing cell lines. A) T-
REx™-293 cells were transfected with dox-inducible vectors containing the cDNA of the selected PA-RING 
family members, downstream of the Tet operator. Addition of doxycycline prevents the Tet repressor 
from binding to the operator and triggers the expression of my genes of interest (Tet-Off system). B-C) 
Western blot analysis and immunocytochemistry confirmed strong and homogeneous overexpression of 
each gene of interest after overnight doxycycline treatment. Scale bar= 200 µm. 
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When analysing the data, common contaminant species, such as nuclear and mitochondrial 
proteins, were filtered out and protein hits with a 10-fold difference between dox- and 
dox+ samples were shortlisted; then, gene ontology annotations (GO) were employed to 
narrow down the list of putative targets to those proteins containing a transmembrane 
domain, which were localised at the plasma membrane and involved in signalling 
transduction. The identification of known targets in my lists that are already described in 
the literature validates the reliability of my approach; for example, CD81 has been 
previously reported in the literature to be targeted by RNF128 (Lineberry et al. 2008) and 
was also present as a hit in my analysis. 
The results of the identification process are summarised in Tables 6.2-6.4, which list the 
putative targets of each PA-RING ligase identified by SPA divided into two columns: 
proteins that are significantly downregulated and proteins that are absent in dox-treated 
samples compared to controls. 
A point worth highlighting is that some common trends can be observed by looking at the 
data: for example, the overexpression of each individual E3 ligase affects different classes 
of adhesion molecules as well as membrane transporters and G-protein coupled receptors 
(GPCRs). In particular, overexpression of the T cell anergy mediator RN128 seems to 
markedly reduce the abundance of tight junction proteins, such as ZO-1 and Occludin, and 
some GPCRs, together with G protein subunits and GPCR-associated proteins; 
overexpression of RNF150 instead seems to lead to a specific depletion of adherens 
junction proteins at the membrane.  
On the other hand, it is possible to notice a certain overlap between RNF128 and RNF150 
as they share some putative targets, such as CD44 antigen, G-protein subunits and the G-
protein associated Rhodopsin kinase; this is in accordance with the fact that these two E3 
ligases are closer to each other in terms of phylogenetic distance when compared to RNF13 
and display a higher sequence similarity (Figure 6.4 A, D). 
In conclusion, this recently described proteomics method allowed us to shortlist 
candidates that may potentially be novel molecular targets of the selected PA-RING family 
members. As could be expected considering the limited information about PA-RING 
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members, none of the hits had ever been associated with any of these E3 ligases before, 
not even to the best-characterised member, RNF128.  
  
 
 
 
 
 
  
Figure 6.6 Surface Proteome Analysis (SPA). A) SPA is the technique that led to the 
identification of Frizzled as a target of RNF43 (Koo et al, 2012). Cells overexpressing the E3 
ligase of interest (+ dox) and control cells (- dox) are both subjected to biotin labelling of 
surface proteins, which are then pulled down and analysed by mass spectrometry. The 
comparison between dox-treated and non-treated samples will reveal those proteins whose 
levels are significantly reduced upon overexpression of the E3 ligase of interest, and which 
could therefore be its putative targets. B) Sample overview: 3 different cell lines were 
employed, each of which was left untreated or treated with 1 µg/µl doxycycline for 12 hours 
and then subjected to biotin labelling and pull-down.  
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Table 6.2 Proteins downregulated by RNF13 overexpression. 
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Table 6.3 Proteins downregulated by RNF128 overexpression  
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Table 6.4 Proteins affected by RNF150 overexpression. 
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6.2.3 In vitro validation of shortlisted targets 
 
The analysis of the surface proteome revealed significantly reduced levels of several 
protein classes upon overexpression of individual PA-RING ligases. This allowed us to draw 
up a shortlist of putative targets that may be specifically ubiquitinated by the E3 ligase of 
interest. However, despite being an extremely useful technique, SPA has some limitations: 
firstly, it does not guarantee that the observed downregulation occurs at the protein level 
and secondly, it does not allow us to establish any direct link between the overexpressed 
E3 ligase and the downregulated protein species. For this reason, I next focused on 
validating some of the putative targets identified with SPA in vitro.  
Therefore, I first checked the expression levels of all the shortlisted candidates (Tables 
6.2-6.4) by RT-qPCR in dox-treated cells compared to untreated cells; this allowed me to 
further narrow down the list of putative targets by discarding those hits that were already 
downregulated at the mRNA level (Figure 6.7). 
Next, I tested antibodies for western blot against the selected hits using both total cell 
lysates and membrane fractions. In some cases the analysis of protein abundance in the 
total cell lysate perfectly matched that in the membrane fraction, e.g. Occludin was found 
to be almost absent in RNF128-overepressing cells in both sample types. However, in some 
other cases only one sample type showed a reduction in the candidate protein, e.g. 
overexpression of RNF150 could be linked to a reduction in K-cadherin levels only in the 
membrane eluate (Figure 6.8). This could indicate either that K-cadherin is being 
internalised or that in the whole cell lysate its intracellular fraction can mask the effect of 
RNF150 at the plasma membrane.  
For the remaining candidates, the investigation of their protein levels has been mainly 
hindered by a lack of suitable antibodies. 
To conclude, it was possible to confirm by western blot the downregulation upon E3 
overexpression of two of the putative targets identified by SPA; their mRNA levels were 
not found to be downregulated in dox-treated samples, as opposed to their protein levels, 
which were. Most importantly, this is the first time that RNF128 has been associated with 
the regulation of tight junctions and has been hypothesised to play a role in a process other 
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than T cell anergy. Even though this study does not provide evidence for a direct interaction 
between the E3 ligase and its putative target, and additional experimental evidence is 
required, its informative value in identifying candidates for future work is great.  
 
  
Figure 6.7 mRNA levels of putative targets upon overexpression of PA-RING E3 
ligases. RT-qPCR analysis allowed the selection of those candidates that were not 
downregulated at the mRNA level in dox-treated samples (red bars) for future work; 
these genes are more likely to encode direct targets for the PA-RING E3 ligases.  
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Figure 6.8 Overexpression of RNF128 and RNF150 leads to the downregulation of Occludin and K-
cadherin, respectively. A) Reduction in the levels of the tight junction protein Occludin upon RNF128-HA 
overexpression (+dox) in both total cell lysate (TCL) and the membrane fraction. B) Reduction in the levels 
of K-cadherin upon RNF150-HA overexpression (+dox) could be observed only in the membrane fraction. 
A 
B 
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6.4 Summary and conclusions 
 
This chapter has illustrated the approaches undertaken in order to investigate 
additional members of the PA-RING family of E3 ubiquitin ligases and deepen our 
understanding of its less well-characterised members. In particular, I was interested in 
unravelling a potential involvement of additional E3 ligases in WNT pathway regulation as 
well as identifying new molecular targets for selected members.  
To address the former, an overexpression screen of all PA-RING members was 
conducted in mouse intestinal organoids with different genetic backgrounds and in 
differing culture conditions (standard and RSPO-depleted). These experiments brought us 
to the conclusion that no PA-RING members are likely to be involved in WNT pathway 
modulation other than RNF43 and ZNRF3, not even their close homolog RNF215. However, 
a complementary knockout screen of the PA-RING members that are expressed in the 
mouse intestine would be required to have a definitive answer and to be able to conclude 
that none of them is linked to WNT signalling.  
Some further data not presented in this chapter is that withdrawal of the other key 
components of organoid culture medium, Noggin and EGF, also did not result in any 
phenotype in E3 ligase-overexpressing organoids; this suggests that PA-RING family 
members are also not likely to be involved in the regulation of either the BMP or EGF 
signalling pathways.  
To look further into the roles of PA-RING members, I then decided to pursue a 
proteomics approach aimed at identifying their targets from among membrane proteins; 
the method I employed allowed the identification of several different classes of proteins 
that were markedly downregulated upon overexpression of RNF13, RNF150 or RNF128. For 
example, I observed a pronounced decrease in the levels of tight junction proteins, GPCRs 
and related proteins upon RNF128 overexpression. Furthermore, RNF150 showed some 
similarities to RNF128 but also differences in that its overexpression mainly caused 
depletion of adherens junction proteins like K-cadherin and Catenin delta-1.  
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Among the putative targets highlighted by the surface proteome analysis, it was possible 
to confirm downregulation of the tight junction protein Occludin and the adherens junction 
protein K-cadherin upon overexpression of RNF128 and RNF150, respectively.  
Thus, this technique was instrumental for the identification of potential molecular targets 
for some of these members of the family, although only co-immunoprecipitation 
experiments will enable us to establish a direct link between a particular E3 ligase and its 
putative target. 
Not surprisingly, none of the potential candidates has ever been associated with any 
member of the family; also in case of RNF128, one of the most well characterised PA-RING 
proteins, no reports exist in the literature associating it with tight junction regulation. In 
this regard, my work might open RNF128 to investigation in the context of a novel role or 
it could also contribute to a better definition of its known role as a mediator of T cell anergy. 
Interestingly, it has been reported that only activated T-lymphocytes express Occludin in 
order to enable their aggregation (Alexander et al. 1998). Therefore, targeting Occludin 
directly for degradation might be an additional way through which RNF128 mediates T cell 
unresponsiveness and anergy.  
Overall, my work suggests new putative targets and potentially suggests novel roles for 
some representative members of the PA-RING family and this may be considered a valid 
starting point for further investigation. 
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Chapter 7  
 
Discussion, conclusions and future 
perspectives 
 
 
 
 
7.1 Summary and main findings 
 
During the course of my PhD studies I have investigated the details of the mechanism 
of action of RNF43 by developing a new intestinal organoid-based screening platform that 
has allowed the identification of novel genes with a functional connection to RNF43 
activity. Following identification of these genes, I then focused on Daam and tried to 
further characterise its role in the RNF43-mediated clearance of Frizzled.  
Since the detailed study of the molecular mechanism of RNF43 activity could also serve as 
a paradigm for its paralogous genes, I also directed my attention to the investigation of 
other PA-RING family members by first evaluating their potential involvement in the WNT 
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signalling pathway and by then identifying some of their putative targets through a 
proteomics approach.   
Below, I have summarised the main findings and achievements of my work, which will 
be further discussed in the next sections of this chapter to provide future perspectives and 
possible ways to develop this study.  
Thus, the main findings presented in this thesis are: 
 
 Establishment of a robust screening platform for genetic studies in intestinal 
organoids by exploiting novel CRISPR/Cas9 techniques.  
 Identification of DAAM1, SEC16A, UBL4A AND SLC12A2 as potential interactors in 
the context of the RNF43-mediated downregulation of Frizzled and WNT pathway 
modulation. 
 The recapitulation of the Rnf43&Znrf3 knockout phenotype by Daam knockout in 
intestinal organoids based on their survival in RSPO-depleted medium and 
continued sensitivity to the complete depletion of WNT ligands.  
 Frizzled5 internalisation seems to be impaired/delayed in DAAM KO HEK293T 
clones. However, there are no significant differences between WT and DAAM KO 
cells in Frizzled5 endocytosis and ubiquitination levels. 
 Interestingly, co-immunoprecipitation studies suggest that DAAM may participate 
in a ternary complex with DVL and RNF43. 
 
 No other PA-RING family members are likely to be involved in WNT pathway 
regulation, based on an overexpression screen in intestinal organoids followed by 
RSPO withdrawal experiments. 
 The expression of different classes of adhesion molecules and G protein-coupled 
receptors are significantly affected by the overexpression of selected PA-RING 
members, as assessed using a mass spectrometry-based approach. In particular, the 
overexpression of RNF128 and RNF150 can strongly downregulate Occludin and K-
cadherin levels, respectively.  
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In summary, I believe that my work overall addressed all of the predetermined aims by 
providing interesting experimental observations, and in addition has provided insightful 
starting points for future lines of research. 
  
 
7.2 Discussion 
 
7.2.1 Establishment of new genetic tools for organoid manipulation 
  
A number of different genetic tools applied to organoid culture have been presented in 
this thesis with the intent to study regulatory mechanisms of the WNT pathway in the 
murine intestine. 
Firstly, the application of the PiggyBac transposon system to intestinal organoids 
allowed establishing a solid platform with inducible overexpression of RNF43, which 
subsequently resulted instrumental to functionally test mass-spectrometry hits after 
RNF43 pull-down. To this purpose, our CRISPR concatemer vector for simultaneous 
multiple gene knockout was indispensable to tackle the possible issue of genetic 
compensation while carrying out knockout screens (Andersson-Rolf et al. 2016). 
Furthermore, by coupling this concatemer strategy with electroporation as a delivery 
method it was possible to sensibly increase the success of loss-of-function studies in 
organoids (Merenda et al, 2017. In press). 
Interestingly, the potential of the CRISPR concatemer strategy is now also being explored 
in vivo in combination with an inducible-Cas9 mouse line, with the aim to simplify the 
generation of conditional knockout models. 
Another example of genetic modification tool applied to intestinal organoids is 
represented by the overexpression screening of all PA-RING members that was enabled by 
the inducible MSCV retroviral system; this could be efficiently delivered to organoid 
cultures by retroviral transduction, as previously described by Koo et al., 2012.  
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In the matter of conditional gene manipulation, it is worth mentioning one more 
strategy that has been recently developed by our group in order to efficiently achieve 
conditional and reversible gene knockouts in diploid cells (Andersson-Rolf et al. 2017).  
It is based on an invertible drug selection intronic cassette, named FLIP cassette, which 
exists in two different configurations. In its non-mutagenic orientation, the cassette 
expresses a resistance gene to select for correct Cas9-assisted targeting into the exon of 
one allele as well as simultaneous enrichment of cells in which the second allele has been 
inactivated by non-homologous end joining (NHEJ).  
Upon Cre recombination, the cassette is then inverted to a mutagenic configuration that 
activates a cryptic splice acceptor while disrupting the initial splicing acceptor; this, 
together with the introduction of polyadenylation signal, results in gene disruption. 
Thorough testing of the FLIP cassette in different cell lines and intestinal organoids proved 
the wide applicability of this strategy. 
For instance, the overall advantage of the genetic tools reported in this dissertation is 
their versatility. For example, it could be possible to apply an analogous approach to the 
one employed for RNF43 to the investigation of other regulators of the WNT pathway as 
well as to the study of other signalling pathways that are key for the maintenance of 
intestinal stem cells. 
 
 
7.2.2 Investigation of the molecular mechanisms of RNF43-mediated 
downregulation of Frizzled  
  
The WNT pathway regulator RNF43 (Koo et al. 2012; Hao et al. 2012) is an E3 ubiquitin 
ligase that has attracted increasing attention because of its crucial role as a tumour 
suppressor in the intestine, consistent with its mutation rate in various types of 
malignancies. Despite that, the molecular details of its mechanism of action and its 
molecular partners have not been fully explored. For this reason, I decided to establish an 
organoid-based screening platform for the identification of genes with a functional 
connection to RNF43. This system has been an extremely advantageous tool for the study 
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of the molecular mechanism of RNF43 activity, and Daam1 was among the first of the 
RNF43-linked candidates to be identified. Furthermore, Daam knockout organoids could 
mimic the RZ KO phenotype, suggesting that DAAM might be involved in membrane-
proximal events of WNT/β-catenin pathway modulation.  
Generally, DAAM1 has always been associated with the “non-canonical” WNT PCP 
pathway as an interactor of Dishevelled able to induce actin cytoskeleton rearrangements 
(Oishi et al. 2003; Komiya & Habas 2008). Up to now, only one report has linked its 
homologue, Daam2, to canonical WNT/β-catenin signalling during chick spinal cord 
development, by showing that the Daam2 loss-of-function phenotype could be rescued by 
activation of β-catenin (Lee & Deneen 2012). Aside from that report, this is the first time 
that DAAM1 has been linked to the regulation of the canonical WNT/β-catenin pathway, 
RNF43 activity and maintenance of intestinal homeostasis.  
These observations appear to be particularly interesting in light of two recent reports 
demonstrating that Dishevelled is an important partner of RNF43 in the downregulation of 
Frizzled (Jiang et al. 2015; Tsukiyama et al. 2015). However, neither of these two studies 
managed to fully clarify the exact mechanism(s) by which DVL and RNF43 cooperate and 
some important questions remained unanswered, for example, whether DVL and RNF43 
could interact directly with one other or not, or whether direct interaction was essential 
for downregulation of the WNT/β-catenin pathway.  
Within this wider context, the novelty of my work was to introduce a new player into 
this picture, DAAM, which could potentially represent the key to understand RNF43-
mediated Frizzled clearance. For instance, it was interesting to observe how DVL2 
overexpression was able to promote the interaction between DAAM1 and RNF43, 
suggesting the formation of a ternary complex, which enables RNF43 to promote Frizzled 
internalisation.  
Among multiple possibilities, such complex might be important for RNF43 activation, for 
example, and DAAM-DVL could function as a docking platform for an effector required for 
post-translational modifications to RNF43, such as phosphorylation.  
Furthermore, it might be also possible that, depending on where in the cell DVL and DAAM 
interact with each other, different signalling events are affected. For instance, if their 
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interaction takes place in the cytoplasm, this leads to a reorganisation of the actin 
cytoskeleton, whereas if the two proteins contact each other at the plasma membrane in 
proximity to RNF43, this could result in the downregulation of Frizzled surface levels.  
Nevertheless, in order to support the existence of a ternary complex among RNF43, DVL2 
and DAAM1, biophysical approaches for the study of protein complexes will be required; 
techniques like the Proximity Ligation Assay (PLA) or Protein complementation assays 
(PCAs) might be instrumental to elucidate the dynamics of interaction among my players 
(Soderberg et al. 2006; Shyu et al. 2008). Details of possible follow-up experiments will be 
discussed in the final paragraph within the context of the future perspectives of my work.  
Additional in vitro assays were employed to characterise the role of DAAM in Frizzled 
endocytosis and ubiquitination but, surprisingly, their outcome was unclear and did not 
explain the phenotype observed in organoids; in fact, Frizzled5 endocytosis and 
ubiquitination did not seem to be impaired in the absence of DAAM in HEK293T cells. 
Although these experiments will be repeated by analysing other members of the Frizzled 
family, discrepancies between the two systems could be due to a context-dependency of 
DAAM activity, which may be specific to the intestinal epithelium. Therefore, it is worth 
noting that HEK293T cells do not depend on WNT signalling for their survival and, assuming 
that DAAM plays a role in regulating both canonical and non-canonical WNT pathways, it 
could be possible that its levels are subject to different regulation in HEK293T cells 
compared to organoids. For this reason, studying Frizzled downregulation in the absence 
of DAAM in a physiologically relevant system might ultimately be necessary, as the 
organoid experiments conducted so far still constitute an indirect evidence for DAAM role 
in Frizzled internalisation. 
In addition, it is worth pointing out that HEK293 is a transformed cell line with highly 
aberrant karyotype (Lin et al. 2014) and as a consequence it could display completely 
different levels of DAAM compared to organoids, which could trigger unknown feedback 
mechanisms.  
Alternatively, DAAM could have a secondary role compared to DVL, or their functions could 
be slightly redundant and DVL alone might be sufficient to promote maximal RNF43 
Chapter 7 
 
142 | P a g e  
 
activity. Determining the potential hierarchy between these two players will be essential 
to get a clearer picture of DAAM’s role. 
In addition to in vitro experiments, in vivo loss-of-function studies will be conclusive in 
assessing DAAM’s contribution to the maintenance of homeostasis in the intestine. To 
date, there are no reports addressing the role of Daam1 and/or Daam2 in the intestine, 
although somatic mutations in both genes have been observed in human tumours of the 
gut (COSMIC database); previous studies have focused mainly on their role in development 
and cardiomyogenesis (Li et al. 2011; Ajima et al. 2015). 
I performed an alternative CRISPR-based strategy to generate an intestine-specific, 
conditional Daam1/2 knockout mouse line, as this strategy was predicted to be faster than 
the conventional Cre-Lox system. However, whilst advantageous in terms of speed, this is 
still a novel approach whose efficiency remains to be fully tested; for this reason, the 
preliminary data presented here using this system are currently inconclusive as a more 
detailed characterisation of the line needs to be undertaken.  
Therefore, I believe that the major contribution of my work to the investigation of the 
mechanism of action of RNF43 has been the identification of a potential new player by 
exploiting novel genetic tools for in vitro and in vivo studies. 
 
 
7.2.3 Characterisation of other PA-RING members 
 
In parallel to the characterisation of the molecular mechanism of RNF43 activity, I also 
focused on the investigation of additional members of the PA-RING family. This 
evolutionarily conserved family comprises genes that are so closely related to each other 
that it is reasonable to assume that they might share common functions. As both RNF43 
and its homologue ZNRF3 are such important modulators of the WNT pathway, my first 
hypothesis was that some other members of the family could play a similar role in the 
regulation of the same signalling cascade. In particular, those genes closer to R&Z in the 
phylogenetic classification, such as RNF215, were hypothesised as the most likely to act on 
Frizzled receptors or on other effectors of the WNT pathway. However, overexpression of 
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each family member in intestinal organoids could not phenocopy the effect of RNF43 
overexpression, suggesting that no additional PA-RING proteins are likely to be involved in 
downregulation of the WNT pathway. This was found to be true even in the absence of 
RNF43&ZNRF3, indicating that there was no redundancy with these two known tumour 
suppressors.  
Hence, it could be plausible that RNF43 has a context-specific role in the intestinal 
epithelium working as a dedicated E3 ligase for the intestinal stem cell compartment, 
where the WNT pathway plays such a pivotal role in the maintenance of tissue homeostasis 
(Koo&Clevers, 2014). 
In accordance with this, it is worth pointing out that no reports have appeared so far in the 
literature linking any PA-RING family member to the WNT pathway, and that no WNT 
receptor or co-receptor emerged from the surface proteome analysis (SPA) that I 
conducted on selected members of the family with the intent of identifying their molecular 
targets. Nevertheless, these data would need to be complemented by a knockout 
screening in intestinal organoids of those family members expressed in the murine 
intestine before being able to definitively conclude that no PA-RING family members, other 
than RNF43 and ZNRF3, are involved in WNT pathway regulation. 
The above-mentioned proteomic approach did, however, provide interesting insights in 
terms of putative targets for RNF13, RNF150 and RNF128; in fact, upon their 
overexpression, it was possible to observe significant downregulation of different classes 
of adhesion molecules, membrane transporters and G-protein coupled receptors. 
Interestingly, none of the molecules identified by this mass spectrometry-based approach 
had been formerly associated with any of the selected PA-RING family members, 
highlighting the value and potential of this strategy.  
In this regard, I believe that one of the most exciting observations concerns RNF128, the 
E3 ubiquitin ligase that mediates T-cell anergy by targeting the T-cell receptor and its co-
stimulatory molecules for degradation (Lineberry et al. 2008; Su et al. 2009; Nurieva et al. 
2010). My work has now linked this protein to tight junction regulation for the first time; 
this could either suggest a novel role for RNF128 or contribute to provide additional details 
on the mechanisms through which RNF128 promotes the establishment and maintenance 
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of immune cell anergy. This latter hypothesis has some support from previous data 
showing that Occludin is expressed by T-cells only when they are in their activated state 
and so need adhesion molecules for cell-cell interactions and aggregation (Alexander et al. 
1998). In light of this, it is reasonable to hypothesise that RNF128 could further promote T-
lymphocyte unresponsiveness by degradation of those tight junction proteins upregulated 
during the immune response. Although proteomic data were confirmed by western blot 
and this strategy has been previously reported in the literature as a robust and useful 
technique (Koo et al. 2012), additional in vitro approaches, such as co-immunoprecipitation 
experiments and ubiquitination assays, will be required in order to consolidate a role for 
RNF128 in the degradation of Occludin. 
In addition to this, it could also be worthwhile to speculate on possible implications of 
the selected PA-RING E3 ligases in cancer biology and cell-cell signalling, as overexpression 
of all three members was shown to significantly affect adhesion molecules, signalling 
receptors and membrane transporters. For instance, when cells lose the ability to respond 
to exogenous signals, they may become cancer cells and when these cells lose adhesion 
molecules, cancer progression is favoured (Behrens, 1993; Knights et al. 2012).  
Thus, it cannot be excluded that the PA-RING family might also include some proto-
oncogenes that, when activated, can facilitate epithelial-mesenchymal transition 
(Lamouille et al. 2014). 
In conclusion, after my initial hypothesis that multiple PA-RING family members could 
regulate the WNT pathway had been discarded, mass spectrometry experiments on plasma 
membrane fractions provided an insightful starting point for the identification of novel, 
putative targets of PA-RING proteins.  
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7.3 Concluding remarks and future work 
 
The aim of my PhD thesis was to expand our current knowledge of the mechanism of 
action of RNF43 and, more broadly, to analyse other members of the PA-RING family in 
terms of putative roles and molecular targets. I believe that my work has made interesting 
contributions to both of these topics, as well as developing some novel approaches for 
their study. 
 
In term of future directions, I would prioritise the following aspects: 
 Understanding interaction dynamics among RNF43, DVL2 and DAAM1. 
Further experiments will be required in order to demonstrate the existence of a ternary 
complex among these three components under physiological conditions; for example, 
techniques such as the Proximity Ligation Assay (PLA) or Protein complementation assays 
(PCAs) allow the study of endogenous protein complexes (Soderberg et al. 2006).  
As further examples of relevant techniques, Bimolecular fluorescence complementation 
assays (BiFC) or FRET (Fluorescence Resonance Energy Transfer) could be pursued in order 
to visualise protein-protein interactions in living cells, and a combination of both 
approaches has been successfully applied to the study of ternary protein complexes (Shyu 
et al. 2008). 
 
 Mapping regions in both DAAM and RNF43 that are responsible for reciprocal 
binding, providing the ternary complex model is confirmed.  
Deletion mutants of DAAM1 will be essential to pinpoint one or more functional domains 
of this protein that are required for interaction with RNF43. Furthermore, the same 
approach can be utilised to map regions in RNF43 responsible for DAAM1 binding.  
 
 Assessing whether overexpression of Daam in intestinal organoids has an 
analogous effect to RNF43 overexpression.  
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 Determine whether all domains of RNF43 are important for its mechanism of 
action.    
Since it has already been shown that the extracellular PA domain of RNF43 could be 
interacting with the extracellular portion of Frizzled (Tsukiyama et al. 2015), it might be 
interesting to assess Frizzled endocytosis and ubiquitination in WT and DAAM mutant cells 
upon the overexpression of both WT and ∆PA RNF43. 
 
 Focus on the role of SEC16 in the regulation and mechanism of action of RNF43. 
From amongst the other candidates identified in the CRISPR screen, SEC16 seems to be one 
of the most promising given its role in the secretory pathway from the ER to Golgi 
(Sprangers & Rabouille 2015); this candidate could be involved in RNF43 maturation and 
targeting to the plasma membrane. Interestingly, preliminary data seem to point to a 
concurrence of RNF43 and SEC16 mutations in human gastric cancer samples 
(unpublished).  
 
In terms of other PA-RING family members, my work may represent a useful starting 
point for in-depth analysis of additional members of the family, especially for those less 
well-characterised members, such as RNF150. I believe it could be particularly interesting 
to further study the mechanism of action of RNF128 and its interaction with Occludin in 
the context of establishment of T cell anergy. For example, in addition to in vitro 
experiments aimed at confirming a direct link between the two proteins, such as co-
immunoprecipitation and ubiquitination assays, it would be worthwhile to check whether 
RNF128 knockout mice display higher levels of Occludin on T lymphocytes after immune 
stimulation compared to wildtype controls.  
 
All of the possible future experiments suggested here, in combination with the ongoing 
studies that have been mentioned in the discussion sections of previous chapters, will 
hopefully help us to clarify the details of RNF43-mediated downregulation of Frizzled and 
potentially suggest a conserved mechanism of action for PA-RING E3 ubiquitin ligases. 
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Appendix A 
Supplementary information  
 
 
Materials 
 
S2.1.1 Devices, consumables and chemicals 
  
  
Table S1. List of devices, software and consumables 
 
Devices / Software / Consumable Supplier 
2720 Thermo Cycler (PCR-Machine) Applied Biosystems 
48-well clear TC treated Microplates Corning 
60x15mm Centre Well IVF Tissue Culture 
Dish 
BD Falcon 
AMAXA Human Nucleofector LONZA 
Amersham Hyperfilm ECL GE Healthcare Life Sciences 
BD FACS-Diva Software BD Biosciences 
BD LSRFortessaTM cell analyser BD Biosciences 
Confocal Microscope LEICA 
Electroporation Cuvettes BioRad 
 Electroporation Cuvettes 2mm gap NepaGene 
EVOS Stand Alone Digital Imaging System Scientific Instrument Company Inc. 
FlowJo | Single Cell Analysis Software FLOWJO, LLC 
Gene Pulser X-Cell BioRad 
LEICA Application Suite LEICA 
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Low binding 15ml tubes Sigma 
MicroAmp® Fast Optical 96-Well Plate Applied Biosystems 
Mini Trans-Blot® Cell Biorad 
Nanodrop ND1000 Labtech 
Nanodrop software ND1000 V3.3.1 Labtech 
NEPA21 Super Electroporator NepaGene 
Protein LoBind tubes low binding Thermo Fisher 
Standard filter pipette tips Starlabs 
StepOne™ Real-Time PCR machine Applied Biosystems 
Trans-Blot® Turbo™ Mini PVDF Transfer 
Packs  
Biorad 
Trans-Blot® Turbo™ Transfer Biorad 
 
 
 
 
Table S2. List of chemicals 
 
Chemical Supplier 
0.1% Gelatine Sigma-Aldrich Co. LLC 
2-Mercaptoethanol Sigma-Aldrich Co. LLC 
4-OHT (4-Hydroxytamoxifen) Sigma-Aldrich Co. LLC 
B27 (50x) Life Technologies 
BlastAssist medium Origio 
Blasticidin Sigma-Aldrich Co. LLC 
Carbenicillin Sigma-Aldrich Co. LLC 
Chiron Stewart lab 
DMEM Hams F12 Medium Sigma-Aldrich Co. LLC 
DMEM, High Glucose, GlutaMAX™, Pyruvate Life Technologies 
DMEM/F-12, no glutamine Life Technologies 
DMSO Sigma-Aldrich Co. LLC 
Doxycycline Invitrogen 
DTT Thermo Scientific 
Dulbecco’s phosphate buffered saline Sigma-Aldrich Co. LLC 
EGF Life Technologies 
FBS (GIBCO) Life Technologies 
G-418 Invitrogen 
Glasgow's MEM (GMEM) Life Technologies 
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HEPES Life Technologies 
IWP-2 Cell Guidance Systems 
L-glutamine (200nM) Life Technologies 
Low-melt agarose BioRad 
MEM NEAA (100x) Life Technologies 
Murine LIF Hyvonen lab 
N2 (200x) Millipore 
Neurobasal Medium Life Technologies 
PDO3 Stewart lab 
Penicillin Streptomycin Sigma-Aldrich Co. LLC 
Polybrene Sigma-Aldrich Co. LLC 
Puromycin Sigma-Aldrich Co. LLC 
Sodium Pyruvate (100mM) Life Technologies 
Synthemax II Coning 
Trypan blue Life Technologies 
TypLE express Invitogen 
Trypsin-EDTA 0.25% Life Technologies 
TeSR-E8 media Stem Cell Technologies 
UltraPure DNase/RNase-Free Distilled Water Life Technologies 
Y-27632 Sigma-Aldrich Co. LLC  
Zeocin Invitrogen 
 
 
 
S2.1.2 Kits and enzymes 
 
  
Table S3. List of kits 
 
Kit Supplier 
BCA Protein Assay Reagent Thermo Scientific 
Dual-Luciferase® Reporter Assay System Promega 
GoTaq G2 Flexi DNA Polymerase Promega 
Hot start LongAmp™ Taq 2X Master Mix New England Biolabs 
In-Fusion® HD Cloning Kit Clontech Laboratories, Inc. 
Lipofectamin2000 Life Technologies 
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Mighty Cloning Kit Takara 
MinElute PCR Purification Kit  Qiagen 
Phusion® High-Fidelity PCR Kit NEB 
Pierce Cell Surface Protein Isolation Kit  Thermo Scientific 
Pierce ECL Western Blotting Substrate Thermo Scientific 
CloneJET PCR Cloning Kit Thermo Scientific 
QIAGEN Plasmid Midi Kit Qiagen 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick Gel Extraction Kit Qiagen 
RNeasy Micro kit Qiagen 
RNeasy Mini kit Qiagen 
 
 
 
Table S4. List of enzymes 
 
 
 
 
 
Enzymes Supplier 
Acc65l NEB 
AloI Thermo Scientific 
BamHI NEB 
BglII NEB 
DpnI NEB 
EcoRI NEB 
EcoRV NEB 
Fast Digest BbsI  NEB 
NcoI NEB 
NotI NEB 
PlasmidSafe™ ATP-Dependent DNase Cambio 
SalI NEB 
SapI NEB 
T4 DNA ligase NEB 
T4 Polynucleotide Kinase NEB 
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S2.1.3 Plasmids 
 
Table S5. List of plasmids 
 
 
 
 
S2.1.4 Cloning and genotyping primers 
 
Table S6. List of cloning primers for PiggyBac vectors 
 
 
 
 
 
 
 
 
Plasmid Supplier 
pCMV-GFP Addgene 
Empty gRNA vector Addgene 
Human codon optimized Cas9 Addgene 
gRNA_GFP-T1 Addgene 
pcDNA4TO Thermo Scientific 
pJet1.2 Thermo Scientific 
pMSCV-loxp-dsRed-loxp-3xHA-Puro-WPRE Addgene 
Primers Sequence 
hRNF43-2F2H_InfL CAAAGAATTCCTCGAGGTTGAAGTGCATTGCTGCAGCTGGTA 
hRNF43-2F2H_InfR GCTTATCGAGCGGCCGTTTAAACGGGCCCTCTAGACTCGATCA 
hCas9-infL CTTGACATGCTCCCCGGAAGCGGAGCTACTAACTTCAGCCTGCTGAAGCA
GGCTGGAGACGTGGAGGAGAACCCTGGACCTATGGACAAGAAGTACTC
CATTGGGCTCG 
hCas9-infR GCTTATCGAGCGGCCTCACACCTTCCTCTTCTTCTTGGGGTCA 
Hygro-infL CACGATGATAATATGGCCACAACCATGAAAAAGCCTGAACTCACCGCG 
Hygro-infR TTAATAGATCATCAATTTCTCGACTATTCCTTTGCCCTCGGACGAG 
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Table S7. List of oligos for concatemer cloning 
 
Gene  Forward primer Reverse primer 
Sh3bp4 CACCGGTCCCCTCCGACTTGCACCGAGT TAAAACTCGGTGCAAGTCGGAGGGGACC 
 ACCGGCATTCAGAAAGGGGTTCGTTG AAAACAACGAACCCCTTTCTGAATGC 
Macc1 CCGGTTGATTTTTTGAGCGTTTCG AAACCGAAACGCTCAAAAAATCAA 
 ACACCGGTGATGTCTGAGTCGGGTAAT
GTT 
CTAAAACATTACCCGACTCAGACATCACCG 
Emerin 
CACCGGCAAGTGAGGTCCCCGGCTGGG
T 
TAAAACCCAGCCGGGGACCTCACTTGCC 
 ACCGGATACATGTCTGAGTCCACGGG AAAACCCGTGGACTCAGACATGTATC 
 CCGGCACTGCGGCCAGCTCAGTAT AAACATACTGAGCTGGCCGCAGTG 
Adam17 CACCGGCATATACCGGAACACGTCGTGT TAAAACACGACGTGTTCCGGTATATGCC 
 ACCGGCGTCCTGGCACCCCGACCTCG AAAACGAGGTCGGGGTGCCAGGACGC 
 CCGGGAATCAAGCTTCTCAAGTCG AAACCGACTTGAGAAGCTTGATTC 
Zmynd19 CACCGGACTTTAAATTGGGCATCGTGGT TAAAACCACGATGCCCAATTTAAAGTCC 
 ACCGGAAATTGGGCATCGTGCGGCTG AAAACAGCCGCACGATGCCCAATTTC 
 CCGGTGGGCATCGTGCGGCTCGGC AAACGCCGAGCCGCACGATGCCCA 
Tmed10 CACCGGAGACTGGTCGGTGATCTCGTGT TAAAACACGAGATCACCGACCAGTCTCC 
 ACCGGGAGACACTTGCGAGAGTTCAG AAAACTGAACTCTCGCAAGTGTCTCC 
 CCGGAGACACTTGCGAGAGTTCAC AAACGTGAACTCTCGCAAGTGTCT 
Bag6 CACCGGTCTTGTCGTCTTGTAGGACCGT TAAAACGGTCCTACAAGACGACAAGACC 
 ACCGGATGAGTGATCTGGTGGGCGAG AAAACTCGCCCACCAGATCACTCATC 
 CCGGTGGGAAATCCGGATGACCCG AAACCGGGTCATCCGGATTTCCCA 
Daam1 
CACCGGACAGGGGGCATGGGCAGCGC
GT 
TAAAACGCGCTGCCCATGCCCCCTGTCC 
 ACCGGTAAAAGCACTGGGCGTTATCG AAAACGATAACGCCCAGTGCTTTTAC 
Daam2 CCGGACCTTCCCGAGATCGACCTC AAACGAGGTCGATCTCGGGAAGGT 
 
ACACCGGTCGAAGCTTAGGCCGCTACC
GTT 
CTAAAACGGTAGCGGCCTAAGCTTCGACCG 
Ap2m1 CACCGGAGATGTTGGACCGCTTAACAGT TAAAACTGTTAAGCGGTCCAACATCTCC 
 ACCGGAGGGGGAGGTGCTTATCTCCG AAAACGGAGATAAGCACCTCCCCCTC 
 CCGGGAGAAGGCATCAAGTATCGC AAACGCGATACTTGATGCCTTCTC 
PLD1 
CACCGGGCTGTGGACGTAGATGAGCTG
T 
TAAAACAGCTCATCTACGTCCACAGCCC 
 ACCGGGCTGTGGACGTAGATGAGCTG AAAACAGCTCATCTACGTCCACAGCC 
PLD2 CCGGGAGTTCAGATAGTCCCCATA AAACTATGGGGACTATCTGAACTC 
 ACACCGGTAGGGAGGGTATATCCTCGG
GTT 
CTAAAACCCGAGGATATACCCTCCCTACCG 
BRI3BP CACCGGCACTCCCTGCACGAACCGCTGT TAAAACAGCGGTTCGTGCAGGGAGTGCC 
 ACCGGAGCTGCTCGTCGCGCGCCGGG AAAACCCGGCGCGCGACGAGCAGCTC 
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TMEM109 CCGGGCGCACACAGCACTCCGTTA AAACTAACGGAGTGCTGTGTGCGC 
 ACACCGGCTTCAGAGATCGGCCAATCTG
TT 
CTAAAACAGATTGGCCGATCTCTGAAGCCG 
Sdcbp 
CACCGGCAGAACAAATGCTTGGCTGGG
T 
TAAAACCCAGCCAAGCATTTGTTCTGCC 
 ACCGGCAGGTAACGATGCTGGAATTG AAAACAATTCCAGCATCGTTACCTGC 
Sdcbp2 CCGGAGGTGGATCTCTCGCACGCC AAACGGCGTGCGAGAGATCCACCT 
 ACACCGGTCTCTGCACGCAGTATACCCG
TT 
CTAAAACGGGTATACTGCGTGCAGAGACCG 
Zyg11a CACCGGCCCTCGAGGATCCATATGAGGT TAAAACCTCATATGGATCCTCGAGGGCC 
 ACCGGCGAGCGGGCGTTTTTCGTTAG AAAACTAACGAAAAACGCCCGCTCGC 
Zer1 CCGGAACCTGGGCCGCATGATTGA AAACTCAATCATGCGGCCCAGGTT 
 ACACCGGTGCGAGTGAGCCGAGTACTG
GTT 
CTAAAACCAGTACTCGGCTCACTCGCACCG 
Vangl1 
CACCGGAAGAGGCCGAACACGAACGCG
T 
TAAAACGCGTTCGTGTTCGGCCTCTTCC 
 ACCGGCAGGTGGTCCGCTCCACCGAG AAAACTCGGTGGAGCGGACCACCTGC 
Vangl2 CCGGTGACCTCACGCGCATCGCCA AAACTGGCGATGCGCGTGAGGTCA 
 ACACCGGTGTGCGCATCTTGGACGCCCG
TT 
CTAAAACGGGCGTCCAAGATGCGCACACCG 
Dvl1 CACCGGCCTCATCGCGGTTTCGACGTGT TAAAACACGTCGAAACCGCGATGAGGCC 
Dvl2 ACCGGCCGAGCGTGATGCGCTCCGCG AAAACGCGGAGCGCATCACGCTCGGC 
Dvl3 CCGGCCTTTGTGGTTCCATTGAGT AAACACTCAATGGAACCACAAAGG 
UBR2 CACCGGGTCCCACCTGACGCGTGATCGT TAAAACGATCACGCGTCAGGTGGGACCC 
 ACCGGTATGGAGGATGATCACGAGCG AAAACGCTCGTGATCATCCTCCATAC 
UBR3 CCGGCGCCCGCACGGTTATCCGGC AAACGCCGGATAACCGTGCGGGCG 
 ACACCGGCGCGGGGTCGTAGGCCCGCA
GTT 
CTAAAACTGCGGGCCTACGACCCCGCGCCG 
SORT1 
CACCGGCCGGTCCGGTCGGGGTGAGCG
T 
TAAAACGCTCACCCCGACCGGACCGGCC 
SORL1 ACCGGCTTCTCCATCCCATTCCGGGG AAAACCCCGGAATGGGATGGAGAAGC 
SORCS2 CCGGCTGGCCCTACTGCGCCGGAC AAACGTCCGGCGCAGTAGGGCCAG 
WDR26 
CACCGGGCCTGCCTGTCGGCGCAGAAG
T 
TAAAACTTCTGCGCCGACAGGCAGGCCC 
 ACCGGGTCCCCTTCGGCGACGTCCGG AAAACCGGACGTCGCCGAAGGGGACC 
 CCGGACGTAGTGAACTGCCAATTG AAACCAATTGGCAGTTCACTACGT 
UBL4A 
CACCGGGGAATGTAGCCTACAGGTGGG
T 
TAAAACCCACCTGTAGGCTACATTCCCC 
 ACCGGCATTCAGCTTATCCGAGACCG AAAACGGTCTCGGATAAGCTGAATGC 
 CCGGCCACCTGTAGGCTACATTCC AAACGGAATGTAGCCTACAGGTGG 
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SEC16A 
CACCGGTGGGGTGATGTTCCGGGGACG
T 
TAAAACGTCCCCGGAACATCACCCCACC 
 ACCGGAAAGCAAACGGATCCGTTACG AAAACGTAACGGATCCGTTTGCTTTC 
SEC16B CCGGGGTACTTCGGCGAGCATCAT AAACATGATGCTCGCCGAAGTACC 
 
ACACCGGAATTGAGGCTATCCAGCGGA
GTT 
CTAAAACTCCGCTGGATAGCCTCAATTCCG 
RAB10 CACCGGCCACTCCCGAGTCCCCGATCGT TAAAACGATCGGGGACTCGGGAGTGGCC 
RAB8A ACCGGTGTTCGAAACCGCTCCTGGCG AAAACGCCAGGAGCGGTTTCGAACAC 
RAB15 CCGGCGAGGAGTGGAACTCGTTGT AAACACAACGAGTTCCACTCCTCG 
PTGFRN CACCGGTGCAATGTCAGCGACTATGAGT TAAAACTCATAGTCGCTGACATTGCACC 
 ACCGGCCACAGTGGGGACGTACGCCG AAAACGGCGTACGTCCCCACTGTGGC 
Igsf8 CCGGCACCTGCCGGGCGTAGCACC AAACGGTGCTACGCCCGGCAGGTG 
 ACACCGGCCACAGAGTACGCAGCATGA
GTT 
CTAAAACTCATGCTGCGTACTCTGTGGCCG 
SPTLC1 
CACCGGGATGAACCGCCGAGTCACACG
T 
TAAAACGTGTGACTCGGCGGTTCATCCC 
 ACCGGCTCAACTACAACATCGTGTCG AAAACGACACGATGTTGTAGTTGAGC 
 CCGGTGTGACTCGGCGGTTCATCG AAACCGATGAACCGCCGAGTCACA 
Armc8 
CACCGGCCTCCGAGAGGACGCTCATGG
T 
TAAAACCATGAGCGTCCTCTCGGAGGCC 
 ACCGGGAGAGGACGCTCATGCGGATG AAAACATCCGCATGAGCGTCCTCTCC 
 CCGGCAACCTCATCGTTCTAGGAG AAACCTCCTAGAACGATGAGGTTG 
Lman2 
CACCGGGTGGCTGCGGATATCACCGAG
T 
TAAAACTCGGTGATATCCGCAGCCACCC 
 ACCGGGCCCTGGTACGAGGCGGTCTG AAAACAGACCGCCTCGTACCAGGGCC 
 CCGGCCCTGGTACGAGGCGGTCTC AAACGAGACCGCCTCGTACCAGGG 
Ap2a2 
CACCGGGACCCATAAACGTAGGATTGG
T 
TAAAACCAATCCTACGTTTATGGGTCCC 
 ACCGGGAGATGGCGGAGGCCTTCGCG AAAACGCGAAGGCCTCCGCCATCTCC 
Ap2a1 CCGGGCACCCCCGGCTCCCGTAGG AAACCCTACGGGAGCCGGGGGTGC 
 ACACCGGCCGTGTTCATCTCCGACATCG
TT 
CTAAAACGATGTCGGAGATGAACACGGCC
G 
Slc12a2 
CACCGGCCGGGTCCACGAAGTTCACGG
T 
TAAAACCGTGAACTTCGTGGACCCGGCC 
Slc12a8 ACCGGGAGGGCCTCTCGGGTACAGAG AAAACTCTGTACCCGAGAGGCCCTCC 
Slc12a9 CCGGTGGCCCCCGCTCGTGTTGAT AAACATCAACACGAGCGGGGGCCA 
TMEM59 CACCGGCTGTTGACTATGGCGCTGGCGT TAAAACGCCAGCGCCATAGTCAACAGCC 
 ACCGGGAGACACAGCGTCCTGTCACG AAAACGTGACAGGACGCTGTGTCTCC 
 CCGGTTTTATCTTCAAGCCGATGA AAACTCATCGGCTTGAAGATAAAA 
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Table S8. List of primers for Daam1 cloning 
 
Primers Sequence  
HA_Daam1_Fwd TAGTCCAGTGTGGTGGAATTATGTACCCATACGATGTTCCAGATTACGCTGC
CCCAAGAAAGAGAGGTGGACGAGGTATTTCATTCATCTTTTGCTGTTT 
HA_Daam1_Rev GGTTTAAACGGGCCCTCTAGTTAGAAATTAAGTTTTGTGATTGGTCTCTCTCT
GCTGCTGTCA 
Daam1_HA_Fwd TAGTCCAGTGTGGTGGAATTATGGCCCCAAGAAAGAGAGGTGGACG 
Daam1_HA_Rev GGTTTAAACGGGCCCTCTAGTTAAGCGTAATCTGGAACATCGTATGGGTAGA
AATTAAGTTTTGTGATTGGTCTCTCTCTGCTGCTGTCAGTCATCTGGT 
Myc_Daam1_Fwd TAGTCCAGTGTGGTGGAATTATGGAGCAAAAGCTCATTAGCGAAGAGGACT
TGGCCCCAAGAAAGAGAGGTGGACGAGGTATTTCATTCATCTTTTGCTGTTT
CCG 
Myc_Daam1_Rev GGTTTAAACGGGCCCTCTAGTTAGAAATTAAGTTTTGTGATTGGTCTCTCTCT
GCTGCTGTCAGTCA 
 
 
Table S9. List of genotyping primers  
 
Gene  Forward primer Reverse primer 
Cas9 ACCCCACCATCTACCACCTGAGAAA GGTGTTCACTCTCAGGATGTCGCTC 
Cre GCCTGCATTACCGGTCGATGCAACGA GTGGCAGATGGCGCGGCAACACCATT 
hDaam1 CTTTCTTGAGTTGGTCTGGCCTTTT AGGAAGGGCAACTTAAGATGCAGTA 
hDaam2 CTGTGTTCTCTCCTCTTGTCCAGAT GAAACTCCAAGGAGCAGAAGAGAGA 
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S2.1.5 RT-qPCR primers 
 
Table S11. List of primers for RT-qPCR 
 
 
 
 
  
Gene Forward Reverse 
hDaam1 ACCAGATTCATCGACTTGGATGG CGGCCTTGAGAGTTGTTCATTA 
hDaam2 CCTGAGGCCATTAGTACCATAGC GACTTCGGTCTAGCTCGTTCA 
mDaam1 CTCTGAGTCTCGGATACACACC GCACGGCCACCTTTGTTTT 
mDaam2 ACCACCTCTCCCCTTTGATAG AGTGGGGCTTCATTGCTGG 
Cadherin-4 CCATCAACAGCGAGACTGG TGACTGTGTACTGCTGAACTTTCTC 
Occludin  AGGAACCGAGAGCCAGGT TGAGCAATGCCCTTTAGCTT 
ZO-1 CATGAAGATGGGATTTCTTCG GCCAGCTACAAATATTCCAACA 
OR4A15 TGAAACTTGCTTGCACCAAT TGAAGAAGGTGACAGCACAAA 
OR6P1 TTTTTCCTTGGCCATCTCTC AGAGCCGAGGAATGGTGAC 
GPCR64 AGAGTAAAGATTCGACCAATGGA CAGGTCACACTGAAGCTTTCC 
Integrin 
beta-5 
GGGAGTTTGCAAAGTTTCAGAG TGTGCGTGGAGATAGGCTTT 
Junctional 
adhesion 
molecule B  
TGGCCTTGGTGTATGCTATG CTCTTCTGGAAGGAGGTTTCTTT 
Utrophin  CAGAGGTCCTGCCTGAGAAG CGCAGAACAGATTCCAGAGAC 
G subunit 
gamma-12 
GAGGAGGAGGAGGAGAGGTC TTTCAGGTTTTAAGTGGAATGAATC 
G subunit 
beta-1  
CTGGCAGGACACACAGGTT CAGAGCTGGTGACGATCTGA 
G(i) subunit 
alpha-1 
AAGTACAATTGTGAAGCAGATGAA
A 
TGGTGTTACTGTAGACCACTGCTT 
EAA 
transporter 1 
CGGACAAATTATTACAATCAGCA ATTCCAGCTGCCCCAATACT 
CD44 CAAGCAGGAAGAAGGATGGAT AACCTGTGTTTGGATTTGCAG 
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S2.1.6 Primary/Secondary Antibodies 
 
Table S12. List of antibodies 
 
 
 
 
  
Antibody Dilution Company 
Mouse anti- β-actin 1:5000 Abcam 
Mouse anti- HA Epitope 1:1000 BioLegend 
Mouse anti- p53  (7F5) 1:500 Cell Signaling 
Mouse anti- αTubulin 1:5000 Abcam 
Rabbit anti- Cadherin-4 1:1000 Abcam 
Rabbit anti- Flag 1:1000 Cell Signaling 
Rabbit anti- HA-probe Antibody 1:1000 Santa Cruz 
Rabbit anti- Occludin  1:50000 Abcam 
Rabbit anti- Vinculin 1:3000 Abcam 
Anti-mouse IgG, HRP-linked 1:5000 Cell Signaling 
Anti-rabbit IgG, HRP-linked  1:5000 Cell Signaling 
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Table S13. PCR programs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene amplification 
Pre-PCR  
98 o C 30 sec 
58 o C 30 sec 
72 o C 3 min 
x 3 cycles  
98 o C 15 sec 
60 o C 30 sec 
72 o C 60 sec/Kb 
x 27 cycles  
98 o C 15 sec 
68 o C 30 sec 
72 o C 60 sec/Kb 
Final extension  
72 o C 3 min 
4o C ∞ 
 Genotyping  
x 3 cycles  
94 o C 5 min 
58o C 1 min 
72 o C 1 min 30 sec 
x 27 cycles  
98 o C 30 sec 
68 o C 40 sec 
72 o C 50 sec 
Final extension  
72 o C 5 min 
4o C ∞ 
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Table S14. Cell medium composition 
 
Medium Reagent Final concentration 
Serum-LIF 2i medium GMEM basal medium (1x) 1x 
 FBS (GIBCO) 10% 
 L-glutamine (200nM) 1% (2nM) 
 Sodium Pyruvate (100mM) 1% (1mM) 
 MEM NEEA (100x) 1% (1x) 
 2-mercaptoethanol (50mM) 0.1% (50uM) 
 Murine LIF (1000x) 20 ng/ml 
 CHIRON 3 µM 
 PD03 1µM 
2i-LIF medium DMEM Hams F12 (1x) 0.5x 
 Neurobasal (1x) 0.5x 
 L-glutamine (200nM) 1% (2nM) 
 2-mercaptoethanol (50mM) 0.1% (50uM) 
 N2 (200x) 0.5% (1x) 
 B27 (50x) 1% (0.5x) 
 Murine LIF (1000x) 20 ng/ml 
 CHIRON 3 µM 
 PD03 1µM 
WNT-LIF medium DMEM Hams F12 (1x) 0.5x 
 Neurobasal (1x) 0.5x 
 L-glutamine (200nM) 1% (2nM) 
 2-mercaptoethanol (50mM) 0.1% (50uM) 
 N2 (200x) 0.5% (1x) 
 B27 (50x) 1% (0.5x) 
 Murine LIF (1000x) 0.1% (1x) 
 WNT-CM 100% 10% 
HEK293 medium 
DMEM High Glucose basal 
medium 
1x 
 FBS (GIBCO) 10% 
 Penicillin Streptomycin (100x) 1% (1x) 
Platinum-E cell medium 
DMEM High Glucose basal 
medium 
1x 
 FBS (GIBCO) 10% 
 Penicillin Streptomycin (100x) 1% (1x) 
 Puromycin 10mg/ml (10000x) 1x 
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 Blasticidin 10mg/ml (1000x) 1x 
T-REx™-293 cell medium DMEM High Glucose basal medium 1x 
 FBS (GIBCO) 10% 
 Penicillin Streptomycin (100x) 1% (1x) 
 Blasticidin 10mg/ml (1000x) 1x 
 
 
 
Table S15. Organoid medium composition 
 
Medium Reagent Final concentration 
DMEM +++ DMEM/F12 1x 
 L-glutamine (200mM) 20mM 
 HEPES 1M 10mM 
 Penicillin Streptomycin (100x) 1% (1x) 
ENR medium DMEM +++  
 B27 50x 2% 
 N2 100x 1% 
 EGF 100 µg/ml (2000x) 50 ng/ml 
 Noggin 100 µg/ml 100 ng/ml  
 R-spondin 1 - CM 100% 5% 
 N-Acetylcysteine 500mM (400x) 125mM 
WENR+Nic medium DMEM +++ 100% 50% 
 WNT-CM 100% 50% 
 Nicotinamide 1M (1000x) 10mM 
 B27 50x 2% 
 N2 100x 1% 
 EGF 100 µg/ml (2000x) 50 ng/ml 
 Noggin 100 µg/ml 100 ng/ml  
 R-spondin 1 - CM 100% 5% 
 N-Acetylcysteine 500mM (400x) 125mM 
Transduction medium DMEM +++ 100% 50% 
 WNT-CM 100% 50% 
 Nicotinamide 1M (1000x) 10mM 
 Polybrene 8mg/ml (1000x) 8 µg/ml 
 Y-27632 10mM (1000x) 10 µM 
EN+CHIR+Y- medium DMEM ++  
 B27 50x 2% 
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 N2 100x 1% 
 EGF 100 µg/ml (2000x) 50 ng/ml 
 Noggin 100 µg/ml 100 ng/ml 
 N-Acetylcysteine 500mM (400x) 125 mM 
 CHIRON 4 µM 
 Y-27632 (1000x) 1x 
 
 
 
Table S16. Cell lysis buffer composition (for DNA extraction) 
 
Chemical Final concentration Supplier 
NP-40 (10%) 4.5% Sigma-Aldrich Co. LLC 
Tween (20%) 2.25% Sigma-Aldrich Co. LLC 
5X Go-Taq buffer 1x Promega 
Proteinase K (20 mg/ml) 0.2 mg/ml Promega 
Distilled water   
 
 
 
 
Table S17. Cell lysis buffer composition (for protein extraction) 
 
 
 
 
Chemical Final concentration Supplier 
2-Mercaptoethanol 0,1% Sigma-Aldrich Co. LLC 
EDTA 1mM Sigma-Aldrich Co. LLC 
EGTA 1mM Sigma-Aldrich Co. LLC 
Glycerol 10% Sigma-Aldrich Co. LLC 
KCl 10mM Sigma-Aldrich Co. LLC 
NaF 50mM Sigma-Aldrich Co. LLC 
Protease inhibitor cocktail 1 tablet/5ml Roche 
TrisHcl pH 7.4 50mM Sigma-Aldrich Co. LLC 
Triton-X100 1% Sigma-Aldrich Co. LLC 
Distilled water   
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Table S18. Western Blot buffer composition 
 
Chemical Final concentration Supplier 
10x Running Buffer pH 8.3 
Glycine 1,92M Sigma-Aldrich Co. LLC 
SDS 10% Sigma-Aldrich Co. LLC 
Tris Base 0,25M Sigma-Aldrich Co. LLC 
Distilled water   
10x Wash Buffer 
Trizma base 0,2M Sigma-Aldrich Co. LLC 
NaCl 1,37M Sigma-Aldrich Co. LLC 
Tween 20 0,1% Sigma-Aldrich Co. LLC 
Distilled water   
Blocking solution 
Wash buffer 10x 1x  
Skim milk 5% Sigma-Aldrich Co. LLC 
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